About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
18F-FDG
- Company
- NYU Langone Health
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 180 recruiting
Efficacy results: Not yet reported
180 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 18, 2026
Find a Clinical Trial Near Me
See recruiting studies for 18F-FDG and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT00588185
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 300 participants Est. completion 2027-02 7 sitesOther conditions: Prostate CancerView official trial listing → -
Recruiting NCT NCT02390635
PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia
Not yet reported M.D. Anderson Cancer Center 77 participants Est. completion 2027-09-15 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Acute Promyelocytic Leukemia With PML-RARAView official trial listing → -
Recruiting NCT NCT02685969
Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation 570 participants Est. completion 2027-12-31 1 siteOther conditions: Alzheimer's DiseaseView official trial listing → -
Recruiting NCT NCT03019757
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
Douglas Scharre 76 participants Est. completion 2027-12-31 1 siteOther conditions: Alzheimer's Disease, Lewy Body Dementia, Parkinson's DiseaseView official trial listing → -
Recruiting NCT NCT03604315
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
Not yet reported M.D. Anderson Cancer Center 300 participants Est. completion 2027-06-30 1 siteOther conditions: Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Solid NeoplasmView official trial listing → -
Recruiting NCT NCT04119024
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Not yet reported Anusha Kalbasi 18 participants Est. completion 2026-10 3 sitesOther conditions: Metastatic Malignant Solid Neoplasm, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IV Cutaneous Melanoma AJCC v8, Recurrent Malignant Solid Neoplasm, Refractory Malignant Solid Neoplasm, Uveal Melanoma, Acral Melanoma, Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma, Adrenocortical Carcinoma, Pancreatic Neuroendocrine Tumor, Thyroid Cancer, Breast Cancer, Lung Adenocarcinoma, Head and Neck Squamous Cell CarcinomaView official trial listing → -
Recruiting NCT NCT04281641
Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer
Not yet reported Fudan University 94 participants Est. completion 2030-04-30 1 siteOther conditions: HER2-positive Breast CancerView official trial listing → -
Recruiting NCT NCT04293562
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Not yet reported Children's Oncology Group 1400 participants Est. completion 2029-06-30 206 sitesOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Recruiting NCT NCT04333537
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Not yet reported, Not yet reported NRG Oncology 686 participants Est. completion 2036-04-27 107 sitesObstructive sleep apnea Other conditions: Floor of Mouth Squamous Cell Carcinoma, Gingival Squamous Cell Carcinoma, Hard Palate Squamous Cell Carcinoma, Lip Squamous Cell Carcinoma, Lower Alveolar Ridge Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Retromolar Trigone Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8, Tongue Squamous Cell Carcinoma, Upper Alveolar Ridge Squamous Cell CarcinomaView official trial listing → -
Recruiting NCT NCT04349358
FCH vs FDG PET/CT in Detection of Lesions in Patients With Multiple Myeloma (MIM)
Not yet reported Centre Georges Francois Leclerc 38 participants Est. completion 2030-12-15 3 sitesOther conditions: Multiple MyelomaView official trial listing → -
Recruiting NCT NCT04362644
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Not yet reported University of Alabama at Birmingham 10 participants Est. completion 2027-06 1 siteOther conditions: Idiopathic Pulmonary FibrosisView official trial listing → -
Recruiting NCT NCT04416165
Comparison of FDG and FAPI in Patients With Various Types of Cancer
Not yet reported The First Affiliated Hospital of Xiamen University 3000 participants Est. completion 2027-12-30 1 site Stand-aloneOther conditions: Tumor, Solid, Positron-Emission Tomography, MetastasisView official trial listing → -
Recruiting NCT NCT04569591
DDAVP for Pituitary Adenoma
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 22 participants Est. completion 2028-02-26 1 siteOther conditions: Cushing's Disease, Pituitary AdenomaView official trial listing → -
Recruiting NCT NCT04665739
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
Not yet reported National Cancer Institute (NCI) 70 participants Est. completion 2032-09-01 29 sitesOther conditions: Advanced Lung Neuroendocrine Tumor, Functioning Lung Neuroendocrine Tumor, Locally Advanced Lung Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm, Lung Neuroendocrine Tumor G1, Lung Neuroendocrine Tumor G2, Metastatic Lung Neuroendocrine Neoplasm, Metastatic Lung Neuroendocrine Tumor, Non-Functioning Lung Neuroendocrine Tumor, Recurrent Lung Neuroendocrine Neoplasm, Unresectable Lung Neuroendocrine Neoplasm, Unresectable Lung Neuroendocrine TumorView official trial listing → -
Recruiting NCT NCT04702022
Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients
Not yet reported University of Liege 50 participants Est. completion 2027-01-01 1 siteOther conditions: Kidney Transplant Rejection, Kidney Transplant; ComplicationsView official trial listing → -
Recruiting NCT NCT04724928
Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer
Not yet reported University Hospital, Ghent 156 participants Est. completion 2030-05 1 site Stand-aloneOther conditions: Muscle-Invasive Bladder CarcinomaView official trial listing → -
Recruiting NCT NCT04737317
Diagnostic Criteria in Cardiac Sarcoidosis
Heart Center Leipzig - University Hospital 100 participants Est. completion 2027-01-01 1 siteOther conditions: Cardiac SarcoidosisView official trial listing → -
Recruiting NCT NCT04780568
Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer
Not yet reported Ohio State University Comprehensive Cancer Center 25 participants Est. completion 2029-07-31 1 site Stand-aloneOther conditions: Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8View official trial listing → -
Recruiting NCT NCT04813705
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
Not yet reported Taizhou Hospital 93 participants Est. completion 2029-06-30 4 sitesOther conditions: Nasopharyngeal CarcinomaView official trial listing → -
Recruiting NCT NCT04901884
PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation
Not yet reported University Health Network, Toronto 40 participants Est. completion 2027-09-01 1 site Stand-aloneOther conditions: Pulmonary HypertensionView official trial listing → -
Recruiting NCT NCT04938362
Cognitive Function and Fatigue After Brain Abscess
University of Oslo 50 participants Est. completion 2030-12-31 1 siteOther conditions: Brain Abscess, Fatigue, Cognitive DysfunctionView official trial listing → -
Recruiting NCT NCT04965454
Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma
Not yet reported Queen's Medical Center 80 participants Est. completion 2028-06-30 1 siteOther conditions: Hepatocellular Carcinoma Non-resectableView official trial listing → -
Recruiting NCT NCT05034146
68Ga-FAPI PET/CT in Malignant Tumors
Not yet reported Zhongnan Hospital 500 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Fibroblast Activation Protein Inhibitor, PET/CT, Malignant NeoplasmView official trial listing → -
Recruiting NCT NCT05121012
Synaptic Loss in Multiple System Atrophy
University of Exeter 36 participants Est. completion 2027-03-31 1 siteOther conditions: Multiple System Atrophy, Progressive Supranuclear Palsy (PSP)View official trial listing → -
Recruiting NCT NCT05121779
Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT
Not yet reported Peking Union Medical College Hospital 80 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Pulmonary FibrosisView official trial listing → -
Recruiting NCT NCT05140746
Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer
Not yet reported Ruijin Hospital 40 participants Est. completion 2027-09-10 1 site Stand-aloneOther conditions: Gastric CancerView official trial listing → -
Recruiting NCT NCT05160480
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
University of California, Davis 9 participants Est. completion 2027-09-01 1 siteOther conditions: Prostate Cancer, Breast Cancer, Neuroendocrine TumorsView official trial listing → -
Recruiting NCT NCT05191940
Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial)
Not yet reported EBG MedAustron GmbH 30 participants Est. completion 2028-12 1 siteOther conditions: Pancreas CancerView official trial listing → -
Recruiting NCT NCT05192655
Artificial Intelligence in Functional Imaging for Individualized Treatment of Head and Neck Squamous Cell Carcinoma Patients
Charite University, Berlin, Germany 250 participants Est. completion 2026-12-01 1 siteOther conditions: HNSCCView official trial listing → -
Recruiting NCT NCT05255926
CXCR4-targeted PET/CT Imaging in Hematological Malignancies
Not yet reported Zhongnan Hospital 300 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: CXCR4, PET/CT, Hematological MalignancyView official trial listing → -
Recruiting NCT NCT05308888
Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Positron Emission Tomography on Exploratory Cohort
Not yet reported University Hospital, Brest 100 participants Est. completion 2028-11-23 1 site Stand-aloneOther conditions: Aortic Valve StenosisView official trial listing → -
Recruiting NCT NCT05321316
Nectin-4 Specific LMW PET Probe Imaging in Multiple Solid Tumors
Not yet reported Peking University Cancer Hospital & Institute 40 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Urothelial Carcinoma, Breast Cancer, Lung Cancer, Pancreatic Cancer, Gastrointestinal Cancers, Ovarian CancerView official trial listing → -
Recruiting NCT NCT05387603
Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.
Not yet reported Lund University Hospital 300 participants Est. completion 2026-10-01 4 sites Stand-aloneOther conditions: Neuroendocrine TumorsView official trial listing → -
Recruiting NCT NCT05436093
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Not yet reported Peking University Cancer Hospital & Institute 50 participants Est. completion 2027-12 1 site Stand-aloneOther conditions: Solid TumorView official trial listing → -
Recruiting NCT NCT05463913
Lung Nodule Detection Using Ultra-long FOV PET/CT
Not yet reported University Medical Center Groningen 20 participants Est. completion 2025-06-01 1 siteOther conditions: Lung CancerView official trial listing → -
Recruiting NCT NCT05501665
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
Not yet reported, Not yet reported Vanderbilt-Ingram Cancer Center 25 participants Est. completion 2027-02-01 1 siteOther conditions: Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage III Lung CancerView official trial listing → -
Recruiting NCT NCT05541744
The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer
Buddhist Tzu Chi General Hospital 120 participants Est. completion 2028-07-31 1 siteOther conditions: Lung CancerView official trial listing → -
Recruiting NCT NCT05549024
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
Not yet reported Peking Union Medical College Hospital 90 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Breast Cancer, Prostate Cancer, Brain Tumor, PET/CT ImagingView official trial listing → -
Recruiting NCT NCT05553899
Utility of PET-MRI in Surveillance of Paediatric Brain Tumours
Not yet reported Sheffield Children's NHS Foundation Trust 5 participants Est. completion 2027-06 1 site Stand-aloneOther conditions: Brain Tumor, PediatricView official trial listing → -
Recruiting NCT NCT05577598
Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Compulsive Disorder
Not yet reported Medical University of Vienna 8 participants Est. completion 2026-09-01 1 siteOther conditions: Obsessive-Compulsive Disorder, Psychiatric DisorderView official trial listing → -
Recruiting NCT NCT05614310
Detecting Early Alzheimer's Using MR
University of Aberdeen 60 participants Est. completion 2025-12-31 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Recruiting NCT NCT05641753
Cholesterol Lowering and Residual Risk in Diabetes, Type 1
Not yet reported NYU Langone Health 125 participants Est. completion 2027-07-31 4 sites Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Recruiting NCT NCT05654675
Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET
Academisch Ziekenhuis Maastricht 30 participants Est. completion 2025-06-01 1 siteOther conditions: Lung Cancer, LymphomaView official trial listing → -
Recruiting NCT NCT05675410
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Not yet reported National Cancer Institute (NCI) 1875 participants Est. completion 2031-04-28 419 sitesOther conditions: Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8View official trial listing → -
Recruiting NCT NCT05688592
Usefulness of PET-CT for Invasive Fungal Infection
Puerta de Hierro University Hospital 224 participants Est. completion 2024-12-01 14 sitesOther conditions: Invasive Fungal InfectionsView official trial listing → -
Recruiting NCT NCT05693363
Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study
Not yet reported University Hospital, Ghent 40 participants Est. completion 2025-07-31 1 site Stand-aloneOther conditions: Lung Neoplasms, PET-CT Specimen ImagerView official trial listing → -
Recruiting NCT NCT05730608
18F-FDG PET/CT Imaging for Breast Cancer
Not yet reported Vestre Viken Hospital Trust 300 participants Est. completion 2032-12-31 1 siteOther conditions: Breast Cancer Female, Breast Cancer RecurrentView official trial listing → -
Recruiting NCT NCT05747625
(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma
Not yet reported Eben Rosenthal 60 participants Est. completion 2030-03-01 1 siteOther conditions: Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and NeckView official trial listing → -
Recruiting NCT NCT05749887
The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer.
Not yet reported Chongqing University Cancer Hospital 188 participants Est. completion 2032-12-31 1 siteOther conditions: Cervical CancerView official trial listing → -
Recruiting NCT NCT05775939
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Not yet reported Thomas Jefferson University 20 participants Est. completion 2028-07-01 1 siteOther conditions: Lung Carcinoma, Esophageal CarcinomaView official trial listing → -
Recruiting NCT NCT05806697
Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study
Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 240 participants Est. completion 2030-10-09 1 siteOther conditions: Alzheimer Disease, Memory Complaint, Memory DisordersView official trial listing → -
Recruiting NCT NCT05835570
Integrin αvβ6-targeted PET in Malignant Tumors
Zhongnan Hospital 200 participants Est. completion 2025-12-30 1 siteOther conditions: Malignant Neoplasm, PET/CT, Non-Small Cell Lung Cancer, Breast Cancer, MetastaticView official trial listing → -
Recruiting NCT NCT05873777
68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG
Not yet reported The First Affiliated Hospital of Xiamen University 30 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: SSTR2, FAP, Positron-Emission TomographyView official trial listing → -
Recruiting NCT NCT05886036
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
Not yet reported National Cancer Institute (NCI) 70 participants Est. completion 2028-10-31 37 sitesOther conditions: Nodular Lymphocyte Predominant B-Cell Lymphoma, Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma, Refractory Nodular Lymphocyte Predominant B-Cell LymphomaView official trial listing → -
Recruiting NCT NCT05892393
Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
Not yet reported Robert Flavell, MD, PhD 20 participants Est. completion 2027-03-01 1 siteOther conditions: Multiple Myeloma, Plasma Cell MyelomaView official trial listing → -
Recruiting NCT NCT05916196
[18F]FES PET/.CT in Uterine Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 30 participants Est. completion 2028-08-01 1 siteOther conditions: Uterine CancerView official trial listing → -
Recruiting NCT NCT05935150
Omission of SLNB in CN0 Early Breast Cancer
Not yet reported The First Affiliated Hospital with Nanjing Medical University 311 participants Est. completion 2027-10-01 1 siteOther conditions: Breast Cancer, Clinically Assessed Negative Axillary Lymph Nodes, Sentinel Lymph NodeView official trial listing → -
Recruiting NCT NCT06014515
Single-tracer Multiparametric PET Imaging
Not yet reported University of California, Davis 60 participants Est. completion 2033-08 1 site Stand-aloneCardiovascular disease Other conditions: Healthy SubjectsView official trial listing → -
Recruiting NCT NCT06059469
PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.
Not yet reported Jules Bordet Institute 20 participants Est. completion 2025-12 1 site Stand-aloneOther conditions: TNBC - Triple-Negative Breast CancerView official trial listing → -
Recruiting NCT NCT06072807
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
Not yet reported Weill Medical College of Cornell University 20 participants Est. completion 2027-12 1 siteOther conditions: Breast Cancer, Brain MetastasesView official trial listing → -
Recruiting NCT NCT06076538
PET/MR for Characterization of Renal Masses (RMs)
University of Texas Southwestern Medical Center 97 participants Est. completion 2028-06-01 2 sitesOther conditions: Renal Tumor, Renal Cell Carcinoma, Renal Tumor, BenignView official trial listing → -
Recruiting NCT NCT06082492
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
Not yet reported Radboud University Medical Center 690 participants Est. completion 2029-06 27 sitesOther conditions: Stage III Non-small Cell Lung CancerView official trial listing → -
Recruiting NCT NCT06092125
Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
Xuanwu Hospital, Beijing 2300 participants Est. completion 2028-10-31 1 siteOther conditions: Alzheimer Disease, Parkinson Disease, Epilepsy, Malignant Brain TumorView official trial listing → -
Recruiting NCT NCT06103838
18F-Fluciclovine PET/CT in Multiple Myeloma
Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2032-12-06 1 site Stand-aloneOther conditions: Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM)View official trial listing → -
Recruiting NCT NCT06104085
99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer
Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06145633
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
Not yet reported Fred Hutchinson Cancer Center 15 participants Est. completion 2027-12-30 1 siteOther conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8View official trial listing → -
Recruiting NCT NCT06171659
FDG PET/MR Imaging of Peripheral Pain Generators
University of Wisconsin, Madison 128 participants Est. completion 2028-06 1 siteOther conditions: Pain, Nociceptive PainView official trial listing → -
Recruiting NCT NCT06179303
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
Not yet reported University of Washington 60 participants Est. completion 2028-06-01 3 sitesOther conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Unresectable HER2-Negative Breast Carcinoma, Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast CarcinomaView official trial listing → -
Recruiting NCT NCT06189898
Functional Imaging to Identify Radiosensitive Esophageal Cancer - a Biomarker Validation Study
Sebastian Zschaeck 48 participants Est. completion 2029-01-31 1 siteOther conditions: Esophagus CancerView official trial listing → -
Recruiting NCT NCT06224309
Preliminary Assessment of [18F]BL40 in PET/CT Scans
British Columbia Cancer Agency 30 participants Est. completion 2027-09-15 1 siteOther conditions: Diffuse Large B-cell Lymphoma, Multiple Myeloma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, Waldenström MacroglobulinemiaView official trial listing → -
Recruiting NCT NCT06225505
Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)
Not yet reported Institut Curie 450 participants Est. completion 2031-08-03 13 sites Stand-aloneOther conditions: Triple Negative Breast CancerView official trial listing → -
Recruiting NCT NCT06232122
Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer
Not yet reported Chang Gung Memorial Hospital 45 participants Est. completion 2028-07-31 1 site Stand-aloneOther conditions: Ovarian CancerView official trial listing → -
Recruiting NCT NCT06232889
Deuterium Metabolic MRI and [18F]FDG PET for Assessment of Treatment Response Following Radioembolization
Not yet reported UMC Utrecht 15 participants Est. completion 2027-01-01 1 siteOther conditions: Fluorodeoxyglucose F18, Phosphoric Monoester Hydrolases, Phosphoric Diester HydrolasesView official trial listing → -
Recruiting NCT NCT06236048
Energetics and Glutamate in Schizophrenia
King's College London 75 participants Est. completion 2028-12-01 1 siteOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT06242119
Clinical Application of the J-PET Scanner Prototype
Jagiellonian University 25 participants Est. completion 2025-10-30 1 siteOther conditions: Prostate Cancer, Prostatic Hyperplasia, Prostatic Neoplasms, Prostate Cancer Metastatic, Neuroendocrine Tumors, Neuroendocrine CarcinomaView official trial listing → -
Recruiting NCT NCT06297902
RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3
Not yet reported Oslo University Hospital 100 participants Est. completion 2030-06 3 sitesOther conditions: Head and Neck Cancer, Radiotherapy Side EffectView official trial listing → -
Recruiting NCT NCT06335069
18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
Not yet reported Maastricht University Medical Center 20 participants Est. completion 2027-03 1 siteOther conditions: Breast Cancer, Breast Neoplasms, Breast DiseasesView official trial listing → -
Recruiting NCT NCT06335888
A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis
Not yet reported Insel Gruppe AG, University Hospital Bern 70 participants Est. completion 2029-05 1 siteOther conditions: Giant Cell ArteritisView official trial listing → -
Recruiting NCT NCT06335914
Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer
Not yet reported University Health Network, Toronto 30 participants Est. completion 2029-09-04 1 siteOther conditions: Advanced Prostate CancerView official trial listing → -
Recruiting NCT NCT06349512
68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)
Not yet reported Institut Curie 60 participants Est. completion 2032-11-30 6 sites Stand-aloneOther conditions: Triple Negative Breast CancerView official trial listing → -
Recruiting NCT NCT06369831
HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011
Not yet reported Abscint NV/SA 60 participants Est. completion 2026-12-31 7 sites Stand-aloneOther conditions: Metastatic Breast Cancer, Metastatic Solid CancerView official trial listing → -
Recruiting NCT NCT06383520
Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100 participants Est. completion 2025-12 1 site Stand-aloneOther conditions: Malignant Neoplasm of LiverView official trial listing → -
Recruiting NCT NCT06385652
PET Imaging Study of 68Ga-NB381 in Multiple Myeloma
Not yet reported Peking University First Hospital 30 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Multiple MyelomaView official trial listing → -
Recruiting NCT NCT06421142
FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer
Not yet reported First Affiliated Hospital of Fujian Medical University 80 participants Est. completion 2029-06-01 1 site Stand-aloneOther conditions: Urinary Bladder NeoplasmsView official trial listing → -
Recruiting NCT NCT06429891
Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization
Not yet reported Hua Zhu 50 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Solid TumorView official trial listing → -
Recruiting NCT NCT06450548
Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA
Not yet reported Centre Henri Becquerel 60 participants Est. completion 2028-03-05 1 site Stand-aloneOther conditions: Prostate Cancer MetastaticView official trial listing → -
Recruiting NCT NCT06453915
NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease
Not yet reported University of California, Davis 12 participants Est. completion 2027-07 1 site Stand-aloneOther conditions: Positron Emission TomographyView official trial listing → -
Recruiting NCT NCT06490757
A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas
Not yet reported Assistance Publique - Hôpitaux de Paris 25 participants Est. completion 2028-09-02 1 siteOther conditions: Inflammatory Hepatocellular AdenomaView official trial listing → -
Recruiting NCT NCT06502691
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer
Not yet reported, Not yet reported University of Washington 22 participants Est. completion 2031-12-31 1 siteOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast CarcinomaView official trial listing → -
Recruiting NCT NCT06503146
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Not yet reported National Cancer Institute (NCI) 320 participants Est. completion 2030-06-01 1 site Stand-aloneOther conditions: Sarcoma, Small Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC), Mesothelioma, Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Ductal Adenocarcinoma, Ovarian Cancer, Hepatocellular Carcinoma, Gastric Cancer, Cholangiocarcinoma, Bladder CancerView official trial listing → -
Recruiting NCT NCT06519760
68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
Not yet reported Peking University First Hospital 200 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Carbonic Anhydrase IX, PET-CT, Clear Cell Renal Cell CarcinomaView official trial listing → -
Recruiting NCT NCT06563479
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 291 participants Est. completion 2027-08 9 sitesOther conditions: HPV-Related Squamous Cell CarcinomaView official trial listing → -
Recruiting NCT NCT06565936
DPA-714 and FDG PET/MRI in Depression
Not yet reported The First Affiliated Hospital of Dalian Medical University 70 participants Est. completion 2026-12 1 siteOther conditions: DepressionView official trial listing → -
Recruiting NCT NCT06597526
The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
Ruijin Hospital 30 participants Est. completion 2029-05-31 1 siteOther conditions: Peritoneal Metastasis, Gastric CancerView official trial listing → -
Recruiting NCT NCT06601075
The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)
Ruijin Hospital 30 participants Est. completion 2029-03-31 1 siteOther conditions: Advanced Colorectal CancerView official trial listing → -
Recruiting NCT NCT06613269
68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.
Not yet reported Peking Union Medical College Hospital 40 participants Est. completion 2028-09 1 site Stand-aloneOther conditions: Clear Cell Renal Cell CarcinomaView official trial listing → -
Recruiting NCT NCT06613841
Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
Not yet reported Abramson Cancer Center at Penn Medicine 15 participants Est. completion 2027-12-31 2 sites Stand-aloneOther conditions: Glioblastoma, Recurrent Glioblastoma, Glioblastoma Multiforme of BrainView official trial listing → -
Recruiting NCT NCT06629207
Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
Not yet reported Insel Gruppe AG, University Hospital Bern 20 participants Est. completion 2026-08-01 1 site Stand-aloneOther conditions: Parkinson Disease, REM Sleep Behavior Disorder, Dementia, Lewy BodyView official trial listing → -
Recruiting NCT NCT06644716
[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin
Not yet reported Erasmus Medical Center 50 participants Est. completion 2027-03 6 sitesOther conditions: Cancer of Unknown PrimaryView official trial listing → -
Recruiting NCT NCT06646952
CD147 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Hua Zhu 30 participants Est. completion 2026-12 1 siteOther conditions: Solid TumorView official trial listing → -
Recruiting NCT NCT06648317
Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
Peking University Cancer Hospital & Institute 20 participants Est. completion 2025-12-01 1 siteOther conditions: Lung Cancer, Non-Small Cell, Lung InfectionView official trial listing → -
Recruiting NCT NCT06653452
Application of PET/MRI in the Evaluation of the Efficacy of Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2026-12-01 1 site Stand-aloneOther conditions: Locally Advanced Rectal Cancer (LARC)View official trial listing → -
Recruiting NCT NCT06706921
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
Not yet reported VA Greater Los Angeles Healthcare System 15 participants Est. completion 2027-11-01 1 siteOther conditions: Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Metastatic Prostate Cancer, Male Urogenital Diseases, Prostatic Diseases, Urogenital Diseases, Male, Genital Diseases, Male, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Genital Neoplasms, MaleView official trial listing → -
Recruiting NCT NCT06708910
AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI
Heinrich-Heine University, Duesseldorf 460 participants Est. completion 2031-07 1 siteOther conditions: HER2 Positive Breast CarcinomaView official trial listing → -
Recruiting NCT NCT06709690
A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases
Ruijin Hospital 35 participants Est. completion 2025-12-31 1 siteOther conditions: Paediatric PatientsView official trial listing → -
Recruiting NCT NCT06712862
A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR
Shanghai East Hospital 100 participants Est. completion 2026-12-31 1 siteOther conditions: Ischemic Heart DiseaseView official trial listing → -
Recruiting NCT NCT06715020
Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging
Not yet reported Peking University Cancer Hospital & Institute 60 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06717113
A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma
Not yet reported Peking University First Hospital 50 participants Est. completion 2028-12 2 sitesOther conditions: Multiple Myeloma and Malignant Plasma Cell NeoplasmsView official trial listing → -
Recruiting NCT NCT06719856
MMP14(MT1-MMP) Targeting Bicyclic Peptide Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute 30 participants Est. completion 2026-12-31 1 siteOther conditions: Solid TumorView official trial listing → -
Recruiting NCT NCT06739473
Total-body Glucose Utilization in Obesity
Not yet reported Turku University Hospital 60 participants Est. completion 2024-12 1 siteOther conditions: Obesity and OverweightView official trial listing → -
Recruiting NCT NCT06740240
68Ga-FAPI-Biotin PET/CT in Patients With Various Types of Cancer
Not yet reported First Affiliated Hospital of Fujian Medical University 30 participants Est. completion 2026-12-31 1 siteOther conditions: TumorView official trial listing → -
Recruiting NCT NCT06769893
A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therapeutic Evaluation, and Restaging of Renal Cell Carcinoma, and Comparing It with 68Ga-PSMA PET/CT Imaging
Not yet reported Xijing Hospital 60 participants Est. completion 2025-11-07 1 site Stand-aloneOther conditions: RCC, Renal Cell CancerView official trial listing → -
Recruiting NCT NCT06770478
A Study to Evaluate the Diagnostic Efficacy of 68Ga- MY6349 PET/CT in Patients With Tumours
Not yet reported Xijing Hospital 40 participants Est. completion 2027-07-31 1 site Stand-aloneOther conditions: Tumour of Epithelial Origin, 68Ga-MY6349View official trial listing → -
Recruiting NCT NCT06782412
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
Not yet reported, Not yet reported KU Leuven 109 participants Est. completion 2027-12 3 sitesOther conditions: Oesophageal Cancer, Gastric Cancer, Pancreatic Ductal Adenocarcinoma, FAP, Oncology, Oncologic DisordersView official trial listing → -
Recruiting NCT NCT06790264
Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer
Not yet reported European Institute of Oncology 92 participants Est. completion 2025-11 1 siteOther conditions: Breast Cancer Invasive, Node Positive Breast CancerView official trial listing → -
Recruiting NCT NCT06791226
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
Not yet reported Peking University Third Hospital 50 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: Orbital NeoplasmsView official trial listing → -
Recruiting NCT NCT06794372
[68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas
Not yet reported John O. Prior 20 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Head and Neck Squamous Cell Carcinoma HNSCCView official trial listing → -
Recruiting NCT NCT06795113
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
Ruijin Hospital 4000 participants Est. completion 2029-12-31 1 siteOther conditions: LymphomaView official trial listing → -
Recruiting NCT NCT06814587
Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy
University of Texas Southwestern Medical Center 15 participants Est. completion 2027-06-30 1 siteCardiovascular disease Other conditions: Coronary Artery Bypass Graft (CABG)View official trial listing → -
Recruiting NCT NCT06815029
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Not yet reported City of Hope Medical Center 27 participants Est. completion 2030-10-11 1 siteOther conditions: Recurrent Astrocytoma, IDH-Mutant, Grade 3, Recurrent Astrocytoma, IDH-Mutant, Grade 4, Recurrent GlioblastomaView official trial listing → -
Recruiting NCT NCT06835426
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
Not yet reported Algemeen Ziekenhuis Maria Middelares 150 participants Est. completion 2027-06-30 1 site Stand-aloneOther conditions: Breast Carcinoma, Prostate Cancer Surgery, Thyroid Cancer, Parathyroid Adenomas, Skin Cancer, Genitourinary Cancer, Head and Neck Cancer, Hepatobiliary Cancers, Metabolic Abnormality, Neuro Endocrine Tumours, Brain Tumours, Gastro Intestinal Cancer, Thoracoscopic SurgeryView official trial listing → -
Recruiting NCT NCT06842615
Prospective Evaluation of Diagnostic Performance of PanTum Detect Test in Adult Patients With Suspected or Confirmed Macroscopic Solid Pre-malignant or Malignant Lesion(s) Referred to Fludeoxyglucose (18F) PET/CT and in Adult Healthy Population
Not yet reported Comenius University 134 participants Est. completion 2028-03-31 1 siteOther conditions: Pre-malignant, MalignantView official trial listing → -
Recruiting NCT NCT06843629
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100 participants Est. completion 2028-06-30 1 siteOther conditions: Ovarian Cancer, Lung Adenocarcinoma, Pancreatic CancerView official trial listing → -
Recruiting NCT NCT06911697
Study on c-Met Targeted PET/CT Imaging in NSCLC
Not yet reported Xilin Sun 88 participants Est. completion 2025-06-28 1 site Stand-aloneOther conditions: PET/CT Imaging, NSCLCView official trial listing → -
Recruiting NCT NCT06914999
PET/CT Assessment of Radiation-Induced Vascular Complications in Head and Neck Cancer
Not yet reported Emory University 20 participants Est. completion 2028-08-31 1 siteOther conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma, Stage III Hypopharyngeal Carcinoma AJCC v8, Stage III Laryngeal Cancer AJCC v8, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVA Hypopharyngeal Carcinoma AJCC v8, Stage IVA Laryngeal Cancer AJCC v8, Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVB Hypopharyngeal Carcinoma AJCC v8, Stage IVB Laryngeal Cancer AJCC v8, Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8View official trial listing → -
Recruiting NCT NCT06915454
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Not yet reported Vanderbilt-Ingram Cancer Center 50 participants Est. completion 2027-07 1 site Stand-aloneOther conditions: Cancer, Solid Malignant Tumors, SCC - Squamous Cell Carcinoma, HNSCC, HNSCC,Larynx, Pharynx and Oral CavityView official trial listing → -
Recruiting NCT NCT06956391
Ultralow Dose PET Imaging of 18F-FDG Uptake
Not yet reported Akiva Mintz 200 participants Est. completion 2030-06-30 1 site Stand-aloneOther conditions: Healthy Volunteer, CancerView official trial listing → -
Recruiting NCT NCT06962163
Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients
Not yet reported Institut Cancerologie de l'Ouest 12 participants Est. completion 2030-06 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT06984861
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 74 participants Est. completion 2028-05 7 sitesOther conditions: Oropharyngeal CarcinomaView official trial listing → -
Recruiting NCT NCT07004673
18F FDG and 68Ga FAPI PET/MR Imaging of Carotid Artery Plaque Vulnerability: A Clinical Study in Carotid Artery Plaque Patients
Ruijin Hospital 100 participants Est. completion 2026-12-31 1 siteCardiovascular disease Other conditions: Carotid Artery Plaque, PET / MRView official trial listing → -
Recruiting NCT NCT07046455
Trop-2 Targeted PET Probes in Advanced TNBC
Not yet reported Peking University Cancer Hospital & Institute 20 participants Est. completion 2027-09-01 1 site Stand-aloneOther conditions: TNBC - Triple-Negative Breast CancerView official trial listing → -
Recruiting NCT NCT07046702
68Ga-MY6349 PET/CT in Solid Tumors
The First Affiliated Hospital of Xiamen University 300 participants Est. completion 2026-12-31 1 siteOther conditions: Solid Tumor, Trop2, PET/CTView official trial listing → -
Recruiting NCT NCT07048405
Intermittent Cold Exposure and Brown Adipose Tissue Hyperplasia
Not yet reported University of Edinburgh 12 participants Est. completion 2027-07 1 site Stand-aloneOther conditions: Brown Adipose Tissue, Cold Exposure, 18F-FDG PET/CTView official trial listing → -
Recruiting NCT NCT07067905
Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
Not yet reported Chinese PLA General Hospital 15 participants Est. completion 2026-06-01 1 site Stand-aloneOther conditions: Clear Cell Renal Cell Carcinoma and GlioblastomaView official trial listing → -
Recruiting NCT NCT07089641
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
Not yet reported Jonsson Comprehensive Cancer Center 50 participants Est. completion 2028-07-30 2 sitesObstructive sleep apnea Other conditions: Glioblastoma, Glioblastoma, IDH-Wildtype, Recurrent Glioblastoma, IDH-Wildtype, Resectable GlioblastomaView official trial listing → -
Recruiting NCT NCT07097363
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
Not yet reported University of Washington 18 participants Est. completion 2030-05-31 1 siteOther conditions: B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma, Not Otherwise Specified, Primary Mediastinal Large B-Cell Lymphoma, T-Cell/Histiocyte-Rich Large B-Cell Lymphoma, Transformed B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma to Diffuse Large B-CeView official trial listing → -
Recruiting NCT NCT07104058
A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD
Not yet reported Luo Yaping 46 participants Est. completion 2027-12-01 1 siteOther conditions: IgG4-Related DiseasesView official trial listing → -
Recruiting NCT NCT07138716
Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC
Not yet reported Luo Yaping 30 participants Est. completion 2028-12-01 1 siteOther conditions: Medullary Thyroid CarcinomaView official trial listing → -
Recruiting NCT NCT07144085
Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.
Not yet reported Yi Tian 30 participants Est. completion 2027-07-30 1 site Stand-aloneOther conditions: Tumor, Metastatic CancerView official trial listing → -
Recruiting NCT NCT07147309
Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy
Weibing Miao, PhD 60 participants Est. completion 2029-09-01 1 siteOther conditions: Epilepsy, PET / MR, Synaptic Vesicle Proteins, Microglial Activation, FDG PETView official trial listing → -
Recruiting NCT NCT07178587
Evaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero-pancreatic Tumors
Not yet reported Nantes University Hospital 28 participants Est. completion 2027-03 3 sitesOther conditions: Hepatocellular Carcinoma (HCC), Gastro-Entero-Pancreatic Tumors (GEPs)View official trial listing → -
Recruiting NCT NCT07215182
[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
Not yet reported Barbara Malene Fischer 20 participants Est. completion 2027-02-20 2 sitesOther conditions: Malignant Melanoma Stage IVView official trial listing → -
Recruiting NCT NCT07235709
Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study
Yonsei University 25 participants Est. completion 2029-11 1 siteOther conditions: Fabry DiseaseView official trial listing → -
Recruiting NCT NCT07245849
Pericardial Imaging Study
Not yet reported Ottawa Heart Institute Research Corporation 44 participants Est. completion 2027-07 1 site Stand-aloneOther conditions: PericarditisView official trial listing → -
Recruiting NCT NCT07278856
Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
Not yet reported City of Hope Medical Center 20 participants Est. completion 2027-12-10 1 siteOther conditions: Follicular Helper T-Cell Lymphoma, Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type, Follicular Helper T-Cell Lymphoma, Follicular-Type, Follicular Helper T-Cell Lymphoma, Not Otherwise Specified, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedView official trial listing → -
Recruiting NCT NCT07301801
Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10 participants Est. completion 2026-09-30 1 site Stand-aloneOther conditions: Malignant Tumors, SSTR2, PETView official trial listing → -
Recruiting NCT NCT07301827
Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 66 participants Est. completion 2026-05-31 1 siteOther conditions: Renal Cell CarcinomaView official trial listing → -
Recruiting NCT NCT07337850
Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers
Tata Memorial Centre 60 participants Est. completion 2026-03 1 siteOther conditions: Gall Bladder Cancer, Intrahepatic Cholangiocarcinoma (Icc)View official trial listing → -
Recruiting NCT NCT07443696
PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy
Not yet reported Sinotau Pharmaceutical Group 40 participants Est. completion 2026-12-31 3 sitesHeart failure Other conditions: Ischemic CardiomyopathyView official trial listing → -
Recruiting NCT NCT07448727
Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT
University of Rome Tor Vergata 25 participants Est. completion 2027-12 1 siteOther conditions: Head & Neck Cancer, Head & Neck Squamous Cell CarcinomaView official trial listing → -
Recruiting NCT NCT07458906
DLL3-Targeted PET/CT in Neuroendocrine Carcinoma
Not yet reported The First Affiliated Hospital of Xiamen University 80 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: DLL3-expressing Tumors, PET / CT, Neuroendocrine CancerView official trial listing → -
Recruiting NCT NCT07463300
A Hierarchical Multi-modal AI Framework for Pathological and Genetic Subtyping of Lung Cancer Based on PET/CT Imaging
Second Affiliated Hospital, Zhejiang University, School of Medicine 5500 participants Est. completion 2027-08-01 9 sitesOther conditions: Lung CancerView official trial listing → -
Recruiting NCT NCT07463807
Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment
Not yet reported, Not yet reported National Cancer Institute (NCI) 162 participants Est. completion 2029-03-31 1 siteOther conditions: Recurrent Multiple Myeloma, Refractory Multiple MyelomaView official trial listing → -
Recruiting NCT NCT07471776
Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer
Not yet reported Fudan University 45 participants Est. completion 2029-03-11 2 sitesOther conditions: Metastatic Breast Cancer ( HER2 Negative)View official trial listing → -
Recruiting NCT NCT07479095
Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma
Not yet reported Fondazione del Piemonte per l'Oncologia 30 participants Est. completion 2027-03-30 1 siteOther conditions: Lepidic-Predominant Lung Adenocarcinoma, Lung AdenocarcinomaView official trial listing → -
Recruiting NCT NCT07482072
Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study
Copenhagen University Hospital, Rigshospitalet 60 participants Est. completion 2026-12 1 siteOther conditions: Alzheimer Dementia (AD), Diabete Type 2View official trial listing → -
Recruiting NCT NCT07487883
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
Peking University People's Hospital 80 participants Est. completion 2027-07-30 1 siteOther conditions: Non-Small Cell Lung Cancer, Malignant Neoplasm, Pulmonary Nodules, PET/CTView official trial listing → -
Recruiting NCT NCT07494162
Imaging Metabolic and Perfusion Changes in Acupuncture Therapy for Myofascial Pain Syndrome
Not yet reported University of California, Davis 64 participants Est. completion 2030-04 1 siteOther conditions: Myofascial Pain Syndrome (MPS), Chronic Low-back Pain (cLBP)View official trial listing → -
Recruiting NCT NCT07508852
68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
Not yet reported, Not yet reported Peking University First Hospital 30 participants Est. completion 2027-12-31 1 siteOther conditions: SCLC, SCLC, Extensive Stage, SCLC, Limited Stage, Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC )View official trial listing → -
Recruiting NCT NCT07510321
FL-261 Imaging for Cancer Diagnosis and Staging
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12 participants Est. completion 2026-12-31 1 siteOther conditions: Non-Small Cell Lung Cancer, Colorectal Cancer, Head & Neck Cancer, Advanced Solid TumorsView official trial listing → -
Recruiting NCT NCT07535554
The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA.
Not yet reported, Not yet reported Universitaire Ziekenhuizen KU Leuven 140 participants Est. completion 2030-03-31 1 siteOther conditions: Fever of Unknown Origin, IgG4 Related Disease, Axial Spondylarthritis (axSpA), Inflammation of Unknown OriginView official trial listing → -
Recruiting NCT NCT07557225
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Not yet reported Peking University First Hospital 200 participants Est. completion 2029-03 1 site Stand-aloneOther conditions: Clear Cell Renal Cell Cancer (ccRCC), Urothelial Carcinoma (UC), Colorectal Cancer, Cervical Cancer, Ovarian Cancer, Head and Neck Cancer, Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Non Small Cell Lung Cancer, Small Cell Lung Cancer, Breast Cancer, Pancreatic Cancer, Endometrial Cancer, Von Hippel Lindau DiseaseView official trial listing → -
Recruiting NCT NCT07569887
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical Treatment
Not yet reported University Hospital, Montpellier 10 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: Unruptured Brain Arteriovenous MalformationView official trial listing → -
Recruiting NCT NCT07577206
Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.
Not yet reported National Cancer Institute, Naples 10 participants Est. completion 2027-01 1 siteOther conditions: Advanced Solid Tumor, Multiple MyelomaView official trial listing → -
Recruiting NCT NCT07587086
Fluorocholine PET/MR in Breast Cancer
Taipei Veterans General Hospital, Taiwan 195 participants Est. completion 2028-07-31 1 siteOther conditions: Breast Neoplasms, FemaleView official trial listing → -
Recruiting NCT NCT07605416
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
Not yet reported National Cancer Institute (NCI) 74 participants Est. completion 2032-11-06 14 sitesOther conditions: Plasma Cell LeukemiaView official trial listing → -
Recruiting NCT NCT07621614
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Not yet reported Children's Oncology Group 51 participants Est. completion 2028-07-31 13 sitesOther conditions: Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage II Cutaneous Melanoma AJCC v8, Cutaneous Melanocytic Neoplasm, Cutaneous Melanoma, Cutaneous Spitz Melanocytoma, Cutaneous Spitz MelanomaView official trial listing → -
Recruiting NCT NCT07625150
FDG PET/MRI Imaging of Patellofemoral Joint Osteoarthritis
University of California, San Francisco 50 participants Est. completion 2028-02 1 siteOsteoarthritis Other conditions: Knee Pain, InflamationView official trial listing → -
Recruiting NCT NCT07632092
Early [18F]-FDG PET Dynamic Analysis in Brain Metastases After Radiotherapy.
Centre Hospitalier Universitaire, Amiens 50 participants Est. completion 2028-11-18 1 siteOther conditions: Short Time Examination, Brain Metastases, Radiation NecrosisView official trial listing → -
Recruiting NCT NCT07660939
GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders
Not yet reported Peking University First Hospital 50 participants Est. completion 2027-05-25 1 site Stand-aloneOther conditions: Plasma Cell Disorders, Multiple Myeloma (MM)View official trial listing → -
Recruiting NCT NCT07670949
Biodistribution, Dosimetry, and Safety of 68Ga-EV203 in Hematological Malignancies
Not yet reported Zhejiang Cancer Hospital 30 participants Est. completion 2029-06-01 1 site Stand-aloneOther conditions: Hematological Malignancies BView official trial listing → -
Recruiting NCT NCT07677787
DLL3-Targeted PET/CT in Small Cell Lung Cancer
Not yet reported The First Affiliated Hospital of Xiamen University 20 participants Est. completion 2028-05-31 1 site Stand-aloneOther conditions: PET/CT, Small Cell Lung Cancer ( SCLC ), DLL3-targeted PET/CT, Delta-like Protein 3View official trial listing → -
Recruiting NCT NCT07691450
Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma
Not yet reported City of Hope Medical Center 40 participants Est. completion 2029-11-24 2 sitesOther conditions: Recurrent Anaplastic Large Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma, Recurrent Follicular Helper T-Cell Lymphoma, Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type, Recurrent Follicular Helper T-Cell Lymphoma, Follicular-Type, Recurrent Follicular Helper T-Cell Lymphoma, Not Otherwise Specified, Recurrent Hepatosplenic T-Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma, Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified, Recurrent Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma, Recurrent Primary Cutaneous Gamma-Delta T-Cell Lymphoma, Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma, Refractory Anaplastic Large Cell Lymphoma, Refractory Enteropathy-Associated T-Cell Lymphoma, Refractory Follicular Helper T-Cell Lymphoma, Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type, Refractory Follicular Helper T-Cell Lymphoma, Follicular-Type, Refractory Follicular Helper T-Cell Lymphoma, Not Otherwise Specified, Refractory Hepatosplenic T-Cell Lymphoma, Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma, Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, Refractory Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma, Refractory Primary Cutaneous Gamma-Delta T-Cell Lymphoma, Refractory Subcutaneous Panniculitis-Like T-Cell LymphomaView official trial listing → -
Recruiting NCT NCT07750470
Diagnostic Accuracy of 18F-FDG PET/CT in Muscle-invasive Bladder Cancer
University Hospital of Ferrara 60 participants Est. completion 2026-12 1 siteOther conditions: Muscle-invasive Bladder CancerView official trial listing → -
Recruiting NCT NCT07760012
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
Not yet reported Peking University Third Hospital 50 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: Melanoma (Skin Cancer), Hepatocellular Carcinoma, Lung Cancer, Breast Cancer, Pancreatic Cancer, Ovarian Cancer, CholangiocarcinomaView official trial listing → -
Recruiting NCT NCT07816783
Comparison of FDG-PET/CT and CECT-CAP as Upfront Imaging Modality for the Diagnosis of Pyrexia of Unknown Origin
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 132 participants Est. completion 2027-06-30 1 siteOther conditions: PyrexiaView official trial listing → -
Recruiting NCT NCT07847346
China Aortic Infection and Graft Infection Study: An Ambispective Cohort
Shanghai Zhongshan Hospital 2000 participants Est. completion 2041-11-01 1 siteOther conditions: Vascular Graft Infection, Infectious Aortitis, Aortoenteric FistulaView official trial listing → -
Recruiting NCT NCT07848243
Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes
Not yet reported Peking University Cancer Hospital & Institute 50 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Lung Cancer (NSCLC), Cervical Squamous Cell Cancer, Melanoma (Skin Cancer), Breast Cancer, Gastrointestinal CancersView official trial listing → -
Recruiting NCT NCT07875959
18F-N230A PET/CT Imaging of Nectin-4 Expression in Renal Tumors
Not yet reported Peking University First Hospital 80 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: Renal Cell Carcinoma (RCC), Renal Pelvic Urothelial CarcinomaView official trial listing → -
Recruiting NCT NCT07925125
Artificial Intelligence-Assisted 4D Dynamic Long-Axial PET Imaging for the Detection of Early Pancreatic Cancer Lesions
Ruijin Hospital 50 participants Est. completion 2029-07-31 1 siteOther conditions: Pancreas Carcinoma, PDAC - Pancreatic Ductal AdenocarcinomaView official trial listing → -
Completed NCT NCT00001849
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 95 participants Est. completion 2019-04-26 1 siteOther conditions: Cushing Syndrome, Endocrine DiseaseView official trial listing → -
Completed NCT NCT00002930
PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 75 participants 1 siteOther conditions: Esophageal Cancer, Lung CancerView official trial listing → -
Completed NCT NCT00002981
PET Scan in Treating Patients With Metastatic Prostate Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 173 participants Est. completion 2023-06-12 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003429
PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery
Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2002-10 1 siteOther conditions: Cervical CancerView official trial listing → -
Completed NCT NCT00004152
PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma
Not yet reported Memorial Sloan Kettering Cancer Center 1 siteOther conditions: Melanoma (Skin)View official trial listing → -
Completed NCT NCT00004891
PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
Not yet reported Memorial Sloan Kettering Cancer Center 149 participants 1 siteOther conditions: Colorectal CancerView official trial listing → -
Completed NCT NCT00039286
Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 118 participants Est. completion 2009-02 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00062374
Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
Not yet reported National Cancer Institute (NCI) 55 participants Est. completion 2011-06 1 siteOther conditions: Gastric Adenocarcinoma, Stage II Gastric Cancer, Stage III Gastric Cancer, Stage IV Gastric CancerView official trial listing → -
Completed NCT NCT00067821
Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor Activity
National Cancer Institute (NCI) 79 participants Est. completion 2019-05-10 1 siteOther conditions: Brain TumorsView official trial listing → -
Terminated NCT NCT00070239
Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies
Not yet reported National Cancer Institute (NCI) 100 participants 1 siteOther conditions: Hematopoietic/Lymphoid Cancer, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00081094
Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
Not yet reported Washington University School of Medicine 31 participants Est. completion 2005-09 1 siteOther conditions: Liver CancerView official trial listing → -
Completed NCT NCT00088374
17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease
Not yet reported National Cancer Institute (NCI) 9 participants Est. completion 2009-01 1 siteOther conditions: Hippel-Lindau Disease, Kidney CancerView official trial listing → -
Completed NCT NCT00095693
Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer
Not yet reported National Cancer Institute (NCI) 57 participants Est. completion 2011-10-07 1 siteOther conditions: Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma, Stage III Thyroid Gland Follicular Carcinoma AJCC v7, Stage III Thyroid Gland Papillary Carcinoma AJCC v7, Stage IV Thyroid Gland Follicular Carcinoma AJCC v7, Stage IV Thyroid Gland Papillary Carcinoma AJCC v7, Thyroid Gland Anaplastic CarcinomaView official trial listing → -
Withdrawn NCT NCT00110006
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
Not yet reported Case Comprehensive Cancer CenterOther conditions: LymphomaView official trial listing → -
Terminated NCT NCT00110032
Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
Not yet reported National Cancer Institute (NCI) 46 participants 1 siteObstructive sleep apnea Other conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma, Adult Brain Stem Glioma, Adult Central Nervous System Germ Cell Tumor, Adult Choroid Plexus Tumor, Adult Craniopharyngioma, Adult Diffuse Astrocytoma, Adult Ependymoblastoma, Adult Ependymoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Grade I Meningioma, Adult Grade II Meningioma, Adult Grade III Meningioma, Adult Medulloblastoma, Adult Meningeal Hemangiopericytoma, Adult Mixed Glioma, Adult Myxopapillary Ependymoma, Adult Oligodendroglioma, Adult Pilocytic Astrocytoma, Adult Pineoblastoma, Adult Pineocytoma, Adult Subependymoma, Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Meningeal MelanocytomaView official trial listing → -
Completed NCT NCT00123747
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer
Not yet reported AHS Cancer Control Alberta 23 participants Est. completion 2008-10 1 siteOther conditions: Lung NeoplasmsView official trial listing → -
Completed NCT NCT00123760
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
Not yet reported, Not yet reported AHS Cancer Control Alberta 10838 participants Est. completion 2008-12 1 siteOther conditions: Brain Neoplasms, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, LymphomaView official trial listing → -
Terminated NCT NCT00123786
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma
Not yet reported AHS Cancer Control Alberta 4 participants Est. completion 2008-03 1 siteOther conditions: SarcomaView official trial listing → -
Completed NCT NCT00135161
Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer
Not yet reported University Hospital, Ghent 40 participants Est. completion 2015-08 1 siteOther conditions: Head and Neck NeoplasmsView official trial listing → -
Status unknown NCT NCT00146458
Usefulness of FDG-PET for Advanced Cervical Cancer
Not yet reported Chang Gung Memorial Hospital 200 participants Est. completion 2007-12 1 siteOther conditions: Cervical CancerView official trial listing → -
Suspended NCT NCT00166803
The Impact of Rosiglitazone on Regression of Atherosclerosis
Not yet reported National Taiwan University Hospital 60 participants 1 siteOther conditions: Diabetes Mellitus, AtherosclerosisView official trial listing → -
Completed NCT NCT00172419
The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients.
Not yet reported National Taiwan University Hospital 43 participants Est. completion 2008-12 1 siteOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00188929
Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma
Not yet reported University Health Network, Toronto 10 participants Est. completion 2009-07 1 siteOther conditions: Lymphoma, Non-HodgkinView official trial listing → -
Completed NCT NCT00193752
Para-Aortic Lymph Nodal Staging & Evaluation of Treatment Outcome by 18F FDG-PET in Advanced Cancer Cervix
Tata Memorial Hospital 100 participants Est. completion 2018-01 1 siteOther conditions: Cancer of CervixView official trial listing → -
Completed NCT NCT00201942
PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)
Not yet reported Ontario Clinical Oncology Group (OCOG) 336 participants Est. completion 2007-05 10 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00207298
18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
British Columbia Cancer Agency 39242 participants Est. completion 2015-08 1 siteOther conditions: Brain Neoplasms, Lung Neoplasms, Lymphoma, Melanoma, Colorectal NeoplasmsView official trial listing → -
Completed NCT NCT00238368
Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 59 participants Est. completion 2007-09-17 1 siteOther conditions: LymphomaView official trial listing → -
Completed NCT NCT00274924
Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Not yet reported Eastern Cooperative Oncology Group 100 participants Est. completion 2019-03 104 sitesOther conditions: LymphomaView official trial listing → -
Completed NCT NCT00286832
Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
Copenhagen University Hospital at Herlev 100 participants Est. completion 2011-01 1 siteOther conditions: Diffuse Large-Cell LymphomaView official trial listing → -
Status unknown NCT NCT00304694
Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients
National Taiwan University Hospital 50 participants 1 siteOther conditions: Nasopharyngeal CancerView official trial listing → -
Status unknown NCT NCT00324467
Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment
Not yet reported British Columbia Cancer Agency 150 participants Est. completion 2021-12 1 siteOther conditions: Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's LymphomaView official trial listing → -
Completed NCT NCT00355329
Randomized Control Trial of Using Tongue Acupuncture in Autistic Spectrum Disorder Using PET Scan for Clinical Correlation
Not yet reported The University of Hong Kong 30 participants 1 siteOther conditions: Autism, Autistic DisorderView official trial listing → -
Status unknown NCT NCT00364663
The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer
National Taiwan University Hospital 100 participants 1 siteOther conditions: Non Small Cell Lung CancerView official trial listing → -
Completed NCT NCT00369980
Diagnostic Usefulness of Fluorine-18-α-Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis Patient
Gunma University Est. completion 2005-08 1 siteOther conditions: SarcoidosisView official trial listing → -
Completed NCT NCT00375830
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
Not yet reported Stanford University 114 participants Est. completion 2019-03-14 1 site Stand-aloneOther conditions: CancerView official trial listing → -
Terminated NCT NCT00379197
Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
Not yet reported Masonic Cancer Center, University of Minnesota 13 participants Est. completion 2013-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00382252
PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases
Not yet reported Institut Bergonié 89 participants Est. completion 2011-05 3 sites Stand-aloneOther conditions: Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00406289
Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor
Not yet reported University Hospital, Ghent 24 participants Est. completion 2010-02 1 siteOther conditions: Head and Neck TumorView official trial listing → -
Terminated NCT NCT00424138
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy
Not yet reported American College of Radiology Imaging Network 96 participants Est. completion 2011-08-31 1 siteOther conditions: Lung CancerView official trial listing → -
Completed NCT NCT00453362
A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
Not yet reported, Not yet reported Genentech, Inc. 88 participants Est. completion 2010-04-23Other conditions: Non-Small Cell Lung CancerView official trial listing → -
Completed NCT NCT00497614
Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)
Not yet reported University Hospital, Tours 8 participants Est. completion 2008-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT00522639
Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation
Not yet reported Maastricht Radiation Oncology 120 participants Est. completion 2009-06 1 siteOther conditions: Lung Cancer, SCLC, NSCLCView official trial listing → -
Terminated NCT NCT00528294
Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area
Not yet reported University Hospital, Ghent 12 participants Est. completion 2015-09 1 siteOther conditions: Head and Neck TumorsView official trial listing → -
Completed NCT NCT00537056
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Not yet reported Stanford University 17 participants Est. completion 2012-04 1 siteOther conditions: Kidney Neoplasms, Carcinoma, Renal Cell, Kidney (Renal Cell) CancerView official trial listing → -
Completed NCT NCT00537797
Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules
Not yet reported Washington University School of Medicine 84 participants Est. completion 2014-02 3 sitesOther conditions: Thyroid NeoplasmsView official trial listing → -
Completed NCT NCT00559377
FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer
Not yet reported National Cancer Institute (NCI) 16 participants Est. completion 2014-05 1 siteOther conditions: Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer, Stage IVB Cervical CancerView official trial listing → -
Completed NCT NCT00576563
Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer
Not yet reported Maastricht Radiation Oncology 103 participants Est. completion 2015-12 1 siteOther conditions: Rectum CancerView official trial listing → -
Completed NCT NCT00590395
FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis
Not yet reported Alan D. Waxman, M.D. 19 participants Est. completion 2010-07 1 siteOther conditions: CholecystitisView official trial listing → -
Completed NCT NCT00599755
Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)
Not yet reported Merck Sharp & Dohme LLC 68 participants Est. completion 2011-04-13Other conditions: Carcinoma, Non-small Cell Lung CancerView official trial listing → -
Completed NCT NCT00602043
F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer
Not yet reported National Cancer Institute (NCI) 20 participants Est. completion 2014-09 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast CancerView official trial listing → -
Withdrawn NCT NCT00604266
Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study
University of Toronto Est. completion 2008-08 1 siteOther conditions: CholangiocarcinomaView official trial listing → -
Completed NCT NCT00606294
Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients
Not yet reported Memorial Sloan Kettering Cancer Center 216 participants Est. completion 2023-06-09 5 sitesOther conditions: Head and Neck CancerView official trial listing → -
Completed NCT NCT00620243
Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.
Not yet reported Memorial Sloan Kettering Cancer Center 9 participants Est. completion 2008-11 1 siteOther conditions: Ovarian CancerView official trial listing → -
Terminated NCT NCT00643591
Positron Emission Tomography-Computed Tomography (PET-CT) High-grade Glioma
Maastricht Radiation Oncology 10 participants Est. completion 2010-06 1 siteOther conditions: Cerebral Astrocytoma, High GradeView official trial listing → -
Completed NCT NCT00671242
Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake
Gunma University 1 siteOther conditions: Angiogenesis, Non-Small Cell Lung CancerView official trial listing → -
Status unknown NCT NCT00675168
Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice
Not yet reported Odense University Hospital 1700 participants Est. completion 2012-06 3 sitesOther conditions: Lung CancerView official trial listing → -
Completed NCT NCT00695305
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
Not yet reported GlaxoSmithKline 83 participants Est. completion 2010-05 10 sitesOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00698373
Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study
Gunma UniversityOther conditions: Non-Small Cell Lung CancerView official trial listing → -
Terminated NCT NCT00707213
FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients
Not yet reported University of Utah 19 participants Est. completion 2010-08-11 1 siteOther conditions: CancerView official trial listing → -
Completed NCT NCT00708045
A Multi-modality Imaging Assessment of Chemobrain
Not yet reported University of Utah 34 participants Est. completion 2015-02-05 1 siteOther conditions: CancerView official trial listing → -
Completed NCT NCT00757549
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
Not yet reported Mayo Clinic 30 participants Est. completion 2017-10-25 1 siteOther conditions: Head and Neck CancerView official trial listing → -
Status unknown NCT NCT00765986
Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy
AHS Cancer Control Alberta 30 participants Est. completion 2015-10 1 siteOther conditions: Lung Neoplasm, Cell HypoxiaView official trial listing → -
Completed NCT NCT00770731
Study of Temsirolimus, Topotecan, and Bortezomib
Not yet reported M.D. Anderson Cancer Center 80 participants Est. completion 2012-11 1 siteOther conditions: Advanced CancerView official trial listing → -
Terminated NCT NCT00771381
A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer
Not yet reported AHS Cancer Control Alberta 23 participants Est. completion 2019-02-04 1 siteOther conditions: Breast NeoplasmView official trial listing → -
Terminated NCT NCT00775268
18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
Not yet reported, Not yet reported National Cancer Institute (NCI) 31 participants Est. completion 2014-10-23 2 sitesOther conditions: LymphomaView official trial listing → -
Completed NCT NCT00788489
A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy
Ontario Clinical Oncology Group (OCOG) 49 participants Est. completion 2010-04 1 siteOther conditions: Locally Advanced Breast CancerView official trial listing → -
Terminated NCT NCT00794339
Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer
Not yet reported American College of Radiology 73 participants Est. completion 2011-12-31 2 sitesOther conditions: Cervical CancerView official trial listing → -
Terminated NCT NCT00809341
R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27 participants Est. completion 2014-04 1 siteOther conditions: Non-Hodgkin's LymphomaView official trial listing → -
Terminated NCT NCT00811122
Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly
Not yet reported University of Utah 2 participants Est. completion 2021-12 1 siteOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT00813566
Multi-Tracer PET Assessment of Primary Brain Tumors
Not yet reported University of Utah 11 participants Est. completion 2015-02-03 1 siteOther conditions: Brain Tumors, CancerView official trial listing → -
Completed NCT NCT00816335
Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors
Not yet reported Ohio State University Comprehensive Cancer Center 65 participants Est. completion 2011-08 1 site Stand-aloneOther conditions: Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Terminated NCT NCT00816582
PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer
Not yet reported British Columbia Cancer Agency 17 participants Est. completion 2018-07 4 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00823810
Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT
Not yet reported Turku University Hospital 20 participants Est. completion 2011-12 1 site Stand-aloneOther conditions: Colorectal CancerView official trial listing → -
Completed NCT NCT00833209
Orbitofrontal Cortex (OFC) Influence on Addictive Medication Overuse Headache (MOH) Deriving From Migraine
Not yet reported University Hospital, Bordeaux 53 participants Est. completion 2012-05 2 sitesOther conditions: Medication Overuse HeadacheView official trial listing → -
Completed NCT NCT00846053
FDG-PET Imaging in Young Cystic Fibrosis Patients
Not yet reported Washington University School of Medicine 21 participants Est. completion 2012-02 1 siteOther conditions: Cystic FibrosisView official trial listing → -
Completed NCT NCT00864110
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Not yet reported Cell>Point LLC 4 participants Est. completion 2010-12 3 sitesOther conditions: Non Small Cell Lung CancerView official trial listing → -
Completed NCT NCT00865319
Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Not yet reported Cell>Point LLC 22 participants Est. completion 2010-12 6 sitesOther conditions: Non Small Cell Lung CancerView official trial listing → -
Completed NCT NCT00871650
Neurobiological Correlates of Post Traumatic Stress Disorder (PTSD) During Rapid Eye Movement (REM) Sleep
University of Pittsburgh 24 participants Est. completion 2011-11 1 siteOther conditions: Post-Traumatic Stress DisorderView official trial listing → -
Completed NCT NCT00887718
Positron Emission Tomography(PET) in Lymphoma Assessment
Not yet reported University Health Network, Toronto 103 participants Est. completion 2011-06 1 siteOther conditions: Hodgkin's Lymphoma, Non Hodgkin's LymphomaView official trial listing → -
Completed NCT NCT00906503
Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules
Not yet reported Barbara Ann Karmanos Cancer Institute 9 participants Est. completion 2012-04 2 sites Stand-aloneOther conditions: Pulmonary NoduleView official trial listing → -
Completed NCT NCT00915096
Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma
Lymphoma Study Association 121 participants Est. completion 2013-02-08 22 sitesOther conditions: Lymphoma, FollicularView official trial listing → -
Withdrawn NCT NCT00932048
Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes
Not yet reported Korea University Est. completion 2012-03 1 siteType 2 diabetes Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00958087
Cardiac Sarcoidosis and FDG-PET
Kurume University 20 participants Est. completion 2010-07 1 siteOther conditions: Sarcoidosis, Dilated CardiomyopathyView official trial listing → -
Completed NCT NCT00959582
Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)
Not yet reported Merck Sharp & Dohme LLC 42 participants Est. completion 2011-10Other conditions: Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube CancerView official trial listing → -
Completed NCT NCT00963807
A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC
Not yet reported National Cancer Institute (NCI) 26 participants Est. completion 2014-11 2 sitesOther conditions: Recurrent Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma, Stage IIB Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung CancerView official trial listing → -
Completed NCT NCT01017133
Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 56 participants Est. completion 2012-09 1 siteOther conditions: Non-small Cell Lung CancerView official trial listing → -
Completed NCT NCT01020097
Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx
Not yet reported Abramson Cancer Center at Penn Medicine 5 participants Est. completion 2013-12 1 siteOther conditions: Squamous Cell CarcinomaView official trial listing → -
Terminated NCT NCT01022138
Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer
Not yet reported Barbara Ann Karmanos Cancer Institute 43 participants Est. completion 2019-02-19 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01022684
Correlation Between Various Inflammatory Markers and Vascular Inflammation Measured by 18FDG-PET
Korea University 150 participants Est. completion 2010-01 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT01031238
Comparison of PEM Uptake Value (PUV) and Standardized Uptake Value (SUV) in Patients With Malignancies of the Breast
M.D. Anderson Cancer Center 5 participants Est. completion 2015-11 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT01038778
Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer
Not yet reported, Not yet reported National Cancer Institute (NCI) 47 participants Est. completion 2027-02-12 4 sitesOther conditions: Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7, Stage IV Renal Cell Cancer AJCC v7View official trial listing → -
Terminated NCT NCT01050283
A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)
Not yet reported Merck Sharp & Dohme LLC 15 participants Est. completion 2012-05Other conditions: Advanced Pancreatic AdenocarcinomaView official trial listing → -
Completed NCT NCT01089998
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations
Not yet reported Lantheus Biosciences Ltd. 35 participants Est. completion 2011-09 2 sitesOther conditions: Diagnostic ImagingView official trial listing → -
Completed NCT NCT01099865
High-sensitivity C-reactive Protein and United Kingdom Prospective Diabetes Study (UKPDS) Risk Score in Type 2 Diabetes
Korea University 56 participants Est. completion 2010-04 1 siteType 2 diabetes Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT01100671
Comparison of 18F-fluorodeoxyglucose Positron Emission Tomography and Coronary Computed Tomography in Assessing Vascular Inflammation
Korea University 120 participants Est. completion 2011-08 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT01103726
Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects
Not yet reported Pfizer 34 participants Est. completion 2011-11 3 sitesOther conditions: HealthyView official trial listing → -
Terminated NCT NCT01104116
Use of PET Imaging to Distinguish Malignant From Benign IPMN
Not yet reported Columbia University 1 participants Est. completion 2016-03 1 siteOther conditions: Neoplasm, Pancreatic CancerView official trial listing → -
Withdrawn NCT NCT01117155
A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
National Cancer Institute (NCI) Est. completion 2012-10-22Other conditions: Ependymoma, Brainstem Glioma, Astrocytoma, Glioblastoma Multiforme, PNETView official trial listing → -
Completed NCT NCT01136720
Clinical Trial to Evaluate the Safety and Clinical Utility of 18F-FDG Produced by the Molecular Imaging and Research Centre of Nova Scotia
Nova Scotia Health Authority 9463 participants Est. completion 2017-04-18 1 siteOther conditions: 18FDGView official trial listing → -
Completed NCT NCT01139827
Association Between Framingham Risk Score, hsCRP and Vascular Inflammation: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography
Korea University Guro Hospital 178 participants Est. completion 2010-02 1 siteOther conditions: Cardiovascular RiskView official trial listing → -
Terminated NCT NCT01141764
Cerebral Metabolic Changes Associated With Thalamic Stimulation
Not yet reported The Hospital for Sick Children 4 participants Est. completion 2014-02 2 sites Stand-aloneOther conditions: EpilepsyView official trial listing → -
Completed NCT NCT01146054
Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
Not yet reported Stanford University 59 participants Est. completion 2015-10 3 sites Stand-aloneOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT01150006
Correlation Between Various Adipokines and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG) (18FDG-PET)
Korea University 90 participants Est. completion 2010-06 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT01150019
Correlation Between Circulating Resistin and Vascular Inflammation Measured by 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) (18FDG-PET)
Korea University 120 participants Est. completion 2010-06 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT01165632
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
Not yet reported Mayo Clinic 24 participants Est. completion 2019-07-26 1 siteObstructive sleep apnea Other conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma, Adult Brain Stem Glioma, Adult Diffuse Astrocytoma, Adult Ependymoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Mixed Glioma, Adult Myxopapillary Ependymoma, Adult Oligodendroglioma, Adult Pilocytic Astrocytoma, Adult Pineal Gland Astrocytoma, Adult Subependymal Giant Cell Astrocytoma, Adult SubependymomaView official trial listing → -
Terminated NCT NCT01169350
18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma
Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2013-08 2 sitesOther conditions: Recurrent Adult Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue SarcomaView official trial listing → -
Status unknown NCT NCT01171300
Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients
Not yet reported Universitaire Ziekenhuizen KU Leuven 94 participants Est. completion 2025-12 1 siteOther conditions: Adenocarcinoma, Rectal NeoplasmsView official trial listing → -
Completed NCT NCT01172041
The Role of Audiovisual Biofeedback on Image Quality During 4D Anatomic and Functional Imaging
Stanford University 10 participants Est. completion 2013-06 1 siteOther conditions: Lung CancerView official trial listing → -
Completed NCT NCT01179360
Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
University Hospital, Antwerp 152 participants Est. completion 2015-12 3 sitesOther conditions: Locally Advanced Squamous Cell Carcinoma of the Head and Neck RegionView official trial listing → -
Status unknown NCT NCT01180751
18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology
Not yet reported University of Manitoba 1000 participants Est. completion 2013-12 1 siteOther conditions: TumorsView official trial listing → -
Completed NCT NCT01202994
Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET
Not yet reported University of Utah 27 participants Est. completion 2020-10-14 1 site Stand-aloneOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT01208883
A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer
Not yet reported University Hospital, Ghent 10 participants Est. completion 2012-03 1 siteOther conditions: Squamous Cell CarcinomaView official trial listing → -
Completed NCT NCT01218191
Acute Neurocardiogenic Injury After Subarachnoid Hemorrhage.
Direction Centrale du Service de Santé des Armées 30 participants Est. completion 2012-02 1 siteOther conditions: Subarachnoid HemorrhageView official trial listing → -
Completed NCT NCT01219985
Benefits Study of Respiratory-gated Positron Emission Tomography Acquisitions of the Liver
Not yet reported Centre Hospitalier Universitaire, Amiens 50 participants Est. completion 2010-06 1 site Stand-aloneOther conditions: Liver CancerView official trial listing → -
Terminated NCT NCT01222416
PET/CT Evaluation of Treatment Response in Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer Center 50 participants Est. completion 2015-04 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01224873
Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET
Copenhagen University Hospital, Rigshospitalet 110 participants Est. completion 2013-09 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01231295
Isotopic Imaging for Prodromal Alzheimer's Disease
Centre Hospitalier Universitaire de Nīmes 143 participants Est. completion 2016-09 25 sitesOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT01237054
Imaging in MGUS, SMM and MM
Not yet reported National Cancer Institute (NCI) 31 participants Est. completion 2011-08-09 1 site Stand-aloneOther conditions: Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined SignificanceView official trial listing → -
Terminated NCT NCT01243333
Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors
Not yet reported University of Utah 26 participants Est. completion 2016-04-08 1 siteOther conditions: Malignant NeoplasmView official trial listing → -
Completed NCT NCT01243359
Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies
Not yet reported National Cancer Institute (NCI) 6 participants 2 sitesOther conditions: Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Terminated NCT NCT01246869
Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
Not yet reported University of Utah 2 participants Est. completion 2014-05-03 1 siteOther conditions: Brain CancerView official trial listing → -
Completed NCT NCT01253252
Endoprosthesis Treatment Effects on Human Abdominal Aorta Aneurysms (AAA) Metabolic Activity
Not yet reported Central Hospital, Nancy, France 45 participants 7 sitesOther conditions: Abdominal Aortic AneurysmView official trial listing → -
Status unknown NCT NCT01254591
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
Not yet reported University College London (UCL) Cancer Institute 500 participants 1 siteOther conditions: Breast Cancer, Colorectal Cancer, Esophageal Cancer, Head and Neck Cancer, Lung CancerView official trial listing → -
Terminated NCT NCT01258283
PET / CT With 18F-FDG: Does it Optimize the I 123-MIBG Imaging Results in the Search for Discriminating Factors for the Implementation of an Implantable Defibrillator?
Centre Hospitalier Universitaire de Nīmes 6 participants Est. completion 2016-06 2 sitesOther conditions: Defibrillators, ImplantableView official trial listing → -
Completed NCT NCT01266954
An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer
Not yet reported GlaxoSmithKline 36 participants Est. completion 2011-09-01 1 siteOther conditions: Solid TumoursView official trial listing → -
Terminated NCT NCT01283178
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Not yet reported Virginia Commonwealth University 3 participants Est. completion 2016-09 1 siteOther conditions: Salivary Gland Squamous Cell Carcinoma, Stage II Salivary Gland Cancer, Stage II Squamous Cell Carcinoma of the Hypopharynx, Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage II Squamous Cell Carcinoma of the Oropharynx, Stage II Verrucous Carcinoma of the Oral Cavity, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Verrucous Carcinoma of the Oral CavityView official trial listing → -
Completed NCT NCT01283347
18F-DTBZ for l Diagnosis of Parkinson's Disease and Monitoring the Severity of Disease by VMAT2 PET Imaging
Not yet reported Chang Gung Memorial Hospital 100 participants Est. completion 2012-12 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01284829
Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study
Not yet reported Assistance Publique Hopitaux De Marseille 87 participants Est. completion 2023-04-05 1 siteOther conditions: Adrenal TumorsView official trial listing → -
Completed NCT NCT01285765
Evaluate a Treatment Adapted to the PET Response Compared to a Standard Treatment, for Low Risk DLBCL CD 20+ Patients
Not yet reported The Lymphoma Academic Research Organisation 650 participants Est. completion 2020-05-23 83 sitesOther conditions: DLBCLView official trial listing → -
Completed NCT NCT01286272
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
Not yet reported National Cancer Institute (NCI) 135 participants Est. completion 2025-09-02 96 sitesOther conditions: Ann Arbor Stage III Grade 1 Follicular Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, Ann Arbor Stage IV Grade 1 Follicular Lymphoma, Ann Arbor Stage IV Grade 2 Follicular Lymphoma, Ann Arbor Stage IV Grade 3 Follicular Lymphoma, Grade 3a Follicular LymphomaView official trial listing → -
Completed NCT NCT01325259
FluoroAv45 Imaging Research-in Alzheimer's Disease
Not yet reported University Hospital, Tours 54 participants Est. completion 2013-12 4 sitesOther conditions: Alzheimer's Disease, Mild Cognitive ImpairmentView official trial listing → -
Status unknown NCT NCT01330186
Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy
Copenhagen University Hospital at Herlev 50 participants Est. completion 2012-05 1 siteOther conditions: Anal CancerView official trial listing → -
Completed NCT NCT01347281
PET With [18F]HX4 in Head and Neck Cancer
Not yet reported Maastricht Radiation Oncology 23 participants Est. completion 2015-09 1 siteOther conditions: Cancer of the Head and NeckView official trial listing → -
Completed NCT NCT01357733
Interim FDG PET/CT in Diffuse Large B Cell Lymphoma (DLBCL) Patients
Not yet reported The Catholic University of Korea 53 participants Est. completion 2024-12-31 1 siteOther conditions: Lymphoma, Large B-Cell, DiffuseView official trial listing → -
Status unknown NCT NCT01374659
Diagnostic Utility of [18F]-FDG-PET/CT and [124I]-PET/CT for Detection of Recurrence in Differentiated Thyroid Carcinoma
Korean Association of Endocrine Surgeons 50 participants Est. completion 2012-08 1 siteOther conditions: Thyroid Cancer, RecurrenceView official trial listing → -
Not yet recruiting NCT NCT01394679
A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer
Not yet reported Cell>Point LLC 154 participants Est. completion 2026-12 1 siteOther conditions: Lung CancerView official trial listing → -
Completed NCT NCT01407796
PET Imaging of Endotoxin-induced iNOS Activation
Not yet reported Washington University School of Medicine 19 participants Est. completion 2012-04 1 siteOther conditions: PneumoniaView official trial listing → -
Completed NCT NCT01421953
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
Not yet reported University Hospital, Bordeaux 7 participants Est. completion 2012-11 1 siteOther conditions: Lung Cancer, Non-small-cell Lung CarcinomaView official trial listing → -
Completed NCT NCT01427010
A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory.
Not yet reported University Hospital, Ghent 10 participants Est. completion 2015-08 2 sitesOther conditions: Re-irradiation in Recurrent and Second Primary Head and Neck CancerView official trial listing → -
Status unknown NCT NCT01432002
FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer
University Hospital, Geneva 60 participants Est. completion 2023-12 1 siteOther conditions: Breast NeoplasmView official trial listing → -
Completed NCT NCT01467219
Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
Not yet reported University Health Network, Toronto 12 participants Est. completion 2014-03 1 site Stand-aloneOther conditions: Endometrial CancerView official trial listing → -
Status unknown NCT NCT01470066
Clinical Usefulness and Prognostic Significance of Interim 18F-FDG PET/CT for the Treatment of Peripheral T Cell Lymphomas
Chonnam National University Hospital 80 participants Est. completion 2012-05 1 siteOther conditions: Peripheral T Cell LymphomaView official trial listing → -
Withdrawn NCT NCT01471418
The Use of PET/CT to Evaluate Synovitis in the Temporomandibular Joint (TMJ)
Not yet reported University of Pennsylvania Est. completion 2012-10 1 siteOther conditions: Temporomandibular Joint, Conservative Treatment TherapyView official trial listing → -
Completed NCT NCT01482182
Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy
Samsung Medical Center 35 participants Est. completion 2014-01 1 siteOther conditions: Non-small Cell Lung CancerView official trial listing → -
Completed NCT NCT01486342
PET Imaging in Patients at Risk for Acute Lung Injury
Washington University School of Medicine 5 participants Est. completion 2012-10 1 siteOther conditions: Acute Lung Injury, Early Pulmonary Neutrophilic InflammationView official trial listing → -
Completed NCT NCT01507428
Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer
Not yet reported National Cancer Institute (NCI) 138 participants Est. completion 2022-05-20 31 sitesOther conditions: Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell Cancer AJCC v7View official trial listing → -
Status unknown NCT NCT01510990
First Line Gefitinib by FDG-PET Metabolic Response
Not yet reported Asan Medical Center 60 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: Non-small Cell Lung CancerView official trial listing → -
Terminated NCT NCT01520025
Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA
Not yet reported Ottawa Heart Institute Research Corporation 18 participants Est. completion 2015-01 1 site Stand-aloneOther conditions: Myocardial IschemiaView official trial listing → -
Suspended NCT NCT01542853
The Value of PET/CT in Diagnosing Residual Disease in Patients With Spinal Infection
Odense University Hospital 10 participants Est. completion 2013-03 3 sitesOther conditions: SpondylodiscitisView official trial listing → -
Status unknown NCT NCT01553513
PET/CT for the Quantification of Atherosclerotic Plaque Inflammation
Ludwig-Maximilians - University of Munich 140 participants Est. completion 2014-12 1 siteCardiovascular disease Other conditions: Acute Coronary SyndromeView official trial listing → -
Status unknown NCT NCT01596192
PETCT for Diagnosing and Monitoring Acute GVHD
Rabin Medical Center 30 participants Est. completion 2013-06 1 siteOther conditions: Acute Graft Versus Host DiseaseView official trial listing → -
Terminated NCT NCT01608516
Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque
Not yet reported, Not yet reported University of Lausanne Hospitals 20 participants Est. completion 2026-07 1 site Stand-aloneOther conditions: Inflammation, Atheromatous Plaques, Carotid Artery DiseasesView official trial listing → -
Completed NCT NCT01612936
T Cell Effector and Regulatory Mechanisms in Asthma
Not yet reported Andrew D. Luster, M.D.,Ph.D. 168 participants Est. completion 2016-09 1 siteOther conditions: Asthma, AllergiesView official trial listing → -
Completed NCT NCT01613196
Positron Emission Tomography in Extrapulmonary Tuberculosis
Not yet reported Assistance Publique - Hôpitaux de Paris 55 participants Est. completion 2018-03 1 siteOther conditions: Extrapulmonary Tuberculosis, Lymph Node Tuberculosis, Bone TuberculosisView official trial listing → -
Status unknown NCT NCT01636674
18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer
Not yet reported Naestved Hospital 66 participants Est. completion 2013-03Other conditions: Colon CancerView official trial listing → -
Completed NCT NCT01655745
Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer
Not yet reported UNC Lineberger Comprehensive Cancer Center 22 participants Est. completion 2019-02-01 1 siteOther conditions: Bladder CancerView official trial listing → -
Completed NCT NCT01663753
Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy
Not yet reported Hospices Civils de Lyon 146 participants Est. completion 2018-08 24 sites Stand-aloneOther conditions: Cancer of the Uterine CervixView official trial listing → -
Completed NCT NCT01664936
Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes
Memorial Sloan Kettering Cancer Center 27 participants Est. completion 2018-04-03 1 siteOther conditions: Head and Neck CancersView official trial listing → -
Status unknown NCT NCT01665196
18F-FDG PET/CT for IgG4-Related Disease
Not yet reported Peking Union Medical College Hospital 100 participants Est. completion 2017-12 1 site Stand-aloneOther conditions: Autoimmune DiseaseView official trial listing → -
Completed NCT NCT01665703
Imaging Correlates of Renal Cell Carcinoma Biological Features
Not yet reported UNC Lineberger Comprehensive Cancer Center 17 participants Est. completion 2019-01 1 siteOther conditions: Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT01666353
PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20 participants Est. completion 2018-12-04 1 siteOther conditions: Melanoma, Renal Cell Carcinoma (RCC), Non-small Cell Lung Cancer (NSCLC)View official trial listing → -
Completed NCT NCT01691391
Early Biomarker With 18F-FDG PET for Treatment Optimization of Anti-EGFR Therapy in Patients With Metastatic Colorectal Cancer.
Amsterdam UMC, location VUmc 46 participants Est. completion 2020-11-03 1 siteOther conditions: Colorectal CancerView official trial listing → -
Active, not recruiting NCT NCT01697527
Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies
Not yet reported Jonsson Comprehensive Cancer Center 6 participants Est. completion 2027-11-02 1 siteOther conditions: Malignant NeoplasmView official trial listing → -
Status unknown NCT NCT01713049
18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound
Not yet reported National Taiwan University Hospital 70 participants Est. completion 2013-12 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT01724749
Cardiovascular Molecular Calcification Assessed by 18F-NaF PET CT
Odense University Hospital 144 participants Est. completion 2016-12 2 sitesCardiovascular disease Other conditions: Atherosclerosis, Angina PectorisView official trial listing → -
Completed NCT NCT01749254
Novel Imaging Approaches To Identify Unstable Coronary Plaques
University of Edinburgh 80 participants Est. completion 2015-04 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01759888
Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
Not yet reported Chang Gung Memorial Hospital 49 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Approved For Marketing NCT NCT01764191
18F-FDG PET Imaging in Cardiac Sarcoidosis
British Columbia Cancer Agency 1 siteOther conditions: Cardiac SarcoidosisView official trial listing → -
Status unknown NCT NCT01783002
11C Methionine PET for the Detection of Hyperfunctional Parathyroid Tissues
Not yet reported University of British Columbia 50 participants Est. completion 2018-07 1 site Stand-aloneOther conditions: Primary HyperparathyroidismView official trial listing → -
Completed NCT NCT01800032
PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)
UNC Lineberger Comprehensive Cancer Center 30 participants Est. completion 2019-12-05 1 siteOther conditions: Neurofibromatosis-1, Optic Glioma, Plexiform NeurofibromaView official trial listing → -
Status unknown NCT NCT01806532
Regional Lung Inflammation and Expansion in Mechanically Ventilated Patients - a PET/CT Study
Massachusetts General Hospital 10 participants Est. completion 2019-03 1 siteOther conditions: Respiratory FailureView official trial listing → -
Completed NCT NCT01806675
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Not yet reported, Not yet reported Sanjiv Sam Gambhir 25 participants Est. completion 2019-04 1 site Stand-aloneObstructive sleep apnea Other conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma, Male Breast Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Adult Brain Tumor, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Colon Cancer, Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Recurrent Hypopharyngeal Cancer, Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Recurrent Laryngeal Cancer, Recurrent Lip and Oral Cavity Cancer, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Lymphoepithelioma of the Oropharynx, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Nasopharyngeal Cancer, Recurrent Non-small Cell Lung Cancer, Recurrent Oropharyngeal Cancer, Recurrent Pancreatic Cancer, Recurrent Paranasal Sinus and Nasal Cavity Cancer, Recurrent Rectal Cancer, Recurrent Renal Cell Cancer, Recurrent Salivary Gland Cancer, Stage IIIA Breast Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Breast Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer, Stage IV Non-small Cell Lung Cancer, Stage IV Pancreatic Cancer, Stage IV Renal Cell Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVA Salivary Gland Cancer, Stage IVB Colon Cancer, Stage IVB Salivary Gland Cancer, Stage IVC Salivary Gland Cancer, Tongue Cancer, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT01812031
Benefits Study of Respiratory-gated PET Acquisition in Lung Disease
Not yet reported Centre Hospitalier Universitaire, Amiens 103 participants Est. completion 2015-02 1 site Stand-aloneOther conditions: Lung Cancer, Non Small Cell Lung Cancer, Chronic Obstructive Pulmonary DiseaseView official trial listing → -
Completed NCT NCT01812668
Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
Not yet reported Barbara Ann Karmanos Cancer Institute 20 participants Est. completion 2019-06-18 1 siteOther conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate CancerView official trial listing → -
Terminated NCT NCT01815112
Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging
Not yet reported Centre Hospitalier Universitaire, Amiens 60 participants Est. completion 2014-04 2 sitesOther conditions: Alzheimer Disease, Mild Cognitive Impairment, Vascular DementiaView official trial listing → -
Completed NCT NCT01824056
The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography
Not yet reported Chang Gung Memorial Hospital 120 participants Est. completion 2013-07 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01825902
18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma
Not yet reported Mayo Clinic 1 participants Est. completion 2015-11-23 1 site Stand-aloneOther conditions: Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Untreated Childhood Supratentorial Primitive Neuroectodermal TumorView official trial listing → -
Completed NCT NCT01826227
Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 5 participants Est. completion 2016-12 1 site Stand-aloneOther conditions: Ovarian Cancer, Fallopian Tube, Primary PeritonealView official trial listing → -
Terminated NCT NCT01886105
Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4 participants Est. completion 2017-06-11 1 siteObstructive sleep apneaView official trial listing → -
Completed NCT NCT01890343
Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.
Not yet reported Avid Radiopharmaceuticals 34 participants Est. completion 2013-04 1 site Stand-aloneOther conditions: Alzheimer's Disease, Frontotemporal DementiaView official trial listing → -
Completed NCT NCT01899404
MRI FDG PET Imaging Cervix
Not yet reported University Health Network, Toronto 25 participants Est. completion 2016-12 1 siteOther conditions: Cervical Cancer Squamous CellView official trial listing → -
Completed NCT NCT01916005
Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Prosthetic Valve Endocarditis
Not yet reported Assistance Publique Hopitaux De Marseille 174 participants Est. completion 2023-04-21 1 site Stand-aloneOther conditions: Prosthetic Valve Endocarditis (PVE)View official trial listing → -
Completed NCT NCT01916057
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
Not yet reported Assistance Publique - Hôpitaux de Paris 100 participants Est. completion 2018-02-28 1 site Stand-aloneOther conditions: Invasive Fungal Disease, Chronic Disseminated Candidiasis, Hematological Malignancies, Hematopoietic Stem Cell Transplantation, NeutropeniaView official trial listing → -
Completed NCT NCT01917136
11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension
Not yet reported University of Pennsylvania 21 participants Est. completion 2018-10 1 site Stand-aloneOther conditions: Pulmonary HypertensionView official trial listing → -
Status unknown NCT NCT01927939
18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
National Taiwan University Hospital 100 participants Est. completion 2014-08 1 siteOther conditions: Breast Cancer, 18F-FDG PETView official trial listing → -
Status unknown NCT NCT01927978
Using "PET Response Criteria in Solid Tumors (PERCIST)" in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal Cancer
National Taiwan University Hospital 60 participants Est. completion 2014-08 1 siteOther conditions: Esophageal CancerView official trial listing → -
Completed NCT NCT01935791
Investigating Brown Adipose Tissue Activation in Humans
Not yet reported Imperial College London 11 participants Est. completion 2018-11-05 1 site Stand-aloneOther conditions: Metabolic DiseasesView official trial listing → -
Status unknown NCT NCT01940926
68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis
Not yet reported Peking Union Medical College Hospital 50 participants Est. completion 2017-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01958411
Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)
Korea University 340 participants 1 siteOther conditions: Atherosclerosis, Non-alcoholic Fatty Liver DiseaseView official trial listing → -
Completed NCT NCT01963221
Relationship Between Thoracic Aortic Structure Assessed B PET/CT Scan and Arterial Stiffness in Elderly Patients
Not yet reported Central Hospital, Nancy, France 30 participants Est. completion 2013-09 1 siteOther conditions: Aging, InflammationView official trial listing → -
Completed NCT NCT01970228
Imaging of Joint Replacement Complications by PET/CT
Not yet reported Turku University Hospital 12 participants Est. completion 2016-12-31 1 siteOther conditions: Adverse Reactions to Metal Debris, Infection of Total Hip Joint Prosthesis, Mechanical Loosening of Prosthetic JointView official trial listing → -
Terminated NCT NCT01984905
Study of Prognostic Factors in Aortic Dissection Type B
University Hospital, Caen 100 participants Est. completion 2018-05-15 1 siteOther conditions: Type B Aortic DissectionView official trial listing → -
Completed NCT NCT01986985
Comparison of 18F FDG PET/CT TO PET MRI
Not yet reported GE Healthcare 58 participants Est. completion 2014-07 2 sitesOther conditions: Any Condition With a Clinical Indication for PET/CT ExamView official trial listing → -
Completed NCT NCT01996046
FDG PET/CT in Breast Cancer Bone Mets
University of Pennsylvania 26 participants Est. completion 2026-07-31 1 siteOther conditions: Estrogen Receptor Positive Breast Cancer, Bone MetastasesView official trial listing → -
Completed NCT NCT02003456
Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging
Not yet reported University of Michigan 30 participants Est. completion 2014-08 1 siteCardiovascular disease Other conditions: Ischemic Heart DiseaseView official trial listing → -
Terminated NCT NCT02010957
Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia
Not yet reported Wuerzburg University Hospital 85 participants Est. completion 2022-07 6 sitesOther conditions: Adrenal NeoplasiaView official trial listing → -
Completed NCT NCT02016872
Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients
Not yet reported Memorial Sloan Kettering Cancer Center 25 participants Est. completion 2024-07-08 1 site Stand-aloneOther conditions: Non-Small-Cell-Lung Cancer (NSCLC)View official trial listing → -
Completed NCT NCT02039024
Imaging Non-motor Symptoms of Parkinson's Disease by Novel 18F-DTBZ and Florbetapir F-18 PET
Not yet reported Chang Gung Memorial Hospital 18 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02043002
Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)
Not yet reported University of Aarhus 67 participants Est. completion 2015-08 1 site Stand-aloneOther conditions: Non-small Cell Lung Cancer PatientsView official trial listing → -
Completed NCT NCT02059733
Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism
Not yet reported Chang Gung Memorial Hospital 72 participants Est. completion 2018-07-31 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Withdrawn NCT NCT02061007
Biomarker Correlates of Hypoxia in Metastatic Melanoma
Not yet reported H. Lee Moffitt Cancer Center and Research Institute Est. completion 2016-02Other conditions: Melanoma, Skin CancerView official trial listing → -
Status unknown NCT NCT02069418
Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient
Not yet reported University Hospital, Angers 80 participants Est. completion 2016-06 8 sites Stand-aloneOther conditions: Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent, No EGFR Activating MutationView official trial listing → -
Status unknown NCT NCT02074202
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
Not yet reported National Taiwan University Hospital 150 participants Est. completion 2015-03 1 siteOther conditions: Hepatocellular Carcinoma, Liver DiseaseView official trial listing → -
Completed NCT NCT02078141
18F-deoxyglucose (FDG) PET-CMD
Not yet reported Nantes University Hospital 30 participants Est. completion 2018-01-18 2 sitesOther conditions: Patients With Idiopathic Dilated CardiomyopathyView official trial listing → -
Terminated NCT NCT02079181
18F-FMAU PET/CT in Imaging Patients With Advanced Cancers
Not yet reported University of Southern California 3 participants Est. completion 2023-08-22 1 siteOther conditions: Malignant NeoplasmView official trial listing → -
Completed NCT NCT02081482
Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation
Not yet reported Centre Hospitalier Universitaire de Nice 20 participants Est. completion 2022-02-02 4 sites Stand-aloneOther conditions: Refractory Chronic Cluster HeadacheView official trial listing → -
Status unknown NCT NCT02089204
Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma
Xuzhou Medical University 300 participants Est. completion 2015-12Other conditions: Nasopharyngeal CarcinomaView official trial listing → -
Completed NCT NCT02124941
Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS
Not yet reported Yale University 6 participants Est. completion 2022-08-14 1 siteOther conditions: Cocaine Dependence, HealthyView official trial listing → -
Active, not recruiting NCT NCT02125786
A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma
Not yet reported St. Jude Children's Research Hospital 68 participants Est. completion 2028-05 1 siteOther conditions: EpendymomaView official trial listing → -
Suspended NCT NCT02130492
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
Not yet reported, Not yet reported Weill Medical College of Cornell University 30 participants Est. completion 2028-07 1 siteOther conditions: Advanced CancerView official trial listing → -
Withdrawn NCT NCT02139150
Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy
Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2020-05 1 siteOther conditions: Histologically-confirmed MalignanciesView official trial listing → -
Completed NCT NCT02167256
A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease
Not yet reported Yale University 159 participants Est. completion 2018-02-27 22 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Withdrawn NCT NCT02169063
Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer
Not yet reported University of Washington 1 siteOther conditions: Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate CancerView official trial listing → -
Completed NCT NCT02173834
Brown Adipose Tissue and Body Mass Index
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20 participants Est. completion 2013-11 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT02175095
[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib
Not yet reported Asan Medical Center 68 participants Est. completion 2019-04-30 1 siteOther conditions: Colorectal CancerView official trial listing → -
Terminated NCT NCT02175745
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
Not yet reported Erik Mittra 2 participants Est. completion 2015-12 1 siteObstructive sleep apnea Other conditions: Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma, Adult Brain Stem Glioma, Adult Diffuse Astrocytoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Mixed Glioma, Adult Oligodendroglioma, Adult Pilocytic Astrocytoma, Adult Pineal Gland Astrocytoma, Adult Subependymal Giant Cell Astrocytoma, Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Low-grade Cerebellar Astrocytoma, Childhood Low-grade Cerebral Astrocytoma, Recurrent Adult Brain Tumor, Recurrent Childhood Anaplastic Astrocytoma, Recurrent Childhood Anaplastic Oligoastrocytoma, Recurrent Childhood Anaplastic Oligodendroglioma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Diffuse Astrocytoma, Recurrent Childhood Fibrillary Astrocytoma, Recurrent Childhood Gemistocytic Astrocytoma, Recurrent Childhood Giant Cell Glioblastoma, Recurrent Childhood Glioblastoma, Recurrent Childhood Gliomatosis Cerebri, Recurrent Childhood Oligoastrocytoma, Recurrent Childhood Oligodendroglioma, Recurrent Childhood Pilomyxoid Astrocytoma, Recurrent Childhood Protoplasmic Astrocytoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Childhood Visual Pathway Glioma, Untreated Childhood Anaplastic Astrocytoma, Untreated Childhood Anaplastic Oligoastrocytoma, Untreated Childhood Anaplastic Oligodendroglioma, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebellar Astrocytoma, Untreated Childhood Cerebral Astrocytoma, Untreated Childhood Diffuse Astrocytoma, Untreated Childhood Fibrillary Astrocytoma, Untreated Childhood Gemistocytic Astrocytoma, Untreated Childhood Giant Cell Glioblastoma, Untreated Childhood Glioblastoma, Untreated Childhood Gliomatosis Cerebri, Untreated Childhood Oligoastrocytoma, Untreated Childhood Oligodendroglioma, Untreated Childhood Pilomyxoid Astrocytoma, Untreated Childhood Protoplasmic Astrocytoma, Untreated Childhood Subependymal Giant Cell Astrocytoma, Untreated Childhood Visual Pathway and Hypothalamic Glioma, Untreated Childhood Visual Pathway GliomaView official trial listing → -
Completed NCT NCT02180308
Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI
NYU Langone Health 23 participants Est. completion 2018-09-11 1 siteOther conditions: Head and Neck CancerView official trial listing → -
Completed NCT NCT02182908
FDG PET-Scan Analysis of Evolutivity of Non-surgical Aneurysm of Abdominal Aorta
Not yet reported Central Hospital, Nancy, France 51 participants Est. completion 2013-05 2 sitesOther conditions: Medically-treated Aneurysm of Abdominal AortaView official trial listing → -
Completed NCT NCT02193425
Reliability of the Human Brain Connectome
Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) 112 participants Est. completion 2023-05-23 1 siteOther conditions: Normal PhysiologyView official trial listing → -
Completed NCT NCT02195154
18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular Parkinsonism
Not yet reported Chang Gung Memorial Hospital 13 participants Est. completion 2017-07-31 1 site Stand-aloneOther conditions: Vascular ParkinsonismView official trial listing → -
Terminated NCT NCT02204202
PET Assessment of Acute Lung Transplant Rejection
Washington University School of Medicine 28 participants Est. completion 2017-02-04 1 siteOther conditions: Lung DiseaseView official trial listing → -
Completed NCT NCT02208544
FDG-PET/CT in Evaluation of Cytological Indeterminate Thyroid Nodules to Prevent Unnecessary Surgery (EfFECTS)
Not yet reported Radboud University Medical Center 132 participants Est. completion 2022-02-15 15 sitesOther conditions: Thyroid Nodule, Thyroid NeoplasmsView official trial listing → -
Completed NCT NCT02211768
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
Not yet reported National Cancer Institute (NCI) 10 participants Est. completion 2019-12-30 1 siteOther conditions: Neurofibromatosis, MPNSTView official trial listing → -
Active, not recruiting NCT NCT02213497
Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 30 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Esophageal CancerView official trial listing → -
Terminated NCT NCT02233387
PET CT With HX4 in Cervix Cancer
Not yet reported Maastricht Radiation Oncology 4 participants Est. completion 2018-05 1 siteOther conditions: Cervix CancerView official trial listing → -
Terminated NCT NCT02236546
FDG-PET in Advanced Melanoma
Not yet reported Vanderbilt-Ingram Cancer Center 3 participants Est. completion 2015-11 1 siteOther conditions: Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV MelanomaView official trial listing → -
Completed NCT NCT02237872
Detection of Brown Adipose Tissue by Magnetic Resonance Imaging
University of North Carolina, Chapel Hill 8 participants Est. completion 2015-08-27 2 sitesOther conditions: Obesity, Brown Adipose TissueView official trial listing → -
Active, not recruiting NCT NCT02285192
Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 42 participants Est. completion 2026-11 7 sites Stand-aloneOther conditions: Cervical Cancer, Endometrial CancerView official trial listing → -
Completed NCT NCT02300402
Detection and Characterization of Residual Masses in Lymphomas
The Lymphoma Academic Research Organisation 120 participants Est. completion 2022-12 1 siteOther conditions: Hodgkin Lymphoma, B-Cell LymphomaView official trial listing → -
Completed NCT NCT02305264
Imaging of Intracerebral Inflammation in MS
Not yet reported Assistance Publique - Hôpitaux de Paris 61 participants Est. completion 2018-09-10 2 sites Stand-aloneOther conditions: Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary ProgressiveView official trial listing → -
Completed NCT NCT02317393
Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy
Not yet reported Centre Francois Baclesse 16 participants Est. completion 2020-03 5 sitesOther conditions: Non-seminomatous Germ Cell Tumors, MetastasisView official trial listing → -
Terminated NCT NCT02317783
Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
Not yet reported University of Utah 15 participants Est. completion 2019-09-24 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02325349
PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents
Not yet reported Assistance Publique - Hôpitaux de Paris 1 participants Est. completion 2018-09-20 1 siteOther conditions: Advanced Head and Neck Carcinoma, Advanced Non-small Cell Lung CarcinomaView official trial listing → -
Status unknown NCT NCT02327442
68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients
Xijing Hospital 46 participants Est. completion 2015-12 1 siteOther conditions: Glioma, Breast CancerView official trial listing → -
Completed NCT NCT02334371
MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study
Not yet reported Maastricht University Medical Center 10 participants Est. completion 2016-03 1 siteOther conditions: Ovarian NeoplasmsView official trial listing → -
Completed NCT NCT02339805
Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS
Not yet reported Centre Henri Becquerel 30 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: Non Hodgkin LymphomaView official trial listing → -
Terminated NCT NCT02343757
Alzheimer's Disease Imaging With PET/MRI - Beta-amyloid
Not yet reported University Hospitals Cleveland Medical Center 4 participants Est. completion 2016-11-09 1 siteOther conditions: Dementia, Alzheimer DiseaseView official trial listing → -
Terminated NCT NCT02350426
A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques
Not yet reported GlaxoSmithKline 10 participants Est. completion 2016-10-26 2 sites Stand-aloneOther conditions: Arthritis, RheumatoidView official trial listing → -
Status unknown NCT NCT02352064
Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH)
Not yet reported University Hospital, Caen 26 participants Est. completion 2018-01 1 siteOther conditions: Chronic Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT02378337
Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality
Hospital Sao Rafael 335 participants Est. completion 2016-03 1 siteOther conditions: Malignant Neoplasm of Breast, Hodgkin Disease, Non-Hodgkin Lymphoma, Follicular (Nodular), Malignant Neoplasm of Bronchus and Lung, Malignant Neoplasm of Colon, Secondary Neoplasm Malignant and Unspecified Lymph Nodes, Malignant Melanoma of the Skin, Malignant Neoplasm of Small IntestineView official trial listing → -
Active, not recruiting NCT NCT02379377
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
Not yet reported M.D. Anderson Cancer Center 110 participants Est. completion 2027-05-31 1 site Stand-aloneOther conditions: Adult Hepatocellular Carcinoma, Resectable Hepatocellular Carcinoma, Cholangiocarcinoma, Benign Liver Tumor, Metastases to LiverView official trial listing → -
Active, not recruiting NCT NCT02386709
Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer
Not yet reported Centre Georges Francois Leclerc 275 participants Est. completion 2028-03-25 1 siteOther conditions: FDG PETView official trial listing → -
Status unknown NCT NCT02391246
Radionecrosis and FDG PET
Ottawa Hospital Research Institute 62 participants Est. completion 2020-03 1 siteOther conditions: Malignant GliomaView official trial listing → -
Completed NCT NCT02394743
Correlation Between Estimated Glomerular Filtration Rate(eGFR) and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)
Korea University 360 participants Est. completion 2016-09 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT02409784
PET Study of Cerebral Metabolism of 11C-acetoacetate and 18F-FDG in Patients Under Moderate Ketosis
Not yet reported Université de Sherbrooke 10 participants Est. completion 2015-01Other conditions: HealthyView official trial listing → -
Completed NCT NCT02424656
Alterations in the Brain's Connectome After Severe Traumatic Brain Injury
Danish Research Centre for Magnetic Resonance 35 participants Est. completion 2021-09 1 siteOther conditions: Traumatic Brain Injury, Disorders of ConsciousnessView official trial listing → -
Terminated NCT NCT02429804
NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer
Not yet reported Stanford University 4 participants Est. completion 2017-05-15 1 siteOther conditions: Hormone-Resistant Prostate Cancer, Metastatic Malignant Neoplasm in the Bone, Metastatic Prostate CarcinomaView official trial listing → -
Withdrawn NCT NCT02446379
Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery
Lightpoint Medical Limited 1 siteOther conditions: Gastric Cancer, Pancreatic Cancer, Bile Duct Cancer, Duodenal CancerView official trial listing → -
Completed NCT NCT02448225
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Not yet reported Vanderbilt-Ingram Cancer Center 46 participants Est. completion 2022-10-10 2 sites Stand-aloneOther conditions: Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking BehaviorView official trial listing → -
Completed NCT NCT02455453
Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography
Not yet reported Washington University School of Medicine 47 participants Est. completion 2019-01-03 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02469129
PET Imaging of PARP Activity in Cancer
Not yet reported Washington University School of Medicine 50 participants Est. completion 2025-07 1 site Stand-aloneOther conditions: CancerView official trial listing → -
Completed NCT NCT02481726
68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT
Not yet reported, Not yet reported Xijing Hospital 31 participants Stand-aloneOther conditions: Lung Cancer, Lung TuberculosisView official trial listing → -
Completed NCT NCT02499471
Brown Adipose Tissue Activity and Thyroid Hormone
Not yet reported Maastricht University Medical Center 12 participants Est. completion 2014-07 1 siteOther conditions: Hypothyroidism, Hyperthyroidism, ObesityView official trial listing → -
Completed NCT NCT02500004
Brown Adipose Tissue Activity and Energy Metabolism in Cachexia
Not yet reported Maastricht University Medical Center 16 participants Est. completion 2018-07 1 siteOther conditions: Cachexia, Neoplasms, Pulmonary Disease, Chronic Obstructive, Pancreatic NeoplasmsView official trial listing → -
Completed NCT NCT02510872
Performance of PET 18 F-FDG Coupled to CT With Contrast Injection Iodized in the Diagnosis of Early Recurrences of Head and Neck Carcinoma Treated With Concurrent Chemoradiation. Comparison With 18F-FDG PET Coupled With CT Not Injected With Filling CT Standard Injection
Not yet reported University Hospital, Caen 19 participants 1 site Stand-aloneOther conditions: Squamous Cell Carcinoma of the Head and NeckView official trial listing → -
Completed NCT NCT02515084
Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma
Not yet reported Centre Henri Becquerel 37 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: Thyroid Cancer, RelapseView official trial listing → -
Completed NCT NCT02528695
Adipose Tissue Imaging in Type 2 Diabetes
Not yet reported Radboud University Medical Center 15 participants Est. completion 2017-01 1 site Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT02550613
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
National Taiwan University Hospital 100 participants Est. completion 2018-04 1 siteOther conditions: Hepatocellular CarcinomaView official trial listing → -
Completed NCT NCT02556502
18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study
Not yet reported Central Hospital, Nancy, France 40 participants Est. completion 2017-11 1 siteOther conditions: Amyloid PET ImagingView official trial listing → -
Active, not recruiting NCT NCT02595879
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer
Not yet reported National Cancer Institute (NCI) 21 participants Est. completion 2027-04-29 17 sitesOther conditions: Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma, Advanced Cervical Squamous Cell Carcinoma, Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advanced Vaginal Squamous Cell Carcinoma, Stage IB2 Cervical Cancer AJCC v6 and v7, Stage II Cervical Cancer AJCC v7, Stage II Vaginal Cancer AJCC v6 and v7, Stage III Vaginal Cancer AJCC v6 and v7, Stage IIIB Cervical Cancer AJCC v6 and v7, Stage IVA Cervical Cancer AJCC v6 and v7, Stage IVA Vaginal Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT02599194
18F-FSPG PET/CT for Cancer Patients on Therapy
Not yet reported Andrei Iagaru 7 participants Est. completion 2016-12-14 1 site Stand-aloneOther conditions: B-Cell Neoplasm, Estrogen Receptor Negative, HER2/Neu Negative, Metastatic Renal Cell Cancer, Progesterone Receptor Negative, Stage III Mesothelioma, Stage III Renal Cell Cancer, Stage IIIA Breast Cancer, Stage IIIA Non-Small Cell Lung Cancer, Stage IIIB Non-Small Cell Lung Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer, Stage IV Mesothelioma, Stage IV Non-Small Cell Lung Cancer, Stage IV Renal Cell Cancer, Triple-Negative Breast CarcinomaView official trial listing → -
Completed NCT NCT02599753
Investigating the Microstructural and Functional Alterations of Brain in Parkinson's Disease Patients
Not yet reported Chang Gung Memorial Hospital 35 participants Est. completion 2018-07-31 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02601547
PET-based Evaluation of Chemotherapy-induced Brain Damage in Lymphoma
Not yet reported University Hospital, Toulouse 18 participants Est. completion 2013-03 1 siteOther conditions: LymphomaView official trial listing → -
Withdrawn NCT NCT02607423
Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
Not yet reported ECOG-ACRIN Cancer Research Group Est. completion 2017-01-31 1 site Stand-aloneOther conditions: Stage IIIA Non-Small Cell Lung CancerView official trial listing → -
Terminated NCT NCT02608528
Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy
Abramson Cancer Center at Penn Medicine 10 participants Est. completion 2019-07-18 1 siteOther conditions: Non-Small Cell Lung Cancer (NSCLC)View official trial listing → -
Completed NCT NCT02608619
Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement
Memorial Sloan Kettering Cancer Center 3 participants Est. completion 2018-08 1 siteOther conditions: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, Histiocytic DisordersView official trial listing → -
Status unknown NCT NCT02621541
Nonfunctional Pancreatic NET and PET Imaging
Not yet reported Turku University Hospital 20 participants Est. completion 2019-02 2 sitesOther conditions: DiagnosisView official trial listing → -
Completed NCT NCT02664792
Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer
Not yet reported Latin American Cooperative Oncology Group 108 participants Est. completion 2016-12 1 siteOther conditions: Non-small Cell Lung CarcinomaView official trial listing → -
Terminated NCT NCT02666547
68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis
Not yet reported University of Lausanne Hospitals 42 participants Est. completion 2023-09 1 siteOther conditions: Pathological AngiogenesisView official trial listing → -
Terminated NCT NCT02666599
Per-operating Use of a Probe for Detection of β+
Not yet reported University of Lausanne Hospitals 5 participants Est. completion 2024-03-30 1 site Stand-aloneOther conditions: NeoplasmsView official trial listing → -
Completed NCT NCT02678884
Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
Not yet reported University Health Network, Toronto 19 participants Est. completion 2025-01-13 1 siteOther conditions: Head and Neck Squamous Cell CarcinomaView official trial listing → -
Status unknown NCT NCT02697669
The Role of Nuclear Imaging in Heart Failure
Far Eastern Memorial Hospital 200 participants Est. completion 2018-12 1 siteHeart failureView official trial listing → -
Completed NCT NCT02708485
Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease
Not yet reported Université de Sherbrooke 15 participants Est. completion 2017-07 1 siteOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT02717572
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Not yet reported Washington University School of Medicine 19 participants Est. completion 2017-06-05 1 siteOther conditions: Solid Tumor, AdultView official trial listing → -
Status unknown NCT NCT02733887
MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma
Not yet reported Guangxi Medical University 66 participants 1 site Stand-aloneOther conditions: LymphomaView official trial listing → -
Completed NCT NCT02751710
Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer
Not yet reported Ontario Clinical Oncology Group (OCOG) 369 participants Est. completion 2023-03-31 6 sitesOther conditions: Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4), Stage IIb Breast Cancer (T3N0)View official trial listing → -
Completed NCT NCT02754375
SMTr-METAB : FDG-PET Assessment of Cerebral Metabolism in Resistant Depression Treated With rTMS
Not yet reported Centre Hospitalier Universitaire de Nice 22 participants Est. completion 2020-03-20 2 sitesOther conditions: DepressionView official trial listing → -
Status unknown NCT NCT02759978
Individualized Diagnosis of Endocarditis and Its Therapy With a Focus on Infected Prosthetic materiAL
University Medical Center Groningen 300 participants Est. completion 2023-05 1 siteOther conditions: Endocarditis, Prosthetic Material Related InfectionView official trial listing → -
Completed NCT NCT02763735
Right Ventricular Metabolism in Pulmonary Arterial Hypertension
Vanderbilt University Medical Center 34 participants Est. completion 2019-06 1 siteOther conditions: Pulmonary Arterial Hypertension, HealthyView official trial listing → -
Completed NCT NCT02783053
Metformin and Core Temperature in Obese and Lean Males
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 18 participants Est. completion 2016-06 1 siteOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT02805608
uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer
Not yet reported Copenhagen University Hospital, Rigshospitalet 40 participants Est. completion 2019-01 1 site Stand-aloneOther conditions: Urinary Bladder NeoplasmsView official trial listing → -
Terminated NCT NCT02810873
Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 19 participants Est. completion 2012-07Other conditions: Breast CarcinomaView official trial listing → -
Terminated NCT NCT02824419
Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis
Not yet reported, Not yet reported Turku University Hospital 5 participants Est. completion 2017-12 1 siteOther conditions: Pulmonary SarcoidosisView official trial listing → -
Status unknown NCT NCT02845570
Evaluation of Somatostatin Receptor Imaging Using PET/MRI as a Novel Approach to Detecting Pathology in Pulmonary TB
Not yet reported National University Hospital, Singapore 8 participants 2 sites Stand-aloneOther conditions: TuberculosisView official trial listing → -
Terminated NCT NCT02847468
Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Not yet reported Centre Georges Francois Leclerc 61 participants Est. completion 2021-12-23 1 siteOther conditions: Carcinoma, HepatocellularView official trial listing → -
Completed NCT NCT02850302
Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET
Not yet reported Centre Georges Francois Leclerc 23 participants Est. completion 2017-10-31 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT02855190
Comparative Study With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection
Not yet reported Chang Gung Memorial Hospital 30 participants Est. completion 2018-12 1 site Stand-aloneOther conditions: Infection and Inflammatory Reaction Due to Internal Joint ProsthesisView official trial listing → -
Completed NCT NCT02886793
Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects
Not yet reported, Not yet reported Joan Albert Barbera Mir 65 participants Est. completion 2018-08Other conditions: Pulmonary HypertensionView official trial listing → -
Terminated NCT NCT02891616
18F-FLT PET Imaging in Patients With Advanced Melanoma
Not yet reported Washington University School of Medicine 4 participants Est. completion 2017-12-31 1 siteOther conditions: MelanomaView official trial listing → -
Withdrawn NCT NCT02899325
FDGal PET/CT to Detect Hepatocellular Carcinoma
British Columbia Cancer Agency Est. completion 2021-10 1 siteOther conditions: Hepatocellular Carcinoma, Liver Cirrhosis, Chronic Liver DiseaseView official trial listing → -
Completed NCT NCT02899377
A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts
Not yet reported GlaxoSmithKline 25 participants Est. completion 2018-07-12 4 sites Stand-aloneOther conditions: Autoimmune DiseasesView official trial listing → -
Withdrawn NCT NCT02919332
Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
Jonsson Comprehensive Cancer Center Est. completion 2018-12-12 1 siteOther conditions: Glioblastoma, GliomaView official trial listing → -
Completed NCT NCT02921581
ReIrradiation With FDG-PET Guided Dose Painting
Not yet reported Oslo University Hospital 10 participants Est. completion 2023-08 1 siteOther conditions: Head and Neck CancerView official trial listing → -
Status unknown NCT NCT02928861
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma
Not yet reported Peking University Cancer Hospital & Institute 100 participants Est. completion 2018-12 2 sites Stand-aloneOther conditions: Lymphoma, Large B-Cell, DiffuseView official trial listing → -
Status unknown NCT NCT02931201
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma
Not yet reported Peking University Cancer Hospital & Institute 100 participants Est. completion 2018-12 1 site Stand-aloneOther conditions: Lymphoma, Large B-Cell, DiffuseView official trial listing → -
Completed NCT NCT02933645
Effects of Intranasal Insulin Administration on Tissue Specific Insulin Sensitivity
Not yet reported Turku University Hospital 10 participants Est. completion 2016-12 1 siteOther conditions: Insulin ResistanceView official trial listing → -
Status unknown NCT NCT02938546
18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study
Not yet reported Shanghai Chest Hospital 200 participants Est. completion 2023-01 Stand-aloneOther conditions: Non-small-cell Lung CancerView official trial listing → -
Completed NCT NCT02941172
CB1 Receptors in Human Brown Adipose Tissue
Not yet reported Turku University Hospital 18 participants Est. completion 2017-12-30 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT02953197
18F-FDG-PET Guided Dose-Painting With Intensity Modulated Radiotherapy in Oropharyngeal Tumours
Not yet reported Guy's and St Thomas' NHS Foundation Trust 26 participants Est. completion 2019-01-31 1 siteOther conditions: Oropharyngeal CancerView official trial listing → -
Completed NCT NCT02955966
PET/CT Guided Antifungal Stewardship in Invasive Pulmonary Aspergillosis
Not yet reported Assistance Publique - Hôpitaux de Paris 51 participants Est. completion 2022-05-02 1 site Stand-aloneOther conditions: Aspergillosis and Haematological MalignancyView official trial listing → -
Status unknown NCT NCT02967666
Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts
Not yet reported National University Hospital, Singapore 30 participants 2 sitesOther conditions: Tuberculosis, PulmonaryView official trial listing → -
Status unknown NCT NCT02969278
Groin Sentinel Node Biopsy and 18FDG-PET/CT in cN0 Vulvar Cancer Patients Candidate to Standard Lymphadenectomy
Not yet reported Catholic University of the Sacred Heart 50 participants Est. completion 2017-07 1 siteOther conditions: Vulvar CancerView official trial listing → -
Terminated NCT NCT02970851
Bosentan in Myocardium Metabolism and Perfusion Measured by 18F-FDG and 82Rb PET/CT on PAH and CTEPH
University of Lausanne Hospitals 2 participants Est. completion 2018-12-31 1 siteOther conditions: Myocardial Dysfunction, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT02977754
18F-FDG PET in HCC Patients Candidate to Treatment With Sorafenib
Istituto Clinico Humanitas 13 participants Est. completion 2019-03 1 siteOther conditions: HCCView official trial listing → -
Status unknown NCT NCT02985424
Polymyalgia Rheumatica and Giant Cell Arteritis
Svendborg Hospital 80 participants Est. completion 2020-02 1 siteOther conditions: Polymyalgia Rheumatica, Giant Cell ArteritisView official trial listing → -
Completed NCT NCT02999490
18F-FDG PET/CT in Diagnostic Patients of Disorder of Consciousness
Not yet reported Guangzhou General Hospital of Guangzhou Military Command 20 participants Est. completion 2017-12-05 1 site Stand-aloneOther conditions: Persistent Vegetative StateView official trial listing → -
Status unknown NCT NCT03015298
Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer
Chinese PLA General Hospital 100 participants Est. completion 2018-06Other conditions: Gastric Cancer StageView official trial listing → -
Completed NCT NCT03015818
Assessment of Osteoblastic Activity With 18F-Fluoride in Aortic Bioprosthesis Structural Valve Dysfunction (SVD)
Not yet reported Nantes University Hospital 25 participants Est. completion 2019-05-03 1 site Stand-aloneOther conditions: Aortic Bioprosthesis Structural Valve DysfunctionView official trial listing → -
Completed NCT NCT03024359
Monounsaturated Fatty Acids and Brown/Beige Adipose Tissue in Humans
Not yet reported University of Campinas, Brazil 45 participants Est. completion 2020-07 1 siteOther conditions: ObeseView official trial listing → -
Status unknown NCT NCT03029793
Biomarkers and Functional Imaging in Predicting Response of Esophageal Cancer
Air Force Military Medical University, China 200 participants Est. completion 2020-01 1 siteOther conditions: Esophageal CancerView official trial listing → -
Status unknown NCT NCT03030365
Orientation in AD Patients: PET-MR Study
Assuta Medical Center 30 participants Est. completion 2020-02-15Other conditions: Alzheimer Disease, Mild Cognitive ImpairmentView official trial listing → -
Enrolling by invitation NCT NCT03032601
Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis
Not yet reported Thomas Jefferson University 55 participants Est. completion 2027-07-08 1 siteOther conditions: Multiple SclerosisView official trial listing → -
Status unknown NCT NCT03033485
18F-Labeled Picolinamide PET Imaging of Melanoma Diagnosis
Not yet reported Xijing Hospital 50 participants Est. completion 2018-12 1 siteOther conditions: MelanomaView official trial listing → -
Status unknown NCT NCT03051542
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma
Not yet reported Peking University Cancer Hospital & Institute 60 participants Est. completion 2020-12-31 1 site Stand-aloneOther conditions: Lymphoma, Extranodal NK-T-CellView official trial listing → -
Status unknown NCT NCT03051555
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma
Not yet reported Peking University Cancer Hospital & Institute 60 participants Est. completion 2020-12-31 1 site Stand-aloneOther conditions: Lymphoma, Extranodal NK-T-CellView official trial listing → -
Status unknown NCT NCT03051568
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma
Not yet reported Peking University Cancer Hospital & Institute 80 participants Est. completion 2020-12-31 1 site Stand-aloneOther conditions: Lymphoma, T-Cell, PeripheralView official trial listing → -
Status unknown NCT NCT03051581
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma
Not yet reported Peking University Cancer Hospital & Institute 80 participants Est. completion 2020-12-31 1 site Stand-aloneOther conditions: Lymphoma, T-Cell, PeripheralView official trial listing → -
Terminated NCT NCT03065790
Early FDG PET/CT Imaging as a Measure of Response in Patients With Non-Hodgkin Lymphoma on Lenalidomide
Abramson Cancer Center at Penn Medicine 1 participants Est. completion 2021-04-28 1 siteOther conditions: Non-Hodgkin LymphomaView official trial listing → -
Completed NCT NCT03089606
Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker
Not yet reported UNC Lineberger Comprehensive Cancer Center 27 participants Est. completion 2023-07-01 2 sitesOther conditions: MelanomaView official trial listing → -
Completed NCT NCT03100227
(18)F-FDG PET Database of Adult Healthy Individuals
Not yet reported Hospices Civils de Lyon 41 participants Est. completion 2017-07-06 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT03106688
Neuromolecular Risk Factors for Obesity (PROSPECT)
Not yet reported Turku University Hospital 60 participants Est. completion 2022-12-01 1 siteOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT03121456
18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma
Not yet reported Centre Antoine Lacassagne 74 participants Est. completion 2024-04-12 1 site Stand-aloneOther conditions: Diffuse Large B Cell LymphomaView official trial listing → -
Terminated NCT NCT03123289
Novel Gallium 68 Citrate in Orthopedic Infections
Not yet reported Rutgers, The State University of New Jersey 1 participants Est. completion 2020-10-14 1 site Stand-aloneOther conditions: Joint ProsthesisView official trial listing → -
Completed NCT NCT03125629
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
Not yet reported Stanford University 53 participants Est. completion 2020-02-05 1 site Stand-aloneOther conditions: Cancer Diagnosis, Diagnostic Techniques and Procedures, Diagnostic ImagingView official trial listing → -
Terminated NCT NCT03129776
Hyperpolarized 13C MR Imaging of Lactate in Patients With Locally Advanced Cervical Cancer (LACC) Cervical Cancer
Not yet reported Sunnybrook Health Sciences Centre 4 participants Est. completion 2022-09-15 1 siteOther conditions: Uterine Cervical NeoplasmsView official trial listing → -
Completed NCT NCT03130036
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Risk Factors for Alzheimer's Disease
Not yet reported Wake Forest University Health Sciences 42 participants Est. completion 2024-06-19 1 siteOther conditions: Mild Cognitive ImpairmentView official trial listing → -
Status unknown NCT NCT03130205
Biomarker Study in Pancreatic Neuroendocrine Tumours
Uppsala University 30 participants Est. completion 2022-01-01 1 siteOther conditions: Neuroendocrine TumorsView official trial listing → -
Active, not recruiting NCT NCT03161353
Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.
Not yet reported MedSIR 377 participants Est. completion 2026-11-01 56 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03163979
Individualized Precise Radiotherapy With the Guidance of Radiosensitivity of Locally Advanced Cervical Cancer
Not yet reported, Not yet reported Nanjing Medical University 300 participants Est. completion 2019-07-31 1 siteOther conditions: Cervical CancerView official trial listing → -
Active, not recruiting NCT NCT03173924
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
Not yet reported National Cancer Institute (NCI) 98 participants Est. completion 2028-02-06 1 site Stand-aloneOther conditions: Metastatic Prostate Cancer, Prostatic Neoplasms, Prostate Cancer, Prostatic Cancer, Prostate NeoplasmsView official trial listing → -
Status unknown NCT NCT03174080
PET MRI for Evaluation of Knee Osteoarthritis in Patients With Bilateral Knee OA
Assuta Medical Center 150 participants Est. completion 2018-07OsteoarthritisView official trial listing → -
Active, not recruiting NCT NCT03181867
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
Not yet reported National Cancer Institute (NCI) 385 participants Est. completion 2031-02-01 1 site Stand-aloneOther conditions: Prostate Neoplasms, Prostatic Cancer, Prostate Cancer, Cancer Of Prostate, Metastatic Prostate CancerView official trial listing → -
Completed NCT NCT03188354
Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma
Not yet reported Norwegian University of Science and Technology 3 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Lymphoma, Non-Hodgkin, Central Nervous System NeoplasmsView official trial listing → -
Completed NCT NCT03191643
PET-guided External Beam Radiotherapy in Differentiated Thyroid Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 16 participants Est. completion 2016-01-31Other conditions: Differentiated Thyroid CancerView official trial listing → -
Completed NCT NCT03195270
Use of PET/MR Imaging in Chronic Pain
Not yet reported Stanford University 88 participants Est. completion 2022-01-20 1 siteOther conditions: Chronic PainView official trial listing → -
Completed NCT NCT03200132
Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)
Maastricht University Medical Center 15 participants Est. completion 2021-10-14 1 siteOther conditions: Cardiac ImagingView official trial listing → -
Terminated NCT NCT03219073
Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis
Not yet reported Thorsten Rudroff 1 participants Est. completion 2018-07-01 1 siteOther conditions: Multiple Sclerosis, Neuropathic PainView official trial listing → -
Terminated NCT NCT03231397
Predictors of AAA Expansion and/or Rupture
Not yet reported Washington University School of Medicine 2 participants Est. completion 2020-04-30 1 siteOther conditions: Abdominal Aortic Aneurysm (AAA)View official trial listing → -
Completed NCT NCT03268369
PET Study of the Nicotinic System in Epilepsy
Not yet reported Fabienne PICARD 48 participants Est. completion 2015-11Other conditions: EpilepsyView official trial listing → -
Completed NCT NCT03272997
The Value of PET-CT in Pleural Effusions
Naestved Hospital 112 participants Est. completion 2019-01-30 1 siteOther conditions: Pleural Effusion, MalignantView official trial listing → -
Completed NCT NCT03279393
PPG Project 3 - PET/MRI of the Brain-hematopoiesis-atherosclerosis Axis in PTSD Patients
Not yet reported Zahi Fayad 190 participants Est. completion 2023-02-14 2 sitesOther conditions: PTSD, Trauma, HealthyView official trial listing → -
Status unknown NCT NCT03288597
Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms
Peking University 146 participants Est. completion 2020-09-01 1 siteOther conditions: Neuroendocrine TumorsView official trial listing → -
Withdrawn NCT NCT03295695
PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient
Not yet reported H. Lee Moffitt Cancer Center and Research Institute Est. completion 2022-12 1 siteOther conditions: Breast Cancer, Breast Cancer, Female, Breast Cancer, Male, Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT03312712
Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation
Cambridge University Hospitals NHS Foundation Trust 36 participants Est. completion 2022-01 2 sitesOther conditions: Lung Inflammation, SarcoidosisView official trial listing → -
Completed NCT NCT03318497
Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma
Not yet reported University of Texas Southwestern Medical Center 6 participants Est. completion 2021-06-15 1 site Stand-aloneOther conditions: Pancreatic AdenocarcinomaView official trial listing → -
Completed NCT NCT03345290
Impact of the Central Blood Pressure Level in Cerebral Metabolic Aging: a 18F-FDG PET Study.
Not yet reported Central Hospital, Nancy, France 92 participants Est. completion 2020-11-06 1 siteOther conditions: Aging DisorderView official trial listing → -
Completed NCT NCT03352037
18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study
Not yet reported University Health Network, Toronto 11 participants Est. completion 2018-07-31 1 siteOther conditions: Pancreatic Cystic NeoplasmsView official trial listing → -
Completed NCT NCT03356470
Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
University of Wisconsin, Madison 5 participants Est. completion 2022-06-17 1 siteOther conditions: MelanomaView official trial listing → -
Completed NCT NCT03356756
PET MRI Study in Patients With Cardiac Sarcoidosis
University Health Network, Toronto 40 participants Est. completion 2024-02-23 1 siteOther conditions: Inflammatory Cardiomyopathy, SarcoidosisView official trial listing → -
Completed NCT NCT03370809
Assessment of Positron Emission Tomography to Early Detect Frailty in Onco-geriatry
Not yet reported Central Hospital, Nancy, France 37 participants Est. completion 2022-08-10 1 site Stand-aloneOther conditions: Patients Over 75 Years Old With a Cancer DiscoveryView official trial listing → -
Status unknown NCT NCT03373994
Perfusion and Hypoxia Evaluation in Tumors Using 18F-FDG PET/CT
Harbin Medical University 40 participants Est. completion 2020-12-31 1 siteOther conditions: Perfusion and HypoxiaView official trial listing → -
Status unknown NCT NCT03385148
The Clinical Application of 68Ga Labeled ssDNA Aptamer Sgc8 in Healthy Volunteers and Colorectal Patients
Not yet reported Xijing Hospital 70 participants Est. completion 2019-12-30 2 sites Stand-aloneOther conditions: Colorectal CancerView official trial listing → -
Completed NCT NCT03403127
PET CT Re-Planning NSCLC (4DCT-PET)
Not yet reported University Health Network, Toronto 36 participants Est. completion 2020-04-28Other conditions: Lung Cancer, Non-Small Cell Lung CancerView official trial listing → -
Status unknown NCT NCT03404414
Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT
Not yet reported Peking Union Medical College Hospital 100 participants Est. completion 2018-11 1 site Stand-aloneOther conditions: Pituitary AdenomaView official trial listing → -
Terminated NCT NCT03423082
Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer.
Not yet reported Nghi Nguyen 1 participants Est. completion 2019-12-18 1 siteOther conditions: Cervical Cancer, Uterine CancerView official trial listing → -
Completed NCT NCT03429868
PET and MRI in Prognosis Prediction of NPC
Not yet reported Chang Gung Memorial Hospital 180 participants Est. completion 2020-07-31 1 site Stand-aloneOther conditions: Nasopharyngeal CarcinomaView official trial listing → -
Terminated NCT NCT03432741
Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer
Not yet reported Mayo Clinic 17 participants Est. completion 2022-10-03 1 siteOther conditions: Breast Adenocarcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma, Recurrent Hodgkin Lymphoma, Recurrent Mycosis Fungoides, Recurrent Non-Hodgkin Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Breast Carcinoma, Refractory Hodgkin Lymphoma, Refractory Mycosis Fungoides, Refractory Nodal Marginal Zone Lymphoma, Refractory Non-Hodgkin Lymphoma, Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Status unknown NCT NCT03458585
Radiation Exposure Awareness From Patients Undergoing Nuclear Medicine Diagnostic Scans
Royal Marsden NHS Foundation Trust 100 participants Est. completion 2018-12-31 1 siteOther conditions: Skeletal Scintigraphy, FDG PET/CTView official trial listing → -
Completed NCT NCT03465098
Evaluation of a Metabolic Preparation by a Low-carbohydrate Diet as Atkins-diet to Help in Detecting Infective Endocarditis by 18F-FDG PET
Not yet reported Central Hospital, Nancy, France 26 participants Est. completion 2021-08-03 1 site Stand-aloneOther conditions: Infective EndocarditisView official trial listing → -
Completed NCT NCT03485170
PET Imaging of Hemophilic Arthropathy
Not yet reported Tri-Service General Hospital (TSGH) 20 participants Est. completion 2018-12-31 1 siteOther conditions: Hemophilia, Arthropathy, InflammationView official trial listing → -
Completed NCT NCT03506529
Identification of Predictive Factors for Physiological Hypermetabolism of the Anal Canal in 18F-FDG PET / CT
Centre Francois Baclesse 644 participants Est. completion 2018-11-15 2 sitesOther conditions: Anal CancerView official trial listing → -
Active, not recruiting NCT NCT03507257
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Indiana University 850 participants Est. completion 2027-01-01 23 sitesOther conditions: Early Onset Alzheimer Disease, Alzheimer Disease, Mild Cognitive ImpairmentView official trial listing → -
Terminated NCT NCT03513042
Early Response Evaluation of Proton Therapy by PET-imaging in Squamous Cell Carcinoma Located in the Head and Neck
Leiden University Medical Center 12 participants Est. completion 2022-11-23 1 siteOther conditions: Squamous Cell Carcinoma of the Head and NeckView official trial listing → -
Status unknown NCT NCT03519659
Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT
Not yet reported University of Cincinnati 190 participants Est. completion 2024-12-31 1 site Stand-aloneOther conditions: PET/CT ImagingView official trial listing → -
Status unknown NCT NCT03557138
Study to Develop a Kinetic Model for FDG and Me4FDG in Kidneys of Type 2 Diabetic Patients
Not yet reported Medical University of Vienna 20 participants Est. completion 2020-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT03561025
Diagnostic Potential of PET/MRI in Cardiac Sarcoidosis
Not yet reported St. Olavs Hospital 33 participants Est. completion 2020-10-01 1 site Stand-aloneOther conditions: Sarcoidosis, CardiomyopathiesView official trial listing → -
Status unknown NCT NCT03568799
4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 30 participants Est. completion 2019-12-31 1 site Stand-aloneOther conditions: Lung Cancer, Solitary Pulmonary Nodule, Cigarette Smoking BehaviorView official trial listing → -
Status unknown NCT NCT03572595
F-18 FDG- PETCT in Staging and Recurrent Colorectal Cancer
Assiut University 45 participants Est. completion 2020-02-01Other conditions: Colo-rectal Cancer, RecurrenceView official trial listing → -
Completed NCT NCT03575949
Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer
Not yet reported M.D. Anderson Cancer Center 14 participants Est. completion 2024-05-10 1 siteOther conditions: Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Malignant Neoplasm in the SpineView official trial listing → -
Status unknown NCT NCT03582254
Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years
Not yet reported Assistance Publique - Hôpitaux de Paris 62 participants Est. completion 2023-05-12 1 siteOther conditions: Primary Central Nervous System LymphomaView official trial listing → -
Active, not recruiting NCT NCT03583528
DOTATOC PET/CT for Imaging NET Patients
British Columbia Cancer Agency 800 participants Est. completion 2028-09-30 1 siteOther conditions: Neuroendocrine Tumors, Insulinoma, Gastrinoma, Glucagonoma, Vipoma, Pheochromocytoma, Paraganglioma, Neuroblastoma, Ganglioneuroma, Medullary Carcinoma, Pituitary Adenoma, Medulloblastoma, Merkel Cell Carcinoma, Small-cell Lung Cancer, Meningioma, CarcinoidView official trial listing → -
Completed NCT NCT03590769
Arterial Imaging of Inflammation and Resolution After Endovascular Surgery
Not yet reported University of California, San Francisco 9 participants Est. completion 2019-09-03 2 sites Stand-aloneAlcohol use disorder Other conditions: Peripheral Arterial Disease, PAD, SFA - Superficial Femoral Artery Stenosis, Iliac Artery Disease, Vascular CalcificationView official trial listing → -
Completed NCT NCT03602911
A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients
Not yet reported West Virginia University 20 participants Est. completion 2021-04-01 1 siteOther conditions: Head and Neck Squamous Cell CarcinomaView official trial listing → -
Completed NCT NCT03626571
PET/MR Imaging In Patients With Infective Endocarditis
University of Edinburgh 5 participants Est. completion 2024-10-28 1 siteOther conditions: Infective EndocarditisView official trial listing → -
Withdrawn NCT NCT03636607
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma
Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Positron-Emission Tomography, Carcinoma, HepatocellularView official trial listing → -
Completed NCT NCT03656250
Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI
NYU Langone Health 17 participants Est. completion 2018-11-19 1 siteOther conditions: Nasopharyngeal CancerView official trial listing → -
Completed NCT NCT03683355
Characterization of RadiOlabeled Tracer Uptake Pattern in Noninfected Transcatheter Aortic Valves.
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec 30 participants Est. completion 2025-03-01 1 siteOther conditions: Infective EndocarditisView official trial listing → -
Completed NCT NCT03688698
PET/MRI in PAH Patients
Medical University of Bialystok 37 participants Est. completion 2018-01-01Other conditions: Pulmonary Arterial HypertensionView official trial listing → -
Status unknown NCT NCT03695731
Influence of Diabetic Neuropathy on Activation of Brown Adipose Tissue
Not yet reported Doctor Giacomo Gastaldi 24 participants Est. completion 2019-10-15 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03695861
Contribution of 18F-FDG PET-CT in the Diagnosis and the Detection of Peripheral Emboli of Infectious Endocarditis on Native Valves
Not yet reported University Hospital, Bordeaux 31 participants Est. completion 2020-09-16 1 site Stand-aloneOther conditions: EndocarditisView official trial listing → -
Completed NCT NCT03705884
PET/MR Imaging In Patients With Cardiac Sarcoidosis
Not yet reported University of Edinburgh 40 participants Est. completion 2018-12-01 1 siteOther conditions: Cardiac SarcoidosisView official trial listing → -
Terminated NCT NCT03712046
Comparison of FDG PET and Bone Scintigraphy/Labelled Leukocyte/Gallium Scintigraphy in Diabetic Foot Osteomyelitis
Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 2 participants Est. completion 2019-11-10 1 site Stand-aloneOther conditions: Diabetic Foot InfectionView official trial listing → -
Status unknown NCT NCT03721055
Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor
Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2019-12-31 1 site Stand-aloneOther conditions: Cancer, Metastatic Cancer, Metastatic Brain CancerView official trial listing → -
Completed NCT NCT03726931
FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET
Not yet reported Amsterdam UMC, location VUmc 40 participants Est. completion 2023-01-29 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03732352
18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
Not yet reported Jonsson Comprehensive Cancer Center 12 participants Est. completion 2024-01-31 1 site Stand-aloneOther conditions: EGFR Gene Amplification, EGFR Gene Mutation, Glioblastoma, Recurrent Glioblastoma, Supratentorial Glioblastoma, TP53 Wt AlleleView official trial listing → -
Completed NCT NCT03733210
Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer
Not yet reported Andrei Iagaru 14 participants Est. completion 2021-08-09 1 site Stand-aloneOther conditions: Squamous Cell Carcinoma of the Head and Neck, Carcinoma of the Head and NeckView official trial listing → -
Completed NCT NCT03740126
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy
Not yet reported Copenhagen University Hospital, Rigshospitalet 750 participants Est. completion 2026-08-01 3 sites Stand-aloneOther conditions: Carcinoma, Non-Small-Cell LungView official trial listing → -
Status unknown NCT NCT03741517
Biomarker Study of Pancreatic Neuroendocrine Tumours
Uppsala University 40 participants Est. completion 2024-12-31 1 siteOther conditions: Pancreatic Neuroendocrine TumorView official trial listing → -
Status unknown NCT NCT03756077
A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100 participants Est. completion 2023-12-31 1 siteOther conditions: Prostate Cancer, PET/MR, PET/CTView official trial listing → -
Completed NCT NCT03765424
Evaluation of Ultrasound and PET/CT in the Diagnosis and Monitoring of Giant Cell Arteritis
University of Aarhus 101 participants Est. completion 2018-12-31Other conditions: Giant Cell Arteritis, VasculitisView official trial listing → -
Completed NCT NCT03777839
PET-FDG in Myocarditis
Montreal Heart Institute 25 participants Est. completion 2024-08-31 1 siteOther conditions: Myocarditis, Viral MyocarditisView official trial listing → -
Completed NCT NCT03781284
PET Combined With MRI for Monitoring Inflammatory Activity in Patients With Ulcerative Colitis
Not yet reported Universität Duisburg-Essen 53 participants Est. completion 2018-10-31Other conditions: Ulcerative ColitisView official trial listing → -
Active, not recruiting NCT NCT03789240
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
Not yet reported National Cancer Institute (NCI) 33 participants Est. completion 2027-01-01 1 site Stand-aloneOther conditions: Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHLView official trial listing → -
Active, not recruiting NCT NCT03811015
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
Not yet reported National Cancer Institute (NCI) 636 participants Est. completion 2030-01-31 727 sitesOther conditions: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8View official trial listing → -
Completed NCT NCT03824535
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Not yet reported Andrei Iagaru 15 participants Est. completion 2021-07-30 1 site Stand-aloneOther conditions: Cigarette Smoker, Current Smoker, Former Smoker, Multiple Pulmonary Nodules, Pulmonary NoduleView official trial listing → -
Status unknown NCT NCT03839706
Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation
Not yet reported University Health Network, Toronto 20 participants Est. completion 2024-09 1 siteOther conditions: Hepatocellular CarcinomaView official trial listing → -
Status unknown NCT NCT03843515
Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction
Not yet reported Amsterdam UMC, location VUmc 17 participants Est. completion 2022-08-31 1 siteOther conditions: Oral Cavity Squamous Cell CarcinomaView official trial listing → -
Completed NCT NCT03847480
Dose Painting of Head and Neck Cancer
Not yet reported Oslo University Hospital 7 participants Est. completion 2022-12-16 1 siteOther conditions: Head and Neck CancerView official trial listing → -
Status unknown NCT NCT03876912
The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer
Not yet reported Turku University Hospital 35 participants Est. completion 2023-03-01 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT03891914
Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma
Not yet reported University Hospital, Bordeaux 20 participants Est. completion 2023-01-31 1 site Stand-aloneOther conditions: Myeloma MultipleView official trial listing → -
Terminated NCT NCT03923049
Feasibility and Accuracy of Hybrid Magnetic Resonance and Positron Emission Tomography With 18F-Fluorodeoxyglucose in Diagnosing Cardiac Sarcoidosis
Not yet reported University of Alabama at Birmingham 5 participants Est. completion 2020-12-02 1 siteOther conditions: Cardiac SarcoidosisView official trial listing → -
Status unknown NCT NCT03937583
Screening for Cancer in Patients With Unprovoked VTE
Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 650 participants Est. completion 2023-12-31 17 sitesOther conditions: Venous Thromboembolic Disease, Respiratory Disease, Pulmonary Disease, Deep Venous Thrombosis, Pulmonary Embolism, Screening, UndefinedView official trial listing → -
Active, not recruiting NCT NCT03952585
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
Not yet reported, Not yet reported National Cancer Institute (NCI) 384 participants Est. completion 2026-12-11 494 sitesOther conditions: Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Oropharyngeal Squamous Cell Carcinoma, Papillary Squamous Cell Carcinoma, Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Squamous Cell CarcinomaView official trial listing → -
Completed NCT NCT03973164
The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma
Guangxi Medical University 142 participants Est. completion 2019-05-22 1 siteOther conditions: LymphomaView official trial listing → -
Completed NCT NCT04000776
3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer
Université de Sherbrooke 100 participants Est. completion 2023-06-30 5 sitesOther conditions: Metastatic Castration-resistant Prostate CancerView official trial listing → -
Status unknown NCT NCT04001023
Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia
Not yet reported Turku University Hospital 40 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma, HypoxiaView official trial listing → -
Status unknown NCT NCT04001491
Interest of 18F-FDG Positron Emission Tomography in the Management of Fevers and Inflammatory Syndromes
University Hospital, Strasbourg, France 150 participants Est. completion 2020-08 1 siteOther conditions: InflammationView official trial listing → -
Completed NCT NCT04006626
18F-FES PET/CT's Additional Clinical Value in ER+ BC
Fudan University 19 participants Est. completion 2019-06-20 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04008095
Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer
University Hospital, Brest 40 participants Est. completion 2026-02-05 2 sitesOther conditions: Cervical CancerView official trial listing → -
Withdrawn NCT NCT04016818
Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution
Not yet reported Stanford University Est. completion 2027-12 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04017104
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
British Columbia Cancer Agency 60 participants Est. completion 2024-08-01 1 siteOther conditions: Neuroendocrine Tumors, Prostate Cancer, Prostatic Neoplasms, Carcinoid Tumor, Paraganglioma, NeuroblastomaView official trial listing → -
Completed NCT NCT04020978
Parametric PET of Genitourinary Cancer
Not yet reported University of California, Davis 11 participants Est. completion 2023-12-15 1 siteOther conditions: Genitourinary CancerView official trial listing → -
Status unknown NCT NCT04036643
Rectal Cancer Response Hybrid Imaging Assessement
Not yet reported Assistance Publique - Hôpitaux de Paris 96 participants Est. completion 2023-02 1 siteOther conditions: Rectal CancerView official trial listing → -
Status unknown NCT NCT04045834
Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60 participants Est. completion 2023-12-31 1 siteOther conditions: PET / CT, PET / MR, Neuroendocrine Tumors, OsteomalaciaView official trial listing → -
Completed NCT NCT04080271
Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases.
Assiut University 66 participants Est. completion 2021-12-01 1 siteOther conditions: Bone MetastasesView official trial listing → -
Terminated NCT NCT04082988
Early Response Evaluation in NSCLC Patients Treated With Immunotherapy
Not yet reported The Netherlands Cancer Institute 9 participants Est. completion 2020-05-22 2 sitesOther conditions: NSCLC, Stage IVView official trial listing → -
Completed NCT NCT04110743
EXPLORER PET/CT in Healthy Volunteers
Not yet reported University of California, Davis 30 participants Est. completion 2020-02-06 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT04114370
Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Glioma
Not yet reported James Mountz 9 participants Est. completion 2021-09-30 1 siteOther conditions: GliomaView official trial listing → -
Status unknown NCT NCT04117139
The Diagnostic Value of PET/MRI in Head and Neck Cancer
Not yet reported Odense University Hospital 142 participants Est. completion 2022-09-30 1 siteOther conditions: Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymph Node MetastasesView official trial listing → -
Completed NCT NCT04125862
Pain in Fibrous Dysplasia
Not yet reported Boston Children's Hospital 37 participants Est. completion 2025-12-01 1 siteOther conditions: Fibrous Dysplasia/McCune-Albright SyndromeView official trial listing → -
Status unknown NCT NCT04127981
Medical Imaging of Cachexia
Not yet reported Olivia Newton-John Cancer Research Institute 40 participants Est. completion 2023-12-28 1 siteOther conditions: Cancer CachexiaView official trial listing → -
Withdrawn NCT NCT04140513
Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal Cancer
Not yet reported Ohio State University Comprehensive Cancer Center Est. completion 2023-11-01 1 siteOther conditions: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Locally Advanced Oropharyngeal Squamous Cell Carcinoma, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8View official trial listing → -
Active, not recruiting NCT NCT04147494
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Not yet reported Jonsson Comprehensive Cancer Center 29 participants Est. completion 2031-10-17 1 site Stand-aloneOther conditions: Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma, Gastric Carcinoma, Head and Neck Carcinoma, Kidney Carcinoma, Lung Carcinoma, Ovarian Carcinoma, Pancreatic Carcinoma, Solid Neoplasm, Uterine Corpus CancerView official trial listing → -
Status unknown NCT NCT04154215
FDG Metabolism in Dementia With Lewy Body (DLB) Patients as Indicated by PET Dynamic Acquisition
Not yet reported Tel-Aviv Sourasky Medical Center 100 participants Est. completion 2021-12-14 Stand-aloneOther conditions: Dementia With Lewy BodiesView official trial listing → -
Status unknown NCT NCT04154228
Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI
Not yet reported Tel-Aviv Sourasky Medical Center 100 participants Est. completion 2021-12-10 Stand-aloneOther conditions: Lymphoma, Non Hodgkin Lymphoma, Follicular LymphomaView official trial listing → -
Status unknown NCT NCT04154254
Applying PET/MR for Dementia Applications
Not yet reported Tel-Aviv Sourasky Medical Center 50 participants Est. completion 2022-01-10 Stand-aloneOther conditions: DementiaView official trial listing → -
Completed NCT NCT04163276
Database of Positon Emission Tomography (PET) Digital Brain Exams, in 50th Age of Patients
Central Hospital, Nancy, France 80 participants Est. completion 2020-10 1 siteOther conditions: Neurodegenerative DiseasesView official trial listing → -
Active, not recruiting NCT NCT04166318
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study
Not yet reported ECOG-ACRIN Cancer Research Group 252 participants Est. completion 2029-12-31 659 sitesOther conditions: Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Canal Squamous Cell Carcinoma, Anal Margin Squamous Cell Carcinoma, Stage I Anal Cancer AJCC v8, Stage IIA Anal Cancer AJCC v8View official trial listing → -
Completed NCT NCT04169581
A Deep Learning Framework for Pediatric TLE Detection Using 18F-FDG-PET Imaging
Second Affiliated Hospital, Zhejiang University, School of Medicine 201 participants Est. completion 2019-04-30 1 siteOther conditions: Epilepsy, Temporal LobeView official trial listing → -
Status unknown NCT NCT04174287
Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease
Not yet reported Chang Gung Memorial Hospital 300 participants Est. completion 2023-09-27 1 siteOther conditions: Alzheimer's DiseaseView official trial listing → -
Status unknown NCT NCT04196985
18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCC
Not yet reported Turku University Hospital 40 participants Est. completion 2024-10-01 1 siteOther conditions: Head and Neck Squamous Cell CarcinomaView official trial listing → -
Completed NCT NCT04206163
Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis
Not yet reported Vastra Gotaland Region 78 participants Est. completion 2024-06-24 1 site Stand-aloneOther conditions: Acute Myocarditis, Cardiac SarcoidosisView official trial listing → -
Active, not recruiting NCT NCT04214262
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer
Not yet reported National Cancer Institute (NCI) 417 participants Est. completion 2027-06-09 390 sitesOther conditions: Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8View official trial listing → -
Active, not recruiting NCT NCT04219904
PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer
Not yet reported M.D. Anderson Cancer Center 25 participants Est. completion 2027-09-30 1 siteOther conditions: Stage IA Cervical Cancer, Stage IA1 Cervical Cancer, Stage IA2 Cervical Cancer, Stage IB Cervical Cancer, Stage IB1 Cervical Cancer, Stage IB2 Cervical Cancer, Stage IB3 Cervical CancerView official trial listing → -
Completed NCT NCT04219969
FDG PET-MRI for the Diagnosis of Spinal Cord Lesions
Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2024-05-07 1 site Stand-aloneOther conditions: Spinal Cord NeoplasmView official trial listing → -
Completed NCT NCT04228172
Genotypic Influences on Network Progression in Parkinson's Disease
Northwell Health 17 participants Est. completion 2026-03-07 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT04233476
99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer
Not yet reported RDO Pharm. 409 participants Est. completion 2021-05-08 11 sites Stand-aloneOther conditions: Lung Cancer, Lymph Node MetastasisView official trial listing → -
Active, not recruiting NCT NCT04251481
Diffusion MRI for Head and Neck Cancer
Not yet reported NYU Langone Health 16 participants Est. completion 2026-04-30 2 sitesOther conditions: Head Cancer NeckView official trial listing → -
Terminated NCT NCT04252859
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
Not yet reported University of Utah 44 participants Est. completion 2024-12-07 1 site Stand-aloneOther conditions: Invasive Lobular Breast CarcinomaView official trial listing → -
Completed NCT NCT04253574
Comparison of PET/CT and Ultrasound in Staging of Malignant Melanoma
University of Basel 258 participants Est. completion 2018-09-01Other conditions: Malignant MelanomaView official trial listing → -
Withdrawn NCT NCT04271436
Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT
Not yet reported Washington University School of Medicine Est. completion 2025-01-31Other conditions: CancerView official trial listing → -
Withdrawn NCT NCT04273555
Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging
Not yet reported, Not yet reported University of Alabama at Birmingham Est. completion 2028-06-30 1 siteOther conditions: HER2-positive Breast CancerView official trial listing → -
Completed NCT NCT04276025
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma
Klinikum Bayreuth GmbH 2000 participants Est. completion 2020-01Other conditions: NSCLCView official trial listing → -
Active, not recruiting NCT NCT04304651
Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism
Not yet reported University Hospital, Brest 1276 participants Est. completion 2030-09-08 16 sitesOther conditions: Embolism and ThrombosisView official trial listing → -
Status unknown NCT NCT04315584
FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
Not yet reported University of Virginia 5 participants Est. completion 2024-06-20 1 siteOther conditions: GlioblastomaView official trial listing → -
Active, not recruiting NCT NCT04316117
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
Not yet reported ECOG-ACRIN Cancer Research Group 138 participants Est. completion 2027-08-31 104 sitesOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Completed NCT NCT04317313
18F-FDG PET Radiomics of Diffuse Large B-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 152 participants Est. completion 2021-07-30 1 siteOther conditions: Lymphoma, Large B-Cell, DiffuseView official trial listing → -
Active, not recruiting NCT NCT04327817
Multifidus PET Scan Study
Not yet reported Barts & The London NHS Trust 20 participants Est. completion 2027-03-17 1 siteOther conditions: Low Back PainView official trial listing → -
Completed NCT NCT04356599
Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Using Dynamic 18F-FDG PET/CT
Not yet reported University Hospital, Montpellier 35 participants Est. completion 2024-02-19 1 site Stand-aloneOther conditions: Aneurysmal Subarachnoid HaemorrhageView official trial listing → -
Completed NCT NCT04357236
18F-FDG PET Imaging Analysis of Antiepileptic Drug Response in BECTS
Second Affiliated Hospital, Zhejiang University, School of Medicine 55 participants Est. completion 2020-04-20 1 siteOther conditions: Benign Epilepsy With Centrotemporal SpikesView official trial listing → -
Status unknown NCT NCT04367948
Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma
Not yet reported Peking University Cancer Hospital & Institute 200 participants Est. completion 2022-12 1 site Stand-aloneOther conditions: Tumor, Solid, Positron-Emission Tomography, LymphomaView official trial listing → -
Completed NCT NCT04391348
Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCC
Not yet reported Assistance Publique - Hôpitaux de Paris 230 participants Est. completion 2023-04-28 1 site Stand-aloneOther conditions: Hepatocellular CarcinomaView official trial listing → -
Status unknown NCT NCT04395651
The Role of 18F-FDG-PET/CT Scan in Lung Cancer Patients
Assiut University 30 participants Est. completion 2021-06Other conditions: Lung CancerView official trial listing → -
Completed NCT NCT04411966
Early Interim 18F-FDG-PET and 18F-FLT-PET for Predicting Treatment Response and Survival in Metastatic Breast Cancer
Not yet reported Chang Gung Memorial Hospital 32 participants Est. completion 2019-05-30Other conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04412369
Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury
University of Cambridge 21 participants Est. completion 2023-08-01 1 siteCardiovascular disease Other conditions: COVID19View official trial listing → -
Completed NCT NCT04417985
Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal Carcinoma
Not yet reported Chang Gung Memorial Hospital 112 participants Est. completion 2014-07-31 Stand-aloneOther conditions: Nasopharyngeal CarcinomaView official trial listing → -
Completed NCT NCT04417998
Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction
Not yet reported Mayo Clinic 80 participants Est. completion 2023-12-20 1 siteOther conditions: Brain Imaging, Whole Body ImagingView official trial listing → -
Completed NCT NCT04437927
Impact of 100mL Lipid Emulsion for Intravenous for Suppression of Myocardial Glucose Metabolism in 18F-FDG PET/CT
Centre Hospitalier Princesse Grace 51 participants Est. completion 2020-11-06 1 siteOther conditions: Metabolic Preparation, Myocardial InflammationView official trial listing → -
Status unknown NCT NCT04441606
The Role of 68Ga-FAPI-04 PET/CT as a Problem Solving Imaging Modality in Various Malignancies
Not yet reported Tel-Aviv Sourasky Medical Center 50 participants Est. completion 2021-07 1 site Stand-aloneOther conditions: Different Types of CancerView official trial listing → -
Active, not recruiting NCT NCT04457258
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
Not yet reported Jonsson Comprehensive Cancer Center 18 participants Est. completion 2027-12-02 1 site Stand-aloneOther conditions: Metastatic Sarcoma, Recurrent Sarcoma, SarcomaView official trial listing → -
Active, not recruiting NCT NCT04459273
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
Not yet reported Jonsson Comprehensive Cancer Center 26 participants Est. completion 2027-07-01 1 site Stand-aloneOther conditions: Bladder Carcinoma, Cervical Carcinoma, Cholangiocarcinoma, Hematopoietic and Lymphoid Cell Neoplasm, Hepatocellular Carcinoma, Malignant Adrenal Gland Neoplasm, Malignant Brain Neoplasm, Malignant Pleural Neoplasm, Malignant Skin Neoplasm, Malignant Solid Neoplasm, Malignant Testicular Neoplasm, Malignant Thymus Neoplasm, Neuroendocrine Neoplasm, Thyroid Gland Carcinoma, Urothelial Carcinoma, Cancer of Unknown Primary SiteView official trial listing → -
Completed NCT NCT04464590
Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT
University Hospital, Brest 100 participants Est. completion 2018-12-31Other conditions: Malignant Lymphoma, Relapsed Non Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult, Diagnostic ImagingView official trial listing → -
Status unknown NCT NCT04467580
Development of Inflammation and Fibrosis Index, Combining MRI and PET 18F-FDG, in Patient's With Crohn's Disease
Not yet reported Central Hospital, Nancy, France 59 participants Est. completion 2023-05-02Other conditions: Crohn DiseaseView official trial listing → -
Status unknown NCT NCT04470076
Neoadjuvant Afatinib Combination With Chemotherapy for Stage Ⅱa-Ⅲb NSCLC With EGFR Activating Mutation
Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University 30 participants Est. completion 2023-07-30 Stand-aloneOther conditions: Non Small Cell Lung Cancer, Surgery, EGFR Activating Mutation, Chemotherapy, EGFR TKIView official trial listing → -
Active, not recruiting NCT NCT04478318
Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma
Not yet reported University of California, Davis 180 participants Est. completion 2026-12-01 1 site Stand-aloneOther conditions: Lung Neoplasm, Lymphoma, Melanoma, Fluorodeoxyglucose, Positron-emission TomographyView official trial listing → -
Status unknown NCT NCT04502303
18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease
Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2021-09 Stand-aloneOther conditions: Crohn DiseaseView official trial listing → -
Status unknown NCT NCT04504110
68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings
Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2021-08 1 site Stand-aloneOther conditions: Epithelial Ovarian CancerView official trial listing → -
Completed NCT NCT04512118
CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients
Central Hospital, Nancy, France 22 participants Est. completion 2020-07-30 1 siteOther conditions: Presence of COVID-19 Compatible CT AbnormalitiesView official trial listing → -
Withdrawn NCT NCT04514328
Highlighting the Benefits of Therapeutic Gardens in Alzheimer's Disease by 18F-FDG Cerebral PET /CT
Not yet reported Central Hospital, Nancy, France Est. completion 2023-01-02 Stand-aloneOther conditions: Alzheimer DiseaseView official trial listing → -
Status unknown NCT NCT04514822
Quantitative Evaluation of Metastatic Lymph Nodes With Dynamic 18F-FDG PET/CT in Patients With ESCC
Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University 40 participants Est. completion 2023-12-30 1 siteOther conditions: Esophageal Squamous Cell Carcinoma, Positron Emission TomographyView official trial listing → -
Status unknown NCT NCT04519255
Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT
Fifth Affiliated Hospital, Sun Yat-Sen University 60 participants Est. completion 2023-07-31 1 siteOther conditions: PET/CT, COVID-19, Respiratory Function, Inflammatory LesionsView official trial listing → -
Active, not recruiting NCT NCT04533750
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Not yet reported National Cancer Institute (NCI) 21 participants Est. completion 2026-12-15 27 sites Stand-aloneOther conditions: Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous Cell Carcinoma, Advanced Oral Cavity Squamous Cell Carcinoma, Advanced Oropharyngeal Squamous Cell Carcinoma, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Stage III Hypopharyngeal Carcinoma AJCC v8, Stage III Laryngeal Cancer AJCC v8, Stage III Lip and Oral Cavity Cancer AJCC v8, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVA Hypopharyngeal Carcinoma AJCC v8, Stage IVA Laryngeal Cancer AJCC v8, Stage IVA Lip and Oral Cavity Cancer AJCC v8, Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVB Hypopharyngeal Carcinoma AJCC v8, Stage IVB Laryngeal Cancer AJCC v8, Stage IVB Lip and Oral Cavity Cancer AJCC v8, Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8View official trial listing → -
Status unknown NCT NCT04553601
Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer
Not yet reported The First Affiliated Hospital of Xiamen University 150 participants Est. completion 2022-10-01 1 site Stand-aloneOther conditions: NSCLC, PET/CT, Biopsy, Radiomics, Genomics, Whole-exome SequencingView official trial listing → -
Status unknown NCT NCT04554719
Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 500 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Malignant NeoplasmView official trial listing → -
Completed NCT NCT04566185
Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
Not yet reported Centre Hospitalier Universitaire de Nīmes 14 participants Est. completion 2023-06-27 1 siteOther conditions: GlioblastomaView official trial listing → -
Completed NCT NCT04588064
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
Not yet reported The First Affiliated Hospital of Xiamen University 63 participants Est. completion 2022-07-01 1 site Stand-aloneOther conditions: Lung Adenocarcinoma, 18F-FDG, 68Ga-FAPI, PET/CTView official trial listing → -
Completed NCT NCT04599634
Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
Not yet reported National Cancer Institute (NCI) 11 participants Est. completion 2024-06-20 1 siteOther conditions: Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Lymphoma, B-Cell LymphomaView official trial listing → -
Completed NCT NCT04600804
The Role of 18F-FDG-PET for Staging and Prognostication
Fondazione Italiana Linfomi - ETS 200 participants Est. completion 2025-07-11 34 sitesOther conditions: Mantle Cell LymphomaView official trial listing → -
Terminated NCT NCT04605848
Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT)
Not yet reported University of Avignon 7 participants Est. completion 2023-10-20 1 site Stand-aloneOther conditions: Pheochromocytoma, ParagangliomaView official trial listing → -
Completed NCT NCT04614116
Cold Induced Futile Cycles In White Adipose Tissue
Not yet reported Kantonsspital Baden 24 participants Est. completion 2022-03-29 1 siteOther conditions: Metabolism DisorderView official trial listing → -
Status unknown NCT NCT04622631
Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT
Dr. Nayruz Knaana 80 participants Est. completion 2023-01 1 siteOther conditions: Neuroendocrine TumorsView official trial listing → -
Completed NCT NCT04692285
Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia
Not yet reported University Medical Centre Ljubljana 24 participants Est. completion 2021-04-30 2 sitesOther conditions: Focal DystoniaView official trial listing → -
Completed NCT NCT04701580
Synaptic Density and Progression of Huntington's Disease.
Not yet reported Universitaire Ziekenhuizen KU Leuven 33 participants Est. completion 2022-10-05 1 site Stand-aloneOther conditions: Huntington DiseaseView official trial listing → -
Status unknown NCT NCT04715503
PET-imaging of Unruptured Intracranial Aneurysm Inflammation
Not yet reported Turku University Hospital 20 participants Est. completion 2022-10 1 site Stand-aloneOther conditions: Intracranial Aneurysm, Cerebral Aneurysm, InflammationView official trial listing → -
Completed NCT NCT04725162
Epileptogenic Focus Localization for Children With Epilepsy Using 18F-FDG PET Molecular Imaging
Second Affiliated Hospital, Zhejiang University, School of Medicine 234 participants Est. completion 2021-06-30 1 siteOther conditions: EpilepsyView official trial listing → -
Status unknown NCT NCT04747561
Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant Melanoma
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: MelanomaView official trial listing → -
Status unknown NCT NCT04750772
Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer
Not yet reported Peking University Cancer Hospital & Institute 60 participants Est. completion 2023-01 1 site Stand-aloneOther conditions: Tumor, Solid, Positron-Emission Tomography, Colorectal CancerView official trial listing → -
Completed NCT NCT04756921
18F-FDG Uptake Heterogeneity Predicts Pyrotinib Response
Biyun Wang, MD 30 participants Est. completion 2020-07-24 1 siteOther conditions: HER2-positive Breast CancerView official trial listing → -
Withdrawn NCT NCT04757090
89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111
Not yet reported Washington University School of Medicine Est. completion 2023-12-31 Stand-aloneOther conditions: HER2-positive Solid Tumor, HER-2 Positive CancerView official trial listing → -
Status unknown NCT NCT04758416
Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer
Fudan University 50 participants Est. completion 2022-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04759235
Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC
RenJi Hospital 118 participants Est. completion 2022-12-31 1 siteOther conditions: Esophageal Squamous Cell CarcinomaView official trial listing → -
Completed NCT NCT04764721
Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19
Not yet reported Central Hospital, Nancy, France 25 participants Est. completion 2023-11-27 1 site Stand-aloneOther conditions: Covid-19View official trial listing → -
Status unknown NCT NCT04778345
Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric Cancer
Not yet reported Fujian Medical University 72 participants Est. completion 2023-03 1 site Stand-aloneOther conditions: Enhanced CT, 18F-FDG PET/CT, 68Ga-FAPI PET/CT, Gastric Cancer, Peritoneal CarcinomatosisView official trial listing → -
Active, not recruiting NCT NCT04804371
Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors
Not yet reported University Health Network, Toronto 40 participants Est. completion 2027-02-22 1 siteOther conditions: Neuroendocrine TumorsView official trial listing → -
Completed NCT NCT04804722
Risk of Developing Dementia and Associated Factors in Patients With Normal Brain FDG PET
Central Hospital, Nancy, France 100 participants Est. completion 2023-07-01 1 siteOther conditions: Neurodegenerative Diseases, Cognitive DisorderView official trial listing → -
Completed NCT NCT04805268
A Single Case Study of Hypermetabolism
Not yet reported The Hospital for Sick Children 1 participants Est. completion 2022-12-15 1 site Stand-aloneOther conditions: Hypermetabolism Due to Defect in Mitochondria, Luft DiseaseView official trial listing → -
Completed NCT NCT04812080
EXPLORER PET/CT: Evaluation of Healthy Individuals From Racial/Ethnic Minority Populations
Not yet reported University of California, Davis 20 participants Est. completion 2021-11-08 1 site Stand-aloneOther conditions: Healthy Volunteers From Racial/Ethnic Minority PopulationsView official trial listing → -
Completed NCT NCT04841707
Total-Body Parametric 18F-FDG PET of COVID-19
Not yet reported University of California, Davis 13 participants Est. completion 2022-07-06 1 site Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT04851379
PLACE OF THE 18F-FDG-PET/CT IN THE DIAGNOSTIC WORKUP IN PATIENTS WITH CLASSICAL FEVER OF UNKNOWN ORIGIN (FUO)
University Hospital, Montpellier 44 participants Est. completion 2021-04-01 1 siteOther conditions: Fever of Unknown OriginView official trial listing → -
Status unknown NCT NCT04853511
Comprehensive Assessment of Interconnection Between Brain Emotional Activity and Coronary Plaque Instability
Korea University Guro Hospital 200 participants Est. completion 2024-12-31 1 siteOther conditions: Atherosclerosis, Coronary, Emotional Stress, Inflammation, Hematopoiesis, Atherosclerosis Coronary Artery With Angina Pectoris, Atheroma; Heart, Atherosclerosis, Acute Coronary SyndromeView official trial listing → -
Terminated NCT NCT04875871
Particle-based Partial Tumor Irradiation of Unresectable Bulky Tumors
Not yet reported EBG MedAustron GmbH 13 participants Est. completion 2025-03-14 1 site Stand-aloneOther conditions: CancerView official trial listing → -
Active, not recruiting NCT NCT04892667
Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG
Not yet reported Assistance Publique - Hôpitaux de Paris 128 participants Est. completion 2026-03-17 1 siteOther conditions: Lymphoma, Non-Hodgkin, Lymphoma, HodgkinView official trial listing → -
Active, not recruiting NCT NCT04910308
RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck
Not yet reported Oslo University Hospital 10 participants Est. completion 2025-08 1 siteOther conditions: Head and Neck CancerView official trial listing → -
Active, not recruiting NCT NCT04929028
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Not yet reported National Cancer Institute (NCI) 40 participants Est. completion 2031-09-15 14 sitesOther conditions: AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma, Anal Non-Keratinizing Squamous Cell Carcinoma, Anal Squamous Cell Carcinoma, HIV Infection, Rectal Squamous Cell Carcinoma, Stage II Rectal Cancer AJCC v8, Stage IIB Anal Cancer AJCC v8, Stage III Anal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8View official trial listing → -
Status unknown NCT NCT04931875
Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma
RenJi Hospital 100 participants Est. completion 2024-07-20 1 siteOther conditions: LymphomaView official trial listing → -
Terminated NCT NCT04933617
Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas
Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2023-11-30 1 site Stand-aloneOther conditions: Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Germinal Center B-cell Type (GCB)View official trial listing → -
Active, not recruiting NCT NCT04943211
Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging
Not yet reported Anna Raciborska 150 participants Est. completion 2027-06-30 1 siteOther conditions: HistiocytosisView official trial listing → -
Completed NCT NCT04954729
Association of Processing Speed Dysfunction and Brain Functional Abnormality in ECTS
Second Affiliated Hospital, Zhejiang University, School of Medicine 68 participants Est. completion 2021-06-30 1 siteOther conditions: Epilepsy, RolandicView official trial listing → -
Status unknown NCT NCT04996927
18F-FDG PET/CT to Evaluate pD-1 Monoclonal Antibody With First-line Chemotherapy in Advanced NSCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50 participants Est. completion 2023-06-01 1 siteOther conditions: NSCLCView official trial listing → -
Completed NCT NCT04999917
Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer
Not yet reported XEOS Medical 206 participants Est. completion 2025-04-03 1 site Stand-aloneOther conditions: Breast Cancer, Breast Cancer Invasive, Breast Cancer in SituView official trial listing → -
Status unknown NCT NCT05003830
Application of Multi-probe PET/MR Imaging in the Diagnosis and Evaluation of Alzheimer's Disease
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 130 participants Est. completion 2023-09-01 1 siteOther conditions: Alzheimer Disease, PET/MRView official trial listing → -
Terminated NCT NCT05009979
18F-DCFPyL PET/CT in Hepatocellular Carcinoma
Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2024-11-20 1 site Stand-aloneOther conditions: Hepatocellular CarcinomaView official trial listing → -
Enrolling by invitation NCT NCT05015881
Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder
Not yet reported, Not yet reported University of Pennsylvania 20 participants Est. completion 2027-12 1 siteAlcohol use disorderView official trial listing → -
Terminated NCT NCT05023291
Peroperative Assessment of Tumour Resection Margins Using High-resolution 18F-FDG-PET/CT in Pancreatic Adenocarcinoma
Not yet reported University Hospital, Ghent 5 participants Est. completion 2022-12-31 1 siteOther conditions: Fluorodeoxyglucose F18View official trial listing → -
Status unknown NCT NCT05027165
Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab
LMU Klinikum 40 participants Est. completion 2025-01-31 1 siteOther conditions: Oncology, Biomarker, NSCLC, Stage III, Durvalumab, ChemoradiotherapyView official trial listing → -
Status unknown NCT NCT05030597
Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma
Zhongnan Hospital 100 participants Est. completion 2025-12-31 1 siteOther conditions: PET/CT, FAPI, Oral CancerView official trial listing → -
Completed NCT NCT05054998
Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases
Not yet reported M.D. Anderson Cancer Center 12 participants Est. completion 2024-04-26 1 siteOther conditions: Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid NeoplasmView official trial listing → -
Status unknown NCT NCT05056259
Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients
Assiut University 42 participants Est. completion 2023-10Other conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT05062395
Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis
M.D. Anderson Cancer Center 13 participants Est. completion 2023-04-04 1 siteOther conditions: Myocarditis AcuteView official trial listing → -
Status unknown NCT NCT05064475
Correlation Between PET/CT Parameters and Tumor Markers in Recurrent Breast Cancer
Assiut University 72 participants Est. completion 2023-05-01Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT05068687
Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT
Not yet reported University Hospital, Ghent 9 participants Est. completion 2022-09-30 1 site Stand-aloneOther conditions: Head and Neck Neoplasms, Thyroid Neoplasm, Skin NeoplasmView official trial listing → -
Status unknown NCT NCT05083936
Prospective Comparison of 18F-FDG and 18F-FET PET for Response Evaluation in Patients With Primary Central Nervous System Lymphoma
Not yet reported Asan Medical Center 30 participants Est. completion 2023-03-31 1 siteOther conditions: Patients With Suspected or Diagnosed Central Nervous System LymphomaView official trial listing → -
Terminated NCT NCT05096234
18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma
Not yet reported Stanford University 2 participants Est. completion 2023-10-09 1 siteOther conditions: Non-Hodgkin's LymphomaView official trial listing → -
Enrolling by invitation NCT NCT05108857
PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9
Turku University Hospital 10 participants Est. completion 2026-12-31 1 siteOther conditions: Systemic SclerosisView official trial listing → -
Status unknown NCT NCT05111197
Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy
Not yet reported Institut Cancerologie de l'Ouest 112 participants Est. completion 2025-01 5 sitesOther conditions: Locally Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung CancerView official trial listing → -
Completed NCT NCT05113576
Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL
Second Affiliated Hospital, Zhejiang University, School of Medicine 132 participants Est. completion 2021-06-30 1 siteOther conditions: Diffuse Large B-cell LymphomaView official trial listing → -
Status unknown NCT NCT05138718
FDG an Myocardial Infarction: The PIAF Trial
International Atomic Energy Agency 2041 participants Est. completion 2026-07-01 1 siteCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT05141643
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 30 participants Est. completion 2026-11-18 1 siteOther conditions: Pancreatic Cancer, Pancreatic Ductal AdenocarcinomaView official trial listing → -
Status unknown NCT NCT05165602
Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System
Peking University 30 participants Est. completion 2023-05-01 1 siteOther conditions: HER2 Positive Gastric CancerView official trial listing → -
Completed NCT NCT05174026
18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery
Not yet reported M.D. Anderson Cancer Center 10 participants Est. completion 2024-06-20 1 site Stand-aloneOther conditions: Metastatic Malignant Neoplasm, Metastatic Malignant Neoplasm in the BoneView official trial listing → -
Completed NCT NCT05183555
Early Feasibility Study of Somatostatin Receptors PET Imaging for the Diagnosis of Infective Endocarditis
Not yet reported Central Hospital, Nancy, France 14 participants Est. completion 2024-06-18 1 site Stand-aloneOther conditions: Infective EndocarditisView official trial listing → -
Active, not recruiting NCT NCT05211336
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System
Not yet reported National Cancer Institute (NCI) 14 participants Est. completion 2029-06-01 1 site Stand-aloneOther conditions: Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNSView official trial listing → -
Completed NCT NCT05234099
Sensitivity and Reproducibility of 18F-fluorodeoxyglucose Positron Emission Tomography for Assessment of Respiratory Muscle Activity
Not yet reported Institut de Myologie, France 15 participants Est. completion 2023-12-22 2 sites Stand-aloneOther conditions: Respiratory MuscleView official trial listing → -
Completed NCT NCT05245630
Comparison of Robotic Arm-assisted PET/CT-guided Lung Biopsy With PET Fused CT- Fluoroscopy-guided Lung Biopsy
Post Graduate Institute of Medical Education and Research, Chandigarh 59 participants Est. completion 2022-01-31 1 siteOther conditions: Lung Cancer, Lung Diseases, Adenocarcinoma of LungView official trial listing → -
Completed NCT NCT05248906
Giant Cell Arteritis - Optimization of Diagnostics
Copenhagen University Hospital, Rigshospitalet 110 participants Est. completion 2024-01-01 1 siteOther conditions: Giant Cell ArteritisView official trial listing → -
Active, not recruiting NCT NCT05255159
Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors
Not yet reported University of Alberta 50 participants Est. completion 2026-12-31 1 siteOther conditions: Neuroendocrine TumorsView official trial listing → -
Active, not recruiting NCT NCT05286801
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
Not yet reported, Not yet reported National Cancer Institute (NCI) 86 participants Est. completion 2030-03-31 40 sitesOther conditions: Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma, Malignant Solid Neoplasm, Poorly Differentiated Chordoma, Recurrent Atypical Teratoid/Rhabdoid Tumor, Recurrent Chordoma, Recurrent Epithelioid Sarcoma, Recurrent Kidney Medullary Carcinoma, Recurrent Malignant Solid Neoplasm, Recurrent Rhabdoid Tumor, Refractory Atypical Teratoid/Rhabdoid Tumor, Refractory Chordoma, Refractory Epithelioid Sarcoma, Refractory Kidney Medullary Carcinoma, Refractory Malignant Solid Neoplasm, Refractory Rhabdoid Tumor, Rhabdoid TumorView official trial listing → -
Status unknown NCT NCT05322512
Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors
Not yet reported Peking University Cancer Hospital & Institute 20 participants Est. completion 2025-12 Stand-aloneOther conditions: Solid TumorView official trial listing → -
Status unknown NCT NCT05339113
Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma
Not yet reported The National Center of Oncology, Azerbaijan 100 participants Est. completion 2022-12 1 siteOther conditions: Breast Neoplasms, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor, Fluorodeoxyglucose F18View official trial listing → -
Completed NCT NCT05355857
Creation of a Probabilistic Atlas of Normal Cerebral Uptake of 18F-FDG in PET/MRI.
Not yet reported Institut de cancérologie Strasbourg Europe 39 participants Est. completion 2023-03-23 1 siteOther conditions: Brain DiseasesView official trial listing → -
Withdrawn NCT NCT05390021
PET/MRI in Endometrial Cancer
Not yet reported Massachusetts General Hospital Est. completion 2026-02-01Other conditions: Cytoreductive Surgery, Grade 3 Endometrial Endometrioid Adenocarcinoma, High Grade Serous Carcinoma, Endometrial Undifferentiated Carcinoma, Endometrial Mixed Cell AdenocarcinomaView official trial listing → -
Status unknown NCT NCT05390632
Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas
Peking University Cancer Hospital & Institute 100 participants Est. completion 2023-12-15 1 siteOther conditions: PET/MRIView official trial listing → -
Completed NCT NCT05392205
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
Not yet reported The First Affiliated Hospital of Xiamen University 67 participants Est. completion 2022-10-31 1 site Stand-aloneOther conditions: Tumor, Solid, Positron-Emission TomographyView official trial listing → -
Status unknown NCT NCT05396118
Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients
Not yet reported Copenhagen University Hospital, Rigshospitalet 15 participants Est. completion 2024-12 1 site Stand-aloneOther conditions: Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Carcinoma Metastatic, Lymphoma, SarcomaView official trial listing → -
Status unknown NCT NCT05418907
Exendin PET/CT for Imaging of Paragangliomas
Radboud University Medical Center 10 participants Est. completion 2024-12-01 1 siteOther conditions: ParagangliomaView official trial listing → -
Withdrawn NCT NCT05423197
89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC
Not yet reported Andrei Iagaru Est. completion 2027-12 1 siteOther conditions: Head-and-neck Squamous Cell CarcinomaView official trial listing → -
Status unknown NCT NCT05428475
Implementation and Evaluation of Improved Access to Medical Imaging for Geriatric Patients of The Royal Ottawa Hospital
Not yet reported Tim Lau 15 participants Est. completion 2024-05-15Other conditions: Dementia, Cognitive Impairment, Dementia With Lewy BodiesView official trial listing → -
Completed NCT NCT05430841
Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT
Not yet reported The First Affiliated Hospital of Xiamen University 120 participants Est. completion 2024-10-31 1 site Stand-aloneOther conditions: Gastric Cancer, Pancreatic Cancer, Liver CancerView official trial listing → -
Completed NCT NCT05432427
64Cu-DOTATATE PET-CT-skanning and Infective Endocarditis.
Not yet reported Emil Loldrup Fosbol 69 participants Est. completion 2023-09-29 1 site Stand-aloneOther conditions: Endocarditis, Endocarditis;Chronic, Endocarditis AcuteView official trial listing → -
Completed NCT NCT05432947
68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients
Not yet reported Peking Union Medical College Hospital 42 participants Est. completion 2022-09-15 1 site Stand-aloneOther conditions: Clear Cell Renal Cell CarcinomaView official trial listing → -
Status unknown NCT NCT05448404
A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma
Not yet reported First Hospital of China Medical University 30 participants Est. completion 2023-06-30 1 site Stand-aloneOther conditions: Multiple MyelomaView official trial listing → -
Completed NCT NCT05455047
Study of Metabolic Connectivity in Drug-resistant Temporal Epilepsy
Central Hospital, Nancy, France 90 participants Est. completion 2022-06-01 1 siteOther conditions: EpilepsyView official trial listing → -
Completed NCT NCT05458089
18F-FDG PET/CT in the Diagnosis of Tuberculous Pericarditis
Wuxi No. 4 People's Hospital 11 participants Est. completion 2022-02-28Other conditions: Diagnostic Self EvaluationView official trial listing → -
Status unknown NCT NCT05485792
18F-FAPI and 18F-FDG PET/CT in Patients With Various Types of Cancer
Not yet reported Affiliated Cancer Hospital & Institute of Guangzhou Medical University 200 participants Est. completion 2023-12-30 Stand-aloneOther conditions: CancerView official trial listing → -
Status unknown NCT NCT05490849
68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Malignant NeoplasmView official trial listing → -
Status unknown NCT NCT05496101
CLI and FAR for Intraoperative Margin Assessment
Not yet reported King's College London 60 participants Est. completion 2024-12-31 1 siteOther conditions: Breast Cancer FemaleView official trial listing → -
Status unknown NCT NCT05506566
68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies
Not yet reported, Not yet reported First Affiliated Hospital of Fujian Medical University 50 participants Est. completion 2025-05-01 1 site Stand-aloneOther conditions: Tumor, Positron-Emission TomographyView official trial listing → -
Completed NCT NCT05515783
68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies
Not yet reported, Not yet reported First Affiliated Hospital of Fujian Medical University 70 participants Est. completion 2025-10-01 1 site Stand-aloneOther conditions: TumorView official trial listing → -
Not yet recruiting NCT NCT05531045
18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic Adenocarcinoma
Assistance Publique - Hôpitaux de Paris 222 participants Est. completion 2027-09 1 siteOther conditions: Metastatic Colorectal CancerView official trial listing → -
Completed NCT NCT05543317
68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG
Not yet reported The First Affiliated Hospital of Xiamen University 27 participants Est. completion 2022-12-31 1 site Stand-aloneOther conditions: Tumor, Solid, Positron-Emission TomographyView official trial listing → -
Status unknown NCT NCT05543954
68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients
Not yet reported Peking Union Medical College Hospital 60 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Lung NeoplasmsView official trial listing → -
Status unknown NCT NCT05545618
Brain-heart Interaction in Coronary Plaque Stability and Cardiovascular Events
Shanghai Zhongshan Hospital 300 participants Est. completion 2022-12-30 4 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT05569733
Simultaneous Fluorodeoxyglucose Positron Emission Tomography (PET) and Magnetic Resonance (MR) in Visual Snow Syndrome
Universitaire Ziekenhuizen KU Leuven 22 participants Est. completion 2022-02-01Other conditions: Visual Snow SyndromeView official trial listing → -
Status unknown NCT NCT05577299
Factors Affecting BAT Activation in PET/CT
Assiut University 80 participants Est. completion 2025-10-01Other conditions: Factors Affecting BAT Activation in PET/CTView official trial listing → -
Status unknown NCT NCT05593107
68Ga-N188 PET/CT Imaging in Malignancy
Not yet reported Peking University First Hospital 203 participants Est. completion 2025-07-31 1 site Stand-aloneOther conditions: NeoplasmsView official trial listing → -
Status unknown NCT NCT05615103
The PET-CT Predicting Response to Immunochemotherapy in Esophageal Cancer
Guangdong Provincial People's Hospital 100 participants Est. completion 2023-12-08 1 siteOther conditions: Esophageal CancerView official trial listing → -
Completed NCT NCT05617742
Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer
Not yet reported Chang Gung Memorial Hospital 58 participants Est. completion 2026-01-31 1 site Stand-aloneOther conditions: Lung CancerView official trial listing → -
Status unknown NCT NCT05619016
[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors
Not yet reported Karolinska University Hospital 72 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Esophageal Neoplasms, Gastric Neoplasms Malignant, Breast Cancer, HER2-positive Gastric CancerView official trial listing → -
Status unknown NCT NCT05622227
68Ga PET/CT Imaging in Breast Cancer Patients
Not yet reported, Not yet reported Peking Union Medical College Hospital 50 participants Est. completion 2024-12-31 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05637034
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2023-09-15 1 site Stand-aloneOther conditions: Tumor, SolidView official trial listing → -
Status unknown NCT NCT05645484
The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100 participants Est. completion 2023-08-31 1 siteOther conditions: MelanomaView official trial listing → -
Status unknown NCT NCT05662488
FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy
Peking Union Medical College Hospital 25 participants Est. completion 2023-08-30 1 siteOther conditions: Hepatocellular Carcinoma, Bile Duct CancerView official trial listing → -
Status unknown NCT NCT05662540
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
Not yet reported Ruijin Hospital 40 participants Est. completion 2026-10 1 site Stand-aloneOther conditions: NK/T-cell LymphomaView official trial listing → -
Status unknown NCT NCT05687552
Role of 18F-FDG PET/CT in Gastric Cancer
Sohag University 50 participants Est. completion 2024-01Other conditions: Gastric CancerView official trial listing → -
Status unknown NCT NCT05709171
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
Not yet reported Copenhagen University Hospital, Rigshospitalet 200 participants Est. completion 2026-01-01 1 site Stand-aloneOther conditions: GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Carcinoma MetastaticView official trial listing → -
Active, not recruiting NCT NCT05710328
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
Not yet reported ECOG-ACRIN Cancer Research Group 235 participants Est. completion 2029-12-31 102 sitesOther conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Invasive Breast CarcinomaView official trial listing → -
Status unknown NCT NCT05788874
Study of 18F-FAPI Applied to Gastrointestinal Cancer
First Affiliated Hospital Xi'an Jiaotong University 50 participants Est. completion 2024-12Other conditions: Gastrointestinal CancerView official trial listing → -
Status unknown NCT NCT05793008
Characterization of priMary And sEcondary STress Related takOtsubo
Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 60 participants Est. completion 2026-09-02 1 site Stand-aloneOther conditions: Takotsubo Cardiomyopathy, Sepsis-induced CardiomyopathyView official trial listing → -
Status unknown NCT NCT05796011
PET-CT-based Study of Central Mechanisms of Cortical Metabolism in 18F-FDG and 18F-AV1451 Age-related Deafness
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30 participants Est. completion 2024-01-01 1 siteOther conditions: Age-related Hearing Loss, PET-CTView official trial listing → -
Status unknown NCT NCT05803629
Characterizing Histiocytosis With 68Ga-FAPI PET/CT
Not yet reported Peking Union Medical College Hospital 100 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: HistiocytosisView official trial listing → -
Status unknown NCT NCT05803746
PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor
Not yet reported Peking University Cancer Hospital & Institute 20 participants Est. completion 2024-07-15 1 site Stand-aloneOther conditions: Lung Cancer, Colorectal CancerView official trial listing → -
Status unknown NCT NCT05806333
[18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG Avidity
Not yet reported Jilin University 60 participants Est. completion 2023-06-01 1 siteOther conditions: Liver CancerView official trial listing → -
Completed NCT NCT05814835
First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
Not yet reported Chinese PLA General Hospital 14 participants Est. completion 2023-12-18 1 site Stand-aloneOther conditions: Malignant Solid TumorsView official trial listing → -
Status unknown NCT NCT05819905
Radiomics for prEdiction of lunG cAncer biologY
Poitiers University Hospital 600 participants Est. completion 2024-01-01 1 siteOther conditions: Non Small Cell Lung Cancer, PET/CT, PD-L1, Gene Mutation-Related CancerView official trial listing → -
Status unknown NCT NCT05824962
A Non-invasive Diagnostic Model for Intestinal Fibrosis in Crohn's Disease Based on 18F-FAPI PET Imaging
Xiao Chen 50 participants Est. completion 2025-12-31 1 siteOther conditions: Crohn DiseaseView official trial listing → -
Status unknown NCT NCT05828238
Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy
Not yet reported Affiliated Hospital of Jiangnan University 10 participants Est. completion 2024-01 1 siteOther conditions: Breast Cancer Stage II, Breast Cancer Stage III, Solid TumorView official trial listing → -
Status unknown NCT NCT05831371
Discard the Curative Causes of Late Onset Epilepsy: the Role of Brain 18F-FDG PET
Central Hospital, Nancy, France 87 participants Est. completion 2023-09-02 1 siteOther conditions: Late Onset Epilepsy, Alzheimer DiseaseView official trial listing → -
Status unknown NCT NCT05840094
Multimodalitic Imaging in the N-stage of Lung Cancer
Not yet reported Peking University First Hospital 100 participants Est. completion 2025-05-01 1 site Stand-aloneOther conditions: Neoplasm of LungView official trial listing → -
Active, not recruiting NCT NCT05844306
RefleXion PET/CT Imaging Performance in Patients With Various Malignancies
Not yet reported City of Hope Medical Center 20 participants Est. completion 2027-08-17 1 siteOther conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid NeoplasmView official trial listing → -
Completed NCT NCT05855278
The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients
Not yet reported Chang Gung Memorial Hospital 22 participants Est. completion 2022-06-30 1 site Stand-aloneOther conditions: Esophageal CancerView official trial listing → -
Completed NCT NCT05855291
PET/MRI in Predicting the Outcome of Neoadjuvant Chemoradiotherapy With Esophagectomy in Esophageal Cancer Patients
Not yet reported Chang Gung Memorial Hospital 43 participants Est. completion 2021-07-31 1 site Stand-aloneOther conditions: Esophageal CancerView official trial listing → -
Active, not recruiting NCT NCT05876858
EXPLORER Total Body PET/CT Imaging for Myofascial Pain
Not yet reported University of California, Davis 53 participants Est. completion 2027-09 1 site Stand-aloneOther conditions: Myofascial PainView official trial listing → -
Status unknown NCT NCT05879471
68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Not yet reported Peking Union Medical College Hospital 39 participants Est. completion 2025-07-01 1 siteOther conditions: Metastatic Clear Cell Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT05884463
18F-FAPI PET Imaging in Pancreatic Adenocarcinoma
Not yet reported Zhejiang University 62 participants Est. completion 2023-02-28 1 site Stand-aloneOther conditions: 18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma, Diagnosis, StagingView official trial listing → -
Completed NCT NCT05885854
XTR003 PET Radiotracer for the Detection of Viable Myocardium
Not yet reported Sinotau Pharmaceutical Group 51 participants Est. completion 2023-03-05 1 site Stand-aloneOther conditions: Ischemic Heart Disease (IHD)View official trial listing → -
Status unknown NCT NCT05887687
68Ga-P3 PET/CT Imaging in Malignancy
Not yet reported Peking University First Hospital 350 participants Est. completion 2025-07-31 1 site Stand-aloneOther conditions: NeoplasmsView official trial listing → -
Status unknown NCT NCT05912465
Predicting Lung Cancer-Associated Cachexia With PET Imaging
Not yet reported Medical University of Vienna 150 participants Est. completion 2025-03-01 3 sitesOther conditions: Cachexia, Lung NeoplasmView official trial listing → -
Status unknown NCT NCT05919199
PET Tracer Based FDG Signal for Predicting Prognosis in Acute Myeloid Leukemia
First Affiliated Hospital of Jinan University 60 participants Est. completion 2024-12 1 siteOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT05930457
Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
Not yet reported The First Affiliated Hospital of Guangzhou Medical University 15 participants Est. completion 2023-12-18 1 site Stand-aloneOther conditions: Malignant Solid TumorsView official trial listing → -
Completed NCT NCT05931302
Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT
Not yet reported Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 40 participants Est. completion 2026-09-03 1 siteOther conditions: Lobular Breast CarcinomaView official trial listing → -
Status unknown NCT NCT05936411
Organ Interaction Patterns in Healthy Individuals for Improved PET/CT Diagnostics
Not yet reported Medical University of Vienna 50 participants Est. completion 2026-01-01Other conditions: HealthyView official trial listing → -
Completed NCT NCT05937776
Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas
OHSU Knight Cancer Institute 4 participants Est. completion 2025-12-31 1 siteOther conditions: GliomaView official trial listing → -
Withdrawn NCT NCT05950113
CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Not yet reported Jonsson Comprehensive Cancer Center Est. completion 2028-03-28 1 siteOther conditions: Recurrent Multiple Myeloma, Refractory Multiple MyelomaView official trial listing → -
Status unknown NCT NCT05963035
Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft Tissue
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10 participants Est. completion 2024-06-30 1 site Stand-aloneOther conditions: Clear Cell Sarcoma of Soft TissueView official trial listing → -
Completed NCT NCT05994768
18F-FDG Tomography and Labeled Leukocyte Scintigraphy
Central Hospital, Nancy, France 18 participants Est. completion 2023-10-18 1 siteOther conditions: Malignant Otitis ExternaView official trial listing → -
Status unknown NCT NCT05999227
68Ga-FAPI-04 PET Imaging in Early Response Evaluation of Rectal Cancer Patients Treated With Immunotherapy
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 20 participants Est. completion 2024-07-31 1 site Stand-aloneOther conditions: Rectal CancerView official trial listing → -
Status unknown NCT NCT06010290
The Novel 18F-labeled MAO-B PET Tracer Study in Parkinsonism Patients
Anhui Provincial Hospital 80 participants Est. completion 2023-12-31 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Not yet recruiting NCT NCT06055764
Role of FDG PET/CT in Patients With Metastasis of Unknown Origin
Assiut University 73 participants Est. completion 2026-12Other conditions: MetastasisView official trial listing → -
Status unknown NCT NCT06116188
Brain Insulin Resistance in Mild Cognitive Impairment
Turku University Hospital 40 participants Est. completion 2025-10-10 1 siteOther conditions: Alzheimer Disease, Mild Cognitive Impairment, Positron Emission TomographyView official trial listing → -
Terminated NCT NCT06125028
[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma
Not yet reported Pentixapharm AG 8 participants Est. completion 2025-07-18 12 sitesOther conditions: Marginal Zone LymphomaView official trial listing → -
Status unknown NCT NCT06126705
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
Not yet reported Affiliated Hospital of North Sichuan Medical College 60 participants Est. completion 2024-07 1 site Stand-aloneOther conditions: Tumor, SolidView official trial listing → -
Withdrawn NCT NCT06145399
A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2024-04-29 Stand-aloneOther conditions: Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer, Metastatic Breast Carcinoma, Female Breast CancerView official trial listing → -
Completed NCT NCT06151054
Relationship Between Aortic Parietal Inflammation on 18F-FDG PET Scan and Arterial Stiffness as a Function of Age
Central Hospital, Nancy, France 89 participants Est. completion 2022-12-06 1 siteOther conditions: Arterial StiffnessView official trial listing → -
Status unknown NCT NCT06159907
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Gynecological Tumors.
IRCCS San Raffaele 380 participants Est. completion 2024-12-27 1 siteOther conditions: Gynecological TumorsView official trial listing → -
Status unknown NCT NCT06159920
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors.
IRCCS San Raffaele 800 participants Est. completion 2024-12-27 1 siteOther conditions: Neuroendocrine TumorsView official trial listing → -
Not yet recruiting NCT NCT06162988
PET Imaging of 68Ga-NOTA-H006 in Malignancy
Not yet reported YiHui Guan 15 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: Tumor, SolidView official trial listing → -
Completed NCT NCT06168877
Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.
IRCCS San Raffaele 30 participants Est. completion 2014-07-03Other conditions: Lung CancerView official trial listing → -
Completed NCT NCT06170151
Role of18F-FDG PET-CT for Assessing and Predicting Response to Daratumumab and for Prognosis With Multiple Myeloma
IRCCS San Raffaele 10 participants Est. completion 2022-12-01 1 siteOther conditions: Multiple MyelomaView official trial listing → -
Completed NCT NCT06171464
Prognostic Value of Pre-therapy 18F-FDG PET/CT for the Outcome of 18 FDG PET-guided SIB-IMRT in Patients With Head and Neck Cancer
IRCCS San Raffaele 19 participants Est. completion 2013-12-01Other conditions: Head and Neck CancerView official trial listing → -
Active, not recruiting NCT NCT06175390
Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer
Not yet reported Institut Curie 81 participants Est. completion 2029-02-15 2 sites Stand-aloneOther conditions: Triple Negative Breast CancerView official trial listing → -
Completed NCT NCT06180226
Evaluation of Brain Functional Changes With 18F-FDG PET and Cognitive Processes After Brain Radiotherapy for Cavernous Sinus Meningiomas and Non-secreting ACTH Adenomas
IRCCS San Raffaele 20 participants Est. completion 2014-12-11Other conditions: MeningiomaView official trial listing → -
Status unknown NCT NCT06182644
Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors
Not yet reported Guangdong Provincial People's Hospital 30 participants Est. completion 2025-09-01 1 siteOther conditions: Renal Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma, Signet Ring Cell Carcinoma, Mucinous Adenocarcinoma, Colorectal CancerView official trial listing → -
Status unknown NCT NCT06186427
A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors
Not yet reported Guangdong Provincial People's Hospital 30 participants Est. completion 2025-12-31 1 siteOther conditions: Cancer, Malignant Neoplasm, Tumors, Metastatic CancerView official trial listing → -
Completed NCT NCT06188468
ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors
Not yet reported The First Affiliated Hospital of Xiamen University 90 participants Est. completion 2024-08-31 1 site Stand-aloneOther conditions: Tumor, Solid Tumor, Positron-Emission TomographyView official trial listing → -
Completed NCT NCT06190574
Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50 participants Est. completion 2023-11-30 1 siteOther conditions: 18F-FDG, Neuroblastoma, Hepatoblastoma, Wilms TumorView official trial listing → -
Status unknown NCT NCT06197698
A Proof-of-concept Study Evaluating the Microbiota-gut-brain Axis
Not yet reported National Taiwan University Hospital 100 participants Est. completion 2025-02-28 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Active, not recruiting NCT NCT06199713
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
University of Wisconsin, Madison 25 participants Est. completion 2029-01 1 siteOther conditions: Melanoma, Melanoma Stage III, Melanoma Stage IV, Unresectable MelanomaView official trial listing → -
Completed NCT NCT06203119
Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe
Not yet reported Peking University Cancer Hospital & Institute 18 participants Est. completion 2025-12-18 1 site Stand-aloneOther conditions: CancerView official trial listing → -
Withdrawn NCT NCT06205888
To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT
Jinling Hospital, China Est. completion 2024-12-01Other conditions: TumourView official trial listing → -
Status unknown NCT NCT06205901
Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies
Sohag University 50 participants Est. completion 2025-04-01Other conditions: Distant MetastasisView official trial listing → -
Completed NCT NCT06206642
Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection
Not yet reported Lanzhou University Second Hospital 92 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Malignant NeoplasmView official trial listing → -
Active, not recruiting NCT NCT06209567
A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors
Not yet reported Memorial Sloan Kettering Cancer Center 11 participants Est. completion 2027-01-05 7 sites Stand-aloneOther conditions: High-grade Glioma, Brain Metastases, Brain Metastases, AdultView official trial listing → -
Completed NCT NCT06211803
Clinical Application of the Prototype J-PET Device
Jagiellonian University 10 participants Est. completion 2022-03-22 1 siteOther conditions: Neurodegenerative Diseases, Brain Neoplasms, Neuroendocrine TumorsView official trial listing → -
Status unknown NCT NCT06241391
Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
Not yet reported All India Institute of Medical Sciences, Bhubaneswar 35 participants Est. completion 2025-02 1 site Stand-aloneOther conditions: Glioma, Astrocytoma, Anaplastic Astrocytoma, Oligodendroglioma, Glioblastoma MultiformeView official trial listing → -
Status unknown NCT NCT06304155
Application of FDG Combined With FAPI PET Dual Imaging in the Diagnosis and Staging of Oropharyngeal and Laryngeal Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 40 participants Est. completion 2026-01-01 1 siteOther conditions: CancerView official trial listing → -
Status unknown NCT NCT06317142
Glucose and Glycogen Dynamics in Prediabetes
Maastricht University Medical Center 45 participants Est. completion 2025-07 1 siteOther conditions: Pre DiabetesView official trial listing → -
Status unknown NCT NCT06318234
PET/MR Evaluation of Regression Grading After Neoadjuvant Therapy for Rectal Cancer
Xiao Chen 32 participants Est. completion 2025-12-31 1 siteOther conditions: Rectal CancerView official trial listing → -
Status unknown NCT NCT06327386
The Therapeutic Efficacy of 18F-FDG Combined With 18F-FAPI PET/MR in Neoadjuvant Therapy for Gastric Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 32 participants Est. completion 2026-01-01 1 siteOther conditions: CancerView official trial listing → -
Status unknown NCT NCT06344845
Clinical Study of [18F] PM-PBB3 PET Imaging of Tau Protein in Neurodegenerative Diseases
Not yet reported Peking Union Medical College Hospital 80 participants Est. completion 2025-11 1 site Stand-aloneOther conditions: Neurodegenerative DiseasesView official trial listing → -
Completed NCT NCT06359054
The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging
Not yet reported Manisa Celal Bayar University 16 participants Est. completion 2023-09-15 2 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06362148
Circulating Tumor DNA in Peripheral T-cell Lymphomas
University of Aarhus 50 participants Est. completion 2030-12 1 siteOther conditions: Peripheral T-cell Lymphoma, NK/T-Cell LymphomaView official trial listing → -
Completed NCT NCT06370234
The Prediction Model of NAC Response for Breast Cancer Based on The Parametric Dynamics Features.
Not yet reported National Taiwan University Hospital 60 participants Est. completion 2020-03-03Other conditions: Breast Cancer, Chemotherapy Effect, Diffusion Weighted MRI, PET Imaging, Multiparametric Magnetic Resonance ImagingView official trial listing → -
Completed NCT NCT06379295
Coronary Artery Calcification Assessed on PET Scanner (PET : Positron Emission Tomography)
Centre Hospitalier Régional d'Orléans 200 participants Est. completion 2024-07-22 1 siteCardiovascular disease Other conditions: Coronary Artery CalcificationView official trial listing → -
Completed NCT NCT06383598
PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors
Not yet reported Hua Zhu 50 participants Est. completion 2026-09-24 1 site Stand-aloneOther conditions: Solid TumorView official trial listing → -
Not yet recruiting NCT NCT06416852
Clinical Study of 18F-Alfatide Injection PET/CT
Not yet reported Yantai LNC Biotechnology Singapore PTE. LTD. 428 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Non-Small Cell Lung Cancer NSCLCView official trial listing → -
Not yet recruiting NCT NCT06452290
PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder
Not yet reported Central Hospital, Nancy, France 30 participants Est. completion 2029-03-01 Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Status unknown NCT NCT06455735
68Ga-JH04 PET/CT in Patients With Various Types of Cancer
Not yet reported First Affiliated Hospital of Fujian Medical University 30 participants Est. completion 2026-04-01 1 site Stand-aloneOther conditions: TumorView official trial listing → -
Status unknown NCT NCT06455761
68Ga-DOTA-NI-FAPI04 PET/CT in Patients With Various Types of Cancer
Not yet reported First Affiliated Hospital of Fujian Medical University 30 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: TumorView official trial listing → -
Completed NCT NCT06460454
PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing
Central Hospital, Nancy, France 100 participants Est. completion 2025-02-25 1 siteOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT06465017
ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer
Not yet reported The First Affiliated Hospital of Xiamen University 149 participants Est. completion 2026-01-31 1 site Stand-aloneOther conditions: Tumor, Solid Tumor, Thyroid Cancer, Positron-Emission TomographyView official trial listing → -
Status unknown NCT NCT06494800
Added Value of PET/CT in Lung Cancer
Sohag University 30 participants Est. completion 2025-12-01Other conditions: Lung CancerView official trial listing → -
Not yet recruiting NCT NCT06511323
Evaluation of Brain Metastases Treated With Stereotactic Radiotherapy Using Dynamic [18F]FDG PET
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 70 participants Est. completion 2027-08Other conditions: Brain MetastasesView official trial listing → -
Status unknown NCT NCT06519240
A Pilot Study Evaluating the Potential of 18F Fluorodeoxyglucose PET-CT Imaging in Diagnosing Cardiac Rejection.
Not yet reported Royal Brompton & Harefield NHS Foundation Trust 20 participants Est. completion 2026-10-02Other conditions: Cardiac Transplant RejectionView official trial listing → -
Status unknown NCT NCT06531343
Advancing Lung Cancer Screening: Artificial Intelligence, Multimodal Imaging and Cutting-Edge Technologies for Early Detection and Characterization
Not yet reported IRCCS San Raffaele 334 participants Est. completion 2026-08-30 1 siteOther conditions: Lung Cancer ScreeningView official trial listing → -
Active, not recruiting NCT NCT06557148
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
Memorial Sloan Kettering Cancer Center 7 participants Est. completion 2027-08-13 7 sitesOther conditions: Breast Cancer, Lobular Breast Carcinoma, Breast Carcinoma, Metastatic Breast Cancer, Metastatic Lobular Breast Carcinoma, Metastatic Breast CarcinomaView official trial listing → -
Terminated NCT NCT06566209
FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis
Mayo Clinic 2 participants Est. completion 2025-12-22 1 siteOther conditions: Subclinical Immune Checkpoint Inhibitor-Induced Myocarditis, Myocarditis, ICI-Myocarditis, Solid Malignant Tumor, Hematologic Malignancy, Subclinical Myocarditis, Subclinical ICI-myocarditisView official trial listing → -
Active, not recruiting NCT NCT06584747
Study of Cerebral Vascular Reserve Using Pharmacological Testing With Acetazolamide: A Non-Inferiority Study of PET Method Compared to Conventional Reference Scintigraphy
Not yet reported Centre Antoine Lacassagne 19 participants Est. completion 2027-04-09 1 site Stand-aloneOther conditions: Cerebrovascular CirculationView official trial listing → -
Status unknown NCT NCT06597045
BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS
NHS Greater Glasgow and Clyde 60 participants Est. completion 2024-11-20 1 siteOther conditions: Cancer, Cardiotoxicity, Atherosclerotic DiseaseView official trial listing → -
Completed NCT NCT06614062
Clinical Study of 18F-FAPI-RGD in Ovarian Cancer
Sichuan Provincial People's Hospital 30 participants Est. completion 2024-08-30 1 siteOther conditions: ObservationalView official trial listing → -
Not yet recruiting NCT NCT06626932
Implications of Biological and Procedural Factors of 18-f FDG Uptake by Normal Organs and Neoplastic Lesions
mahenoor alaa eldeen naem 259 participants Est. completion 2026-11 1 siteOther conditions: Oncologic DiseasesView official trial listing → -
Active, not recruiting NCT NCT06630845
Comparison of Whole Body DWI to FDG PET
Not yet reported University of California, San Francisco 25 participants Est. completion 2027-02-28 1 siteOther conditions: Metastatic CancerView official trial listing → -
Status unknown NCT NCT06632860
A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors
Not yet reported Peking Union Medical College Hospital 40 participants Est. completion 2025-12-30 1 site Stand-aloneOther conditions: Iodine-resistant Thyroid Cancer, Meningioma, NETsView official trial listing → -
Not yet recruiting NCT NCT06700564
The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic Malignancies
Shanghai East Hospital 60 participants Est. completion 2027-11-30Other conditions: HepatomaView official trial listing → -
Not yet recruiting NCT NCT06720298
CD147 Targeting Peptide Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute 30 participants Est. completion 2026-12-31 1 siteOther conditions: Solid TumorView official trial listing → -
Completed NCT NCT06721130
Role of 18F-FDG PET/CT in the Evaluation of Cavernous Sinus Syndrome: a Pilot Study
Post Graduate Institute of Medical Education and Research, Chandigarh 54 participants Est. completion 2024-06-30 1 siteOther conditions: Cavernous Sinus Syndrome, Cavernous Sinus Meningioma, Cavernous Sinus LesionsView official trial listing → -
Enrolling by invitation NCT NCT06723665
The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
Not yet reported Affiliated Hospital of Jiangnan University 50 participants Est. completion 2026-12-31 1 siteOther conditions: Prostate CancerView official trial listing → -
Not yet recruiting NCT NCT06726512
Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy
Not yet reported University Medical Center Groningen 30 participants Est. completion 2026-04 1 siteObstructive sleep apnea Other conditions: Oral Cancer, Soft Tissue Sarcoma, Oral Squamous Cell Carcinoma (OSCC)View official trial listing → -
Not yet recruiting NCT NCT06738680
PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1
University Hospital, Brest 120 participants Est. completion 2026-11-02 2 sitesOther conditions: Non-Small Cell Lung CancerView official trial listing → -
Not yet recruiting NCT NCT06747299
The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study
Ruijin Hospital 200 participants Est. completion 2027-12-31 1 siteOther conditions: T-NK Cell LymphomaView official trial listing → -
Not yet recruiting NCT NCT06755086
TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute 20 participants Est. completion 2026-12-31 1 siteOther conditions: Solid TumorsView official trial listing → -
Status unknown NCT NCT06774209
Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors
Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2025-10-01 1 site Stand-aloneOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT06796959
Combined [18F]-FDG PET-MRI in Diagnostics and Surveillance of Small Bowel Crohn's Disease
Turku University Hospital 35 participants Est. completion 2024-10-31 1 siteOther conditions: Small Bowel Crohn's DiseaseView official trial listing → -
Terminated NCT NCT06820957
Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
Not yet reported, Not yet reported Children's Oncology Group 2 participants Est. completion 2026-09-22 8 sitesOther conditions: CIC-Rearranged Sarcoma, Metastatic Ewing Sarcoma, Metastatic High Grade Sarcoma, Metastatic Undifferentiated Round Cell Sarcoma, Metastatic Undifferentiated Sarcoma, Not Otherwise Specified, Round Cell Sarcoma With EWSR1-non-ETS Fusion, Sarcoma With BCOR Genetic AlterationsView official trial listing → -
Enrolling by invitation NCT NCT06829043
18F-FDG PET/TC in TIR3A e TIR3B
IRCCS Azienda Ospedaliero-Universitaria di Bologna 216 participants Est. completion 2027-02-01 1 siteOther conditions: PET / CT, FDG PET/CT, Cytology, Thyroid NodulesView official trial listing → -
Status unknown NCT NCT06834412
A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging
Not yet reported Xijing Hospital 120 participants Est. completion 2025-12-01 1 site Stand-aloneOther conditions: Hematological MalignanciesView official trial listing → -
Enrolling by invitation NCT NCT06852144
PET-TC in Thyroid Evaluation
IRCCS Azienda Ospedaliero-Universitaria di Bologna 418 participants Est. completion 2029-04-30 1 siteOther conditions: Medullary Thyroid Carcinoma, Hyperparathyroidism, Parathyroid CarcinomaView official trial listing → -
Active, not recruiting NCT NCT06877208
The Effect of Glucagon on Cerebral Glucose Metabolism in Healthy Humans
Not yet reported Nicolai Jacob Wewer Albrechtsen 12 participants Est. completion 2027-08 1 site Stand-aloneOther conditions: Cerebral Glucose MetabolismView official trial listing → -
Not yet recruiting NCT NCT06916442
Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy
Zhongnan Hospital 200 participants Est. completion 2027-12-31 1 siteOther conditions: PET/CT, Solid Tumors, Adult, Solid Tumors, Advanced Solid TumorsView official trial listing → -
Completed NCT NCT06919159
Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer
Jiequn Yu 45 participants Est. completion 2022-11-30 1 siteOther conditions: Prostate Cancer (Diagnosis), Prostate-specific Membrane Antigen, Positron Emission Tomography (PET)View official trial listing → -
Completed NCT NCT06945432
Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection
Lanzhou University Second Hospital 27 participants Est. completion 2025-04-05 1 siteOther conditions: Tumors, PET / CT, FDG PET/CT, FAPIView official trial listing → -
Not yet recruiting NCT NCT06947759
Application of 18F-FDG PET/MRI for Initial Staging in Locally Advanced Nasopharyngeal Carcinoma
Taichung Veterans General Hospital 20 participants Est. completion 2026-04-30 1 siteOther conditions: Nuclear Medicine, OncologyView official trial listing → -
Withdrawn NCT NCT06978478
An Imaging Study in ER Negative Breast Cancer by Targeting αvβ6
Not yet reported Queen Mary University of London Est. completion 2020-07-27 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT06982053
[68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant Therapy
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 21 participants Est. completion 2025-03-31 1 siteOther conditions: Colorectal Cancer Control and Prevention, Colorectal Cancer Recurrent, Colorectal Cancer Metastatic, Colorectal Cancer ScreeningView official trial listing → -
Not yet recruiting NCT NCT06994078
Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 56 participants Est. completion 2026-04-30 1 siteOther conditions: Urothelial Carcinoma, Breast Cancer, Lung CarcinomaView official trial listing → -
Completed NCT NCT06995976
Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73
Not yet reported First Affiliated Hospital of Fujian Medical University 15 participants Est. completion 2026-03-01 1 site Stand-aloneOther conditions: Malignant TumourView official trial listing → -
Not yet recruiting NCT NCT07007325
Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC)
Not yet reported Institut Cancerologie de l'Ouest 15 participants Est. completion 2030-09-30 3 sitesOther conditions: Small Cell Lung Carcinoma (SCLC)View official trial listing → -
Not yet recruiting NCT NCT07022080
Evaluating the Effectiveness of 68Ga-grazytracer PET/CT in Inflammatory Bowel Disease
Not yet reported Xijing Hospital 69 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Inflammatory Bowel Diseases (IBD)View official trial listing → -
Enrolling by invitation NCT NCT07023848
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors
Not yet reported Affiliated Hospital of Jiangnan University 10 participants Est. completion 2026-12-01 1 site Stand-aloneOther conditions: Breast Cancer, Gastric Cancer (GC), Urothelial Carcinoma (UC)View official trial listing → -
Enrolling by invitation NCT NCT07023861
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Not yet reported Affiliated Hospital of Jiangnan University 20 participants Est. completion 2026-12-01 1 site Stand-aloneOther conditions: Breast Cancer, Gastric Cancer (GC), Urothelial Carcinoma (UC)View official trial listing → -
Not yet recruiting NCT NCT07029295
Evaluation of the Impact of a Patient Education Protocol on the Quality of 18F-FDG PET Imaging Indicated for Investigation of Cardiac Inflammation
Not yet reported Assistance Publique - Hôpitaux de Paris 138 participants Est. completion 2027-08-31 2 sitesOther conditions: Infective Endocarditis, Cardiac SarcoidosisView official trial listing → -
Not yet recruiting NCT NCT07055048
The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver Lesions
Shanghai East Hospital 60 participants Est. completion 2025-12-31Other conditions: Liver Cancer, AdultView official trial listing → -
Not yet recruiting NCT NCT07066436
ImmunoMRI for Assessment of Tumor-associated Macrophages
Not yet reported Medical University of Vienna 60 participants Est. completion 2028-09 1 site Stand-aloneOther conditions: DLBCL - Diffuse Large B Cell LymphomaView official trial listing → -
Active, not recruiting NCT NCT07118176
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Not yet reported Jonsson Comprehensive Cancer Center 30 participants Est. completion 2027-09-07 1 site Stand-aloneOther conditions: Anal Carcinoma, Bladder Carcinoma, Breast Carcinoma, Cervical Carcinoma, Cholangiocarcinoma, Colorectal Carcinoma, Esophageal Carcinoma, Gastric Carcinoma, Head and Neck Carcinoma, Hematopoietic and Lymphatic System Neoplasm, Hepatocellular Carcinoma, Lung Carcinoma, Malignant Adrenal Gland Neoplasm, Malignant Brain Neoplasm, Malignant Neoplasm of Unknown Primary, Malignant Solid Neoplasm, Malignant Testicular Neoplasm, Malignant Uterine Neoplasm, Neuroendocrine Neoplasm, Ovarian Carcinoma, Pancreatic Carcinoma, Penile Carcinoma, Pleural Carcinomatosis, Primary Peritoneal Carcinoma, Prostate Carcinoma, Salivary Gland Carcinoma, Sarcoma, Skin Carcinoma, Solitary Fibrous Tumor, Thymus Carcinoma, Thyroid Gland Carcinoma, Thyroid Gland Medullary Carcinoma, Urothelial Carcinoma, Vaginal CarcinomaView official trial listing → -
Not yet recruiting NCT NCT07127627
Characterization of Abdomino-pelvic Lesions by 18Fluorine- Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
Assiut University 79 participants Est. completion 2028-11Other conditions: Abdominal SepsisView official trial listing → -
Not yet recruiting NCT NCT07130344
PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer
Not yet reported Centre Paul Strauss 262 participants Est. completion 2030-09 1 site Stand-aloneOther conditions: Metastatic Breast Cancer, HER 2 Low-expressing Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07163806
Volumetric Parameter of 18F-FDG PET/CT in Characterizing Thyroid Incidentalomas
Fatma Abelzaher Mahmoud Ahmed 88 participants Est. completion 2028-05-30Other conditions: Thyroid IncidentalomasView official trial listing → -
Not yet recruiting NCT NCT07172503
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 56 participants Est. completion 2026-12-31 1 siteOther conditions: Colorectal Cancer, Gastric Cancer (GC), Pancreatic CancerView official trial listing → -
Active, not recruiting NCT NCT07203495
Spatiotemporal Dynamics and Prognostic Value of the 18F-FDG PET Neuro-Metabolic Network
The First Affiliated Hospital of Zhengzhou University 200 participants Est. completion 2027-12 1 siteOther conditions: Lung Diseases, Endocrine Diseases, Gastrointestinal DiseasesView official trial listing → -
Completed NCT NCT07285564
Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer
Not yet reported Centre Henri Becquerel 12 participants Est. completion 2026-03-28 1 siteOther conditions: Head & Neck CancerView official trial listing → -
Not yet recruiting NCT NCT07285993
Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET
Not yet reported Randy Yeh 15 participants Est. completion 2027-12-30 1 site Stand-aloneOther conditions: Breast Cancer, Metastatic Invasive Lobular Breast CancerView official trial listing → -
Active, not recruiting NCT NCT07295171
HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG
Not yet reported British Columbia Cancer Agency 27 participants Est. completion 2027-08-25 1 siteOther conditions: Multiple Cancers, Multiple Indications Cancer, Feasibility StudiesView official trial listing → -
Not yet recruiting NCT NCT07306975
Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.
Assiut University 80 participants Est. completion 2027-12-01Other conditions: Cancer Patients Referred to do PET/CT StudyView official trial listing → -
Not yet recruiting NCT NCT07313033
[68]GA-FAPI-46 PET/CT for the Diagnosis of Metastatic Lesions in Patients With Lobular Breast Cancer (ICL).
Not yet reported Hospices Civils de Lyon 45 participants Est. completion 2027-08-30 1 site Stand-aloneOther conditions: Lobular Carcinoma, Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07327515
PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors
Not yet reported Li Min 90 participants Est. completion 2028-06-01 1 site Stand-aloneOther conditions: Malignant TumorsView official trial listing → -
Not yet recruiting NCT NCT07353554
Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma
Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2028-02-01 1 site Stand-aloneOther conditions: Multiple Myeloma (MM)View official trial listing → -
Active, not recruiting NCT NCT07366710
Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET
Not yet reported Copenhagen University Hospital, Rigshospitalet 36 participants Est. completion 2027-10 1 site Stand-aloneMASLD Other conditions: Glucose MetabolismView official trial listing → -
Not yet recruiting NCT NCT07370805
18F-FAPI PET in Lung Cancer
First Affiliated Hospital of Zhejiang University 120 participants Est. completion 2028-12-31 1 siteOther conditions: Lung Cancer (Diagnosis)View official trial listing → -
Not yet recruiting NCT NCT07419867
A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI
Not yet reported Fudan University 300 participants Est. completion 2032-01-01 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT07430475
Utility of 18F-FDG PET/CT for Suspected Infection in the Inpatient Setting: a Single Centre Retrospective Cohort Study
University of Adelaide 266 participants Est. completion 2024-01-29 1 siteOther conditions: Fever of Unknown Origin, Inflammation of Unknown Origin, Fever, InflammationView official trial listing → -
Not yet recruiting NCT NCT07431255
Generation of Synthetic [18F]FDG PET From Early-Phase Amyloid PET in Alzheimer's Disease
IRCCS San Raffaele 35 participants Est. completion 2026-12-31 1 siteOther conditions: Alzheimer Disease (AD)View official trial listing → -
Not yet recruiting NCT NCT07442292
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
Peking University Cancer Hospital & Institute 40 participants Est. completion 2027-06Other conditions: Lung Cancer (NSCLC), Lung Cancer (SCLC), Melanoma (Skin Cancer), Melanoma Metastatic, PD-L1, PET / CTView official trial listing → -
Active, not recruiting NCT NCT07449858
18F-FDG PET/CT Radiomics Models for Precision Diagnosis and Prognosis in NSCLC
Second Affiliated Hospital, Zhejiang University, School of Medicine 500 participants Est. completion 2027-12-31 4 sitesOther conditions: Non Small Cell Lung CancerView official trial listing → -
Not yet recruiting NCT NCT07454096
Application of Radiomics for Diagnosis and Follow-up of Cardiovascular Device Infections: PREDICT Study
Not yet reported Fundacion Clinic per a la Recerca Biomédica 200 participants Est. completion 2028-04-30 1 siteOther conditions: Cardiac Disease, Device Related InfectionView official trial listing → -
Completed NCT NCT07506447
The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 68 participants Est. completion 2026-03-13 1 siteObstructive sleep apnea Other conditions: FDG PETView official trial listing → -
Not yet recruiting NCT NCT07523516
Diagnostic Performance of 18F-FDG PET/CT in Detecting Distant Metastases in Breast Cancer
Assiut University 97 participants Est. completion 2029-04-01Other conditions: Breast Cancer (Locally Advanced or Metastatic)View official trial listing → -
Completed NCT NCT07528131
18F-FDG PET/CT in Gastric Cancer
Sohag University 50 participants Est. completion 2024-09-22 1 siteOther conditions: Gastric CancerView official trial listing → -
Not yet recruiting NCT NCT07536321
Diagnostic Accuracy and Prognostic Value of 18F FDG PET-CT in the Follow up of Patients With Colorectal Carcinoma.
Assiut University 46 participants Est. completion 2031-03-05Other conditions: Rectal Cancer (Stage III)View official trial listing → -
Not yet recruiting NCT NCT07552207
Comparison of [68Ga]Ga-CTR-FAPI and 18F-FDG PET/MRI for Lymph Node Staging in Rectal Cancer
Not yet reported Peking University Cancer Hospital & Institute 30 participants Est. completion 2028-12-31 Stand-aloneOther conditions: Rectal Cancer, Lymph Node Metastases, PET / MRView official trial listing → -
Completed NCT NCT07553741
Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27 participants Est. completion 2026-04-01 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07589101
5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Not yet reported Peking University Cancer Hospital & Institute 20 participants Est. completion 2027-12-30 1 site Stand-aloneOther conditions: Lung Cancer, Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07604207
Multi-organ Imaging of Microvascular and Metabolic Function
Not yet reported Massachusetts General Hospital 60 participants Est. completion 2031-07 Stand-aloneCardiovascular disease Other conditions: Healthy Subjects (HS)View official trial listing → -
Not yet recruiting NCT NCT07628075
Long-Axial Field of View (LAFOV) [18F]FDG PET/CT Imaging in Large Vessel Vasculitis (LVV): Protocol Optimisation Study.
Not yet reported Imperial College London 18 participants Est. completion 2028-01-01 3 sitesOther conditions: Large Vessel Vasculitis, Takayasu Arteritis, Giant Cell Arteritis (GCA)View official trial listing → -
Not yet recruiting NCT NCT07628257
Cerebral Connectivity and Metabolic Phenotype of Gliomas: Prospective Addition of DTI and Rs-fMRI to a Preoperative FDG PET Strategy, With Neuropsychological Correlates and Post-treatment Follow-up
Not yet reported Centre Paul Strauss 80 participants Est. completion 2030-09-15 1 siteOther conditions: GlioblastomaView official trial listing → -
Not yet recruiting NCT NCT07634289
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
Not yet reported Olivia Newton-John Cancer Research Institute 40 participants Est. completion 2032-12 5 sitesOther conditions: Relapsed /Refractory DLBCLView official trial listing → -
Not yet recruiting NCT NCT07646873
PET-Enabled Dual-Energy CT in Multiple Myeloma
Not yet reported University of California, Davis 45 participants Est. completion 2030-11 1 site Stand-aloneOther conditions: Multiple Myeloma (MM)View official trial listing → -
Not yet recruiting NCT NCT07705074
FAPI PET Imaging - An Exploratory Study
Not yet reported, Not yet reported Martin Huellner 770 participants Est. completion 2029-09 5 sitesOther conditions: Thyroid Pathology, Head and Neck Cancer (H&N), Sinonasal Tract Tumor, Sarcoidosis, Thyroid Cancer, Breast Cancer, Hepatocellular Carcinoma (HCC), Gastric Cancer (GC), Pancreatic Cancer, Adult, Urothelial Carcinoma (UC), Multiple Myeloma or Plasmacytoma, Mesothelioma, Hepatic Fibrosis, Endometriosis (Diagnosis), Lung Fibrosis, Neck Node Metastasis, Prostate Cancer (CRPC)View official trial listing → -
Not yet recruiting NCT NCT07708103
Clinical Evaluation of [68Ga]Ga-FFD PET Imaging in Healthy Volunteers and Patients With Solid Tumors
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12 participants Est. completion 2027-07-30 1 site Stand-aloneOther conditions: Solid Tumor MalignanciesView official trial listing → -
Completed NCT NCT07712172
Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3
Post Graduate Institute of Medical Education and Research, Chandigarh 31 participants Est. completion 2026-05-30 1 siteOther conditions: Granulomatosis With Polyangiitis (Wegener's)View official trial listing → -
Not yet recruiting NCT NCT07727317
Evaluate the Diagnostic Efficacy and Safety of INR 202 PET/CT Imaging in Participants With Advanced Solid Tumors
Not yet reported Shanghai Zhongshan Hospital 30 participants Est. completion 2028-07 Stand-aloneOther conditions: Solid TumorsView official trial listing → -
Not yet recruiting NCT NCT07770672
An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging
Not yet reported Tan Lijie 92 participants Est. completion 2029-03-01 1 site Stand-aloneOther conditions: Esophageal Cancer, ESCCView official trial listing → -
Completed NCT NCT07825467
Brown Adipose Tissue Activity and NAFLD Progression
Renmin Hospital of Wuhan University 96 participants Est. completion 2026-02-05 1 siteMASLDView official trial listing → -
Completed NCT NCT07827482
Pretreatment 18F-FDG PET/CT Radiomics for Predicting Response to First-Line Targeted Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma
First Affiliated Hospital of Fujian Medical University 228 participants Est. completion 2026-06-30 1 siteOther conditions: Metastatic Renal Cell CarcinomaView official trial listing → -
Not yet recruiting NCT NCT07828691
18F-FDG PET/CT for Diagnosis of Diabetic Foot Osteomyelitis
Jewish General Hospital 150 participants Est. completion 2029-04 4 sitesOther conditions: Diabetic Foot InfectionsView official trial listing → -
Not yet recruiting NCT NCT07838649
Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity
Not yet reported Washington University School of Medicine 36 participants Est. completion 2029-12-12 1 site Stand-aloneOther conditions: Lymphoma Cancer, Breast Cancer, Cancer of the Breast, Non-Hodgkin Lymphoma, Hodgkin LymphomaView official trial listing → -
Not yet recruiting NCT NCT07859800
Positron Emission Tomography and Organ-Specific Changes in Participants Co-Enrolled in NIH Studies of Plasmodium Vivax Controlled Human Malaria Infection
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 45 participants Est. completion 2030-11-01 1 siteOther conditions: Healthy Volunteer, MalariaView official trial listing → -
Not yet recruiting NCT NCT07867925
Predicting Endocrine Resistance Using Molecular Imaging and Liquid Biopsy in Metastatic Breast Cancer
Asan Medical Center 100 participants Est. completion 2030-12-31 1 siteOther conditions: Metastatic Breast Cancer (HR+/ HER2-)View official trial listing → -
Active, not recruiting NCT NCT07875244
MAMMI-BB PET for Monitoring Response to Neoadjuvant Therapy in Breast Cancer
Not yet reported Fudan University 1024 participants Est. completion 2027-05 1 site Stand-aloneOther conditions: Breast Cancer, Neoadjuvant Therapy, Axilla; BreastView official trial listing → -
Not yet recruiting NCT NCT07875946
68Ga- and 18F-CAIX PET Imaging Study
Not yet reported Peking University First Hospital 100 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Renal TumorView official trial listing → -
Completed NCT NCT07906158
PET/CT-Based Intratumoral Heterogeneity and Multimodal Imaging for Tumor Diagnosis and Prognosis
Shengjing Hospital 900 participants Est. completion 2024-06-30 1 siteOther conditions: Solid Neoplasms, Non-Small Cell Lung CancerView official trial listing → -
Not yet recruiting NCT NCT07914855
Testing the Anti-cancer Drug DSP-5336 (Enzomenib) in Prostate Cancer
Not yet reported National Cancer Institute (NCI) 24 participants Est. completion 2029-01-04Other conditions: Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8View official trial listing → -
Active, not recruiting NCT NCT07917650
PET/CT-Guided Maintenance Therapy in Previously Untreated MZL
Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 45 participants Est. completion 2029-12-02 1 site Stand-aloneOther conditions: Marginal Zone Lymphoma(MZL)View official trial listing → -
Active, not recruiting NCT NCT07934056
PSMA-Targeting Dual-Target Radiopharmaceuticals for Prostate Cancer Imaging
Not yet reported The First Affiliated Hospital of Soochow University 30 participants Est. completion 2028-09-24 1 siteOther conditions: Prostate CancerView official trial listing → -
Enrolling by invitation NCT NCT07942090
Role of 68Ga-FAPI PET/CT in Patients in Whom 18F-FDG PET/CT Has Been Found to be Questionable or Inconclusive Due to Oncological Pathology
Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 200 participants Est. completion 2030-06-03 1 siteOther conditions: Lung Cancer Diagnosis, Head and Neck Cancer (H&N), Breast Cancer, Ovarian CancerView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
